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Abstract 
 
Maternal behaviour during the peri-partum period, albeit in differing forms, can be 
observed in all mammals, thus it must serve an important evolutionary purpose in 
enabling the successful raising of offspring. Maternal behaviour is comprised of a 
large suite of behaviours; in rodents these are generally defined as lactation, pup 
retrieval, maternal aggression and pup grooming. The maternal behaviour circuitry 
involves many brain regions including the hypothalamus and the limbic system 
which work together to regulate the motor, motivational and emotional demands of 
the lactation period. The main aim of this thesis is to understand how different 
neuromodulators, specifically oxytocin (OXT), vasopressin (AVP), allopregnanolone 
(AP) and GABA, influence the expression of maternal behaviour, especially 
maternal aggression, and where in the brain they act to control this.   
Maternal aggression in rats changes dramatically throughout pregnancy, 
parturition and lactation. This expression is highly influenced by pups and during 
early lactation, pup cues are essential in maintaining it. Towards the end of lactation 
pup cues appear to result in the down regulation of maternal aggression. The 
maternal aggression circuitry is highly complex and i volves many of the brain 
regions highlighted to be involved in maternal behaviour. The neuropeptides, OXT 
and AVP, are observed to have significant changes in their systems that correlate 
with maternal aggression, specifically within the BnST and PVN. This leads to the 
proposal they work oppositely to control maternal aggression by regulating fear and 
anxiety in the lactating rat. There is also evidence the OXT system mediates the 
motor output of maternal aggression. AP and GABA are lso important in maternal 
behaviour, especially in relation to fear; whether this in context with OXT to enable 
maternal aggression or if they are a back up mechanism for OXT secretion 
malfunctioning remains to be determined.  
By understanding the complex maternal behaviour neual circuitry and how 
neuromodulators work to control it, enables the development of potential therapies 
for disorders a woman may experience during the peri-partum period. Prevention of 
these disorders is not only beneficial to the mother and her immediate family but is 
also crucial for her offspring’s development in prevention of adulthood disorders 
stemming from their childhood experience which can impact their own paternal or 
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Chapter One: General Introduction 
1.1 Maternal Behaviour 
Maternal behaviour can be observed in all vertebrats from birds to rodents to 
humans. Although maternal behaviour expression varies greatly between species, it’s 
main objective to ensure offspring survival and hence that of the species remains the 
same. Maternal behaviour consists of a whole suite of behavioural components 
displayed during the peri-partum period which enable the successful raising of 
offspring; in rodents these are generally defined as [1]: 
• Pup retrieval – the process of picking up a pup in the mouth and moving it 
to the nest area. 
• Nursing – feeding pups by their attachment to the dam’s nipple and suckling 
to induce milk ejection.  
• Nest building – constructing a nest using suitable material (e.g. paper and 
wood shavings) that is used for birth and looking after pups. 
• Pup grooming and licking – general cleaning of the pups. 
• Maternal aggression – exhibition of offensive and defensive behaviour in 
defence of nest and pups from harmful con- or inter-specific intruder  
Each maternal behaviour component has distinct expression throughout the peri-
partum period often closely related to the physical and behavioural changes in the 
young as they develop (see appendix 1 for a brief description of changes to specific 
maternal behaviour components during lactation) [1, 2].  
Maternal behaviour expression is greatest immediately fter parturition but its 
display can be induced during late pregnancy in all primiparous and multiparous rats 
around 3.5h before parturition coinciding with the onset of vigorous uterine 
 2 
contractions [1, 3, 4]. These experiments imply that parturition is a critical time point 
when the physiological processes of pregnancy that prime the female for maternal 
behaviour become receptive to external cues to enabl  expression and maintenance of 
maternal behaviour i.e. sensory information at parturition stimulates an increase in 
maternal responsiveness [1, 5]. If the pelvic nerve is cut in hormonally primed 
pregnancy-terminated rats, they display a prolonged latency to express maternal 
responsiveness compared to intact sham controls leading to the hypothesis that pelvic 
nerve excitation (as occurs during parturition) enhances maternal responsiveness [5]. 
Oxytocin (OXT) secretion is indicated as the mechanism linking an increase in 
maternal responsiveness to pelvic nerve excitation because stimulation of the vagina 
and cervix is known to result in pituitary OXT release (the role of OXT in maternal 
behaviour onset is discussed further in section 1.4) [5].  
Maternal behaviour develops around parturition in all primiparous rats and mice 
with no differences observed compared to multiparous rats [6-8]. If the pups are 
immediately removed after birth then little maternal behaviour is expressed by the 
lactating rat in a subsequent maternal behaviour test with pups [1, 2]. However, 
maternal behaviour is expressed in virgin female rats but only after exposure to pups 
continuously for at least 7 days; a process known as pup-sensitization [4, 9, 10]. Thus, 
it may be proposed that the brain has evolved a mechanism to switch maternal 
behaviour on and off allowing the appropriate behaviour to be exhibited only at the 
correct life history stage. Rosenblatt and Lehrman (1963) therefore proposed that 
pregnancy ‘primes’ the rat ready for the onset of maternal behaviour but post-partum 
stimulation from pups is essential for full maternal behaviour development [1, 11, 
12]. The influence of these two mechanisms, the hormonal change of pregnancy and 
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parturition and pup cues, on maternal behaviour will be discussed in the next sections 
of this chapter.  
 It is essential to understand maternal behaviour because the maternal care a pup 
or young receives during their formative time can have lifelong behavioural and 
physiological consequences [13-22]. For example, th type of maternal separation (a 
stressor for pups) a female pup experiences during the post-partum period can 
programme their physiology, behaviour and anxiety lve s which then impacts upon 
the maternal care they display as adults [15]. Brief daily maternal separation (15 
min), when a pup, causes lower acute stress-induced anxiety behaviour and 
hypothalamic-pituitary-adrenal (HPA) axis activation during adulthood for a female 
rat, whereas long maternal separation (3h) result in higher levels [15]. Furthermore, 
female rats who experienced brief maternal separation as a pup exhibit greater 
maternal aggression and better maternal care than dams who experienced long 
periods maternal separation [15]. Maternal separation in both male and female mice 
when pups results in higher anxiety behaviour on the elevated plus maze (EPM), 
open-field and novel object exploration tests in adulthood [16]. Post natally stressed 
dams display poor maternal care which for male rat offspring results in heightened 
anxiety and aggressive behaviour during adulthood [23-25].  
It is not only the experience during the postnatal time period that is crucial in 
programming adult behaviour, but experiences during the prenatal period also have 
consequences. Prenatal stress for dams significantly increases anxiety behaviour in 
female offspring [17]. In adulthood, the female offspring of prenatally stressed dams 
display poorer maternal care during lactation themselves indicating prenatal stress in 
dams causes long-lasting behavioural changes in offspring. Prenatal stress also altered 
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the HPA axis as an increase in HPA axis activity is ob erved in the female offspring 
of prenatally stressed dams as compared to controls and virgins to a mild stressor 
[17]. Thus, pre- and post-natal experiences can programme HPA reactivity to 
stressors which can have lifelong consequences causing mood or behavioural 
disorders in offspring during adulthood; therefore it is important to understand how 
maternal behaviour is regulated to enable prevention and possible treatment of these 
disorders [14, 17].  
1.1.1 Non-hormonal influences on maternal behaviour  
There are two important features in the control of maternal behaviour 
highlighted by research into pup-sensitized virgin rats. The first is that the hormonal 
experience of pregnancy is essential for the full expr ssion of maternal behaviour. 
Virgin rats will not exhibit maternal behaviour unless sensitized to pups continuously 
for at least 7 days [10]. Pup-sensitization was concluded not to be due to changing 
circulating ovarian hormones levels as no effect of oestrous cycle stage or 
ovariectomy was observed on pup-sensitization latency [10]. However, when the 
intensity of maternal behaviour displayed was compared between intact and 
ovariectomised pup-sensitized virgin rats, it was ob erved that intact rats retrieved 
pups faster, built better nests and spent more time in the nest than ovariectomised rats 
[26, 27]. This suggests that the endocrine background of the ovarian hormone cycling 
rat enables improved maternal behaviour quality once maternal behaviour has been 
stimulated by pups [26, 27]. The long latency until v rgins express maternal 
behaviour is proposed to be due to the fear of pups virgin female rats normally exhibit 
and that they therefore must become habituated to the pups before they can express 
maternal behaviour [3, 28, 29]. For example, if virgin female rats are sensitized to 
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pups in a large cage compared to small, the latency to express maternal behaviour is 
greater as the rats are able to avoid pups and do not need to overcome their aversion 
[4].  
One of the main negative stimuli from the pups must be olfactory cues 
because anosmia (lack of olfactory functioning) in v rgin female rats reduces the 
latency to express maternal behaviour [4, 30]. In pregnant rats, it is assumed that the 
hormonal influences during pregnancy and at parturition reduce fear to enable her to 
express maternal behaviour immediately after birth (see section 1.1.2) [3]. Fear and 
anxiety are observed to decrease throughout pregnancy d into lactation with 
evidence from studies of behaviour on the EPM, in open field paradigms and from 
HPA axis responses [3, 29, 31-40]. Pup-sensitized virgin rats also cannot exhibit a 
full lactating posture because they do not experience the hormonal changes which 
induce milk production and nipple development so pups cannot attach to feed [4, 41].  
The second is that once maternal behaviour is initiated regardless of prior 
hormonal experience pup stimulation is essential for maternal behaviour maintenance 
and re-establishment [4]. Latency to retrieve pups is imilar to lactating rat levels 
once maternal behaviour is initiated in pup-sensitized virgin rats [2, 4, 41, 42]. No 
differences are observed in nest building or time sp nt in the nest between pup-
sensitized virgin female and lactating rats [4]. Previous maternal experience, 
irrespective of whether it had been lactation or pup-sensitization, was reported to 
reduce latency to express maternal behaviour when rats were presented with foster 
pups outside of the lactation period [4, 27]. This indicates that maternal 
responsiveness is rapidly switched on at the time of parturition, which is probably 
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controlled by hormonal factors, but once initiated maternal behaviour is maintained 
by pup cues [43].  
Pup-sensitized ovariectomised virgin rats provide a baseline of maternal 
behaviour expression under non-hormonal conditions with which the efficacy of 
exogenous hormonal applications in inducing maternal behaviour can be compared; 
this provides a useful model to try to understand the complexity of maternal 
behaviour regulation [44].  
1.1.2 Hormonal influences on maternal behaviour 
As pregnancy proceeds dramatic changes occur in the ovarian hormones (estrogen 
and progesterone) and the pituitary hormone, prolactin (Fig 1.1); it is these hormonal 
changes that are proposed to develop the ability for dams to express maternal 
behaviour [3]. Ovariectomy in late pregnant rats reduces the likelihood of maternal 
behaviour display by 50% indicating that ovarian horm nes are important in the 
initiation of maternal behaviour [45]. In non-pregnant ovariectomised rats, treatment 
with estrogen, progesterone and prolactin to resemble their fluctuations during 
pregnancy is able to significantly reduce the latency for maternal behaviour onset 
from 7 days when no hormonal manipulation to 35-40h [46]. Treatment with only 
estrogen and progesterone was also able to reduce maternal behaviour onset latency 
but not to the extent when all three hormones were administered together [46]. This 
was hypothesised to be due to stimulation of prolactin release by estrogen from the 
anterior pituitary [46-49]. Evidence of this hypothesis is that estrogen and 
progesterone implants releasing physiological amounts over a specific time (i.e. to 
mimic pregnancy) significantly reduced maternal behaviour onset latency [27, 50]. 
The same effect was observed even if the progesterone implant was removed prior to 
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estrogen treatment [27, 50]. Hence in both instances, application of exogenous 
progesterone and estrogen alone was able to reduce maternal behaviour onset latency 
without the need for exogenous prolactin. 
 From Fig. 1.1, it can be observed that circulating progesterone levels rapidly 
decline during late pregnancy whilst estrogen increases, so there is a rapid change in 
the estrogen to progesterone ratio. Thus it was proposed that progesterone withdrawal 
‘primes’ the pregnant rat to become sensitive to the estrogen rise which enables 
maternal behaviour onset [3, 46]. If hysterectomised, ovariectomised pregnancy-
terminated rats are treated with estrogen at the tim of surgery and later progesterone, 
rapid development of maternal behaviour occurred similar to hysterectomised 
pregnancy- terminated rats [44, 51]. (Hysterectomy causes a similar change in ratio of 
progesterone to estrogen as observed at late pregnancy). Furthermore, it was shown 
that treatment with estrogen alone in these hysterectomised, ovariectomised 
pregnancy-terminated rats was effective in reducing latency for maternal behaviour 
onset but the amount of estrogen required was supraphysiological [44, 51].  
Supraphysiological estrogen applications alone are also able to induce maternal 
behaviour in ovariectomised virgin rats whereas normal physiological doses could not 
elicit maternal behaviour [27, 46]. Physiological estrogen levels only induced 
maternal behaviour in hysterectomised and ovariectomised virgin rats if they had 
prior progesterone exposure and withdrawal, this is evidence that progesterone 
withdrawal reduces the estrogen threshold allowing normal pregnancy levels to 
facilitate maternal behaviour [27]. Withdrawal of progesterone is essential as 
maintaining high progesterone levels along with estrogen in an ovariectomised virgin 
rat inhibited maternal behaviour onset [52]. Injecting progesterone to prevent its  
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Figure 1.1: Circulating hormone levels during pregnancy, parturition and lactation in 
rats. Adapted from Gammie and Lonstein (2006) and Rosenblatt et al (1998) [53, 54].  
normal decline inhibited the rapid induction of maternal behaviour in hysterectomised 
only or hysterectomised, ovariectomised pregnancy-terminated rats treated with 
estrogen [27]. Administration of progesterone at the same time as supraphysiological 
estrogen levels to hysterectomised, ovariectomised virgin rats also inhibited maternal 
behaviour induction [27, 44].  
The change in the estrogen and progesterone ratio occurs at the same time 
point as maternal behaviour is first observed, justprior to the beginning of delivery 
(see results in chapter 4 of this study), and hence it was proposed to be the point of 
maternal behaviour initiation [3]. Hysterectomy to terminate pregnancy in rats was 
observed to cause an increase in maternal responsiveness [3, 44]. Ovariectomy at the 
same time as hysterectomy in pregnant rats increased the maternal responsiveness 
onset latency providing more evidence that these ovarian hormones are necessary for 
increased maternal responsiveness expression [3, 55]. At the end of pseudopregnancy 
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(when the animal displays signs of pregnancy along with similar hormonal changes, 
following mating with a sterile male, but is not actually pregnant), changes in 
circulating estrogen and progesterone levels resemble those of late pregnancy and 
during this time pseudopregnant rats express increased maternal responsiveness [3]. 
Estrogen levels start to rise around pregnancy day 15 and it is this early rise that is 
important for maternal behaviour initiation because ovariectomy performed on 
pregnancy day 20 or 21 does not prevent maternal beh viour development [51].  
This is not the complete story because although matern l behaviour was able 
to be induced in ovariectomised nulliparous rats with just estrogen and progesterone 
administration, it was a combination of estrogen, progesterone and prolactin which 
resulted in the shortest maternal behaviour onset latency [46, 50].  Also, 
hypophysectomised (to remove the source of prolactin) rats treated with 
estrogen/progesterone failed to reduce latencies to become maternal unlike 
estrogen/progesterone treatment alone indicating circulating pituitary hormones, such 
as prolactin, may be involved in maternal behaviour nset [56]. Prolactin is essential 
in maternal behaviour initiation because administration of bromocriptine, a dopamine 
agonist which prevents the release of prolactin, to estrogen and progesterone treated 
ovariectomised nulliparous rats blocked the rapid onset of maternal behaviour [57]. 
This block in rapid maternal behaviour onset also occurred when rats were 
hypophysectomised and in both cases this block could be prevented by application of 
prolactin [57-59]. This research supported the theory mentioned above that estrogen 
administration acts to enhance prolactin release, thus enabling reduced maternal 
behaviour latencies when only estrogen and progesterone were applied to the 
ovariectomised nulliparous rat [48-50]. The effect of prolactin on the initiation of 
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maternal behaviour was demonstrated to be dependent on having had prior experience 
of these ovarian hormones as prolactin administration alone in the nulliparous rat did 
not reduce maternal behaviour onset latency [57]. Furthermore, it was shown that a 
regimen of both estrogen and progesterone treatment was required, as giving either 
separately with prolactin did not result in the rapid onset of maternal behaviour [57, 
60].  
Central prolactin effects are crucial for maternal behaviour initiation because 
both ICV and direct medial preoptic area (MPOA) infusions of prolactin reduced 
maternal behaviour onset latency whereas systemic inje t ons had no effect [57, 60, 
61]. This effect on the initiation of maternal behaviour was not restricted to ovine 
prolactin as it also could be induced by human placental lactogen, rat prolactin and rat 
placental lactogens (I and II) [60-62]. Therefore th central actions of any lactogenic 
hormones maybe crucial for the onset of maternal behaviour, with recent research 
indicating that it is their interactions with the prolactin receptor are essential [60-62]. 
Mice with a null mutation for the prolactin receptor (allowing examination of 
behaviour without manipulating any lactogenic hormone level) exhibit a maternal 
behaviour deficit phenotype, especially in pup retrieval [63]. This was specific to 
maternal behaviour as no deficiency was observed in the water-maze, a spatial 
(cognitive) memory test [63]. In addition, ICV application of a specific prolactin 
receptor antagonist, S179D-PRL, blocked the rapid onset of maternal behaviour in 
estrogen, progesterone primed, nulliparous rats [64]. This remained the case when 
applied to the MPOA (a brain region significantly linked with maternal behaviour, 
see section 1.1.3) where dramatic changes in prolactin receptor immunoreactivity and 
mRNA expression are observed during the peri-partum period [64-66]. Hence the full 
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experience of the hormonal changes during pregnancy re required for the display of 
full maternal behaviour where rising levels of progesterone followed by its natural 
decline act in the brain to prime the rat to respond fully to rising estrogen and 
prolactin levels to initiate maternal behaviour.  
1.1.3 Maternal behaviour: brain circuitry  
Although the exhibition of maternal behaviour components may occur alongside 
each other (for example pup licking may occur whilst the dam is nursing) usually the 
brain is required to rapidly switch the expression from one maternal behaviour to 
another [67]. As each maternal behaviour results in its own specific motor output, it 
must therefore have its own unique neuronal circuity [67]. However, to ensure each 
behaviour is expressed appropriately, there must be some commonalities in these 
neural circuits which control the dynamic switch in maternal behaviour expression 
[67]. The brain must therefore have complex neural circuitry regulating maternal 
behaviour and research, using mainly lesion and immunocytochemistry (ICC) 
techniques, are elucidating brain regions involved an  which aspects of maternal 
behaviour they feature. Other techniques used include in-situ hybridisation (ISH), 
histochemical tracers and clinical brain imaging such as magnetic resonance imaging 
(MRI) and these may be mentioned as appropriate. 
Brain lesions destroy neurones and are generally performed in one particular 
region of the brain preventing the flow of information from that region to another; 
hence indicate that that brain region is required for the control of a specific behaviour. 
They can be performed in numerous ways including knife cuts, excitotoxic or 
electrical methods. Electrical lesions destroy both neurones and fibre projections of 
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the brain region whereas excitotoxic lesions just destroy specific neuron cell bodies 
[27].  
Another way researchers examine the maternal behaviour circuitry is to 
employ immediate early gene (IEG) ICC. The IEGs normally investigated include 
Fos, pCREB, Fos B and Egr-1 (also known as Zif). IEGs generate proteins which act 
as transcription factors and therefore link extracellular input signalling with genomic 
outputs. For example Fos can bind to the activator pr tein-1 site, which is on the 
promoter region of many genes, to induce their transcription [68-71]. A change in the 
electrical activity of a cell causes an immediate up regulation of IEGs [12]. Thus the 
ability to examine IEG expression within the rodent brain provides indirect evidence 
of neural activity in specific brain areas during exhibition of a behaviour of interest 
[12]. However it is important to note that IEGs only provide information about 
postsynaptic activity and cannot tell us about the nature of the synaptic input to these 
neurones [28]. Furthermore they only reflect activation in the brain region during the 
behaviour display of behaviour and provide no evidence of how it is regulating the 
behaviour [12, 28].  
The IEG, Fos, can be used in two main ways to investigate the maternal brain 
circuitry; the first is to observe if altered behavioural expression results from changes 
in functional subcellular mechanisms induced by Fos [70]. The second, and the 
method used in this thesis, is to map Fos expression in specific brain regions in 
rodents following exposure to different experimental conditions as an indicator of 
whether the neuron have been stimulated [70].  
The maternal brain circuitry is complex and involves many different brain 
regions highlighted by lesion or IEG studies (see Fig. 1.2). The next sections of this 
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chapter will examine these brain regions and discuss how the lesion and IEG studies 
provide evidence of how they are important and what t eir function may be in the 
regulation of maternal behaviour. 
1.1.3.1 Medial preoptic area and bed nucleus of stria terminalis 
The MPOA is a brain region described with varying roles in females and males, i.e. it 
is sexually dimorphic in nature. In male rats, only, the MPOA is essential for sexual 
behaviour [72-75]. In females, the MPOA is critical for maternal behaviour (although  
  
Figure 1.2: Schematic showing brain regions involved in maternal behaviour. Brain 
regions (filled pink circles) where c-fos expression is significantly higher in lactating rats and 
mice compared to virgin rats and mice. Abbreviations: BnST = bed nucleus of stria terminalis, 
LS = lateral septum, MPOA = medial preoptic area, NAcc = nucleus accumbens (this is linked 
to the ventral striatum which is also indicated as important in the maternal brain circuitry), OB 
= olfactory bulbs, PAG = periaqueductal grey area, SON = supraoptic nucleus and VMH = 
ventromedial hypothalamus.  
 
the MPOA does have links with parental behaviour in males) [72]. This could be due 
to the role of the MPOA in the regulation of prolactin release which is described 
above as essential in the onset of maternal behaviour [74, 76-78]. 
The MPOA is considered to play a central role in regulating maternal behaviour 
because both electrical and excitotoxic MPOA lesion disrupt most if not all 
components of maternal behaviour in rats [67, 79]. MPOA electrical lesions disrupt 
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maternal behaviour if performed pre- or post-partum in pregnant rats or in pup-
sensitized virgin rats or before maternal behaviour nset in hormonally primed 
pregnancy-terminated rats [27, 79-82]. Excitotoxic MPOA lesions in rats disrupt 
maternal behaviour indicating that MPOA neuronal cel bodies are important for 
maternal behaviour, and are not just part of the pathw ys that pass through the MPOA 
to different brain regions [27, 83]. In addition, electrical stimulation of the MPOA 
enhances the display of maternal behaviour [79].  
The bed nucleus of stria terminalis (BnST) is included in this section because it 
has been reported that MPOA excitotoxic and knife cut lesions which included the 
BnST, specifically the ventral part (vBnST), caused the greatest disruption of 
maternal behaviour [27, 67]. Specific vBnST lesions are also observed to impair 
expression of maternal behaviour, but only certain components, however this does 
highlight that the two brain regions may work together to regulate maternal behaviour 
[67]. Deficits in maternal behaviour caused by MPOA and vBnST lesions are 
unlikely to be caused by neuroendocrine changes becaus  disruption of maternal 
behaviour still occurs in hormonally primed and pup-sensitized MPOA lesioned 
virgin female rats [27]. These lesions also do not result in other behavioural 
dysfunction which might indirectly affect maternal behaviour as normal sexual 
behaviour, locomotion, body temperature and body weight regulation are observed in 
MPOA/vBnST lesioned rats [27, 82, 83].  The BnST is part of the limbic system 
which is essential for controlling emotional output [84-87]. Thus the importance of 
the BnST may be in controlling the emotional state of the mother during the peri-
partum period when there are dramatic hormonal and emotional changes [84]. 
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 Fos activation in the MPOA is higher following the maternal behaviour display 
in both mice and rats [9, 69, 88, 89]. Examination of expression of other IEGs in rats, 
namely Fos B and Egr-1, also show higher levels in the MPOA following display of 
maternal behaviour [69]. These IEGs have different patterns of expression during 
maternal behaviour exhibition; Fos was increased 2h following pup exposure and 
remained high during dam-pup interactions whereas Fos B expression significantly 
increased gradually as the duration of dam-pup interac ion increased [69]. Egr-1 
expression, by contrast, rose dramatically 2h after pup exposure but then decreased to 
basal levels following 4h of pup exposure [69]. The differences in Fos and Fos B 
expression patterns could be considered to be revealing short and long term maternal 
behaviour stimulation [69]. However, over time dam-pup interactions may change 
and the change in Fos-B expression may actually reflect these instead [69].  
Higher Fos expression in the MPOA of mice was unaffected by ovariectomy, 
therefore the ovarian hormones are not the only important neuroactive substances 
controlling the neural circuits regulating maternal behaviour [88]. Furthermore, 
removal of the noradrenaline source in the olfactory bulbs (OBs) did not affect Fos 
expression in the MPOA in mice, so we may conclude that information other than 
olfactory cues can activate this neural circuitry [88]. Interestingly, it was 
hypothesised that MPOA activity is controlled by the ‘maternal’ state because in 
lactating rats neither anomsia nor ventral desensitization by anaesthesia (removal 
sensory input from nipples and ventrum hence preventing somatosensory cues from 
pups) has any effect on Fos MPOA expression compared to intact control rats [89]. 
These results suggest the MPOA could be a brain region that is part of an ‘effector 
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mechanism’ which controls maternal behaviour but does not require sensory or 
olfactory input to regulate it [89].  
However this seems unlikely as Fos expression is higher in the MPOA of pup-
sensitized maternal virgin rats compared to non-matern l virgins. Therefore rats that 
experience only olfactory and sensory cues to ‘switch on’ maternal behaviour show 
increased activation of the MPOA [70]. This elevated Fos expression in pup-
sensitized maternal rats is greater than in rats exposed only to an inanimate object 
(marbles) emphasizing the necessity for all pup cues for MPOA IEG activation when 
hormonal influences are not available [70]. MPOA lesioned rats were unlikely to 
obtain pups where pups were a reward for using an operant bar press, but no 
difference was observed for food pellets in the same paradigm [79]. This suggests the 
MPOA is required to integrate the rewarding and reinforcing cues from pups to 
increase maternal behaviour in the primiparous rat [79].  
The MPOA and vBnST areas project to many specific brain areas which are 
also activated during maternal behaviour display in the rat [90]. The main MPOA 
projections activated during maternal behaviour were to the medial hypothalamus 
(MH) and the lateral septum (LS) and are proposed to be involved in an inhibitory 
circuit which acts on these areas to reduce fear and anxiety towards pups [90]. vBnST 
projections that are activated during maternal behaviour include the ventral tegmental 
area (VTA), the retrorubral field (RRF) and the periaqueductal grey area (PAG) [90]. 
The VTA and RRF are linked to the with dopaminergic system involved in 
motivation, which indicates that the vBnST projections are important for the 
motivation to express maternal behaviour [90]. The projections to the PAG from both 
the MPOA and vBnST may also play an important role in pup retrieval behaviour as 
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the PAG itself projects directly to the trigeminal sensory complex, as does the RRF 
[90-92]. Lesioning of the trigeminal nerve in the lactating rat significantly disrupts 
most if not all oral motor maternal behaviour functions such as pup retrieval, licking 
and grooming [93]. This is probably due to the loss f ufficient somatosensory inputs 
to the snout from the pup to cause the jaw opening relex to pick up the pup [93]. 
Examination of 14C-2-deoxyglucose (2-DG) uptake is an indication of activity 
of nerve terminals and hence provides information about inputs into specific brain 
regions [28]. 2-DG is a radioactively labelled glucose molecule with hydrogen 
replacing one of its hydroxyl groups; this means it cannot be broken down any further 
by enzymes hence when taken up into the active presynaptic neuron for energy it 
remains there and levels can be read by autoradiography. If investigated alongside 
Fos expression (that reflects post synaptic activity) this uptake enables researchers to 
interpret the nature of the input-output relationship of that specific brain region during 
expression of a particular behaviour [28]. In post-partum, pup-sensitized or 
hysterectomised maternal rats, it was observed that increased 2DG levels correlated 
with increased post synaptic activity in the MPOA compared to non-maternal controls 
suggesting an excitatory input-output relationship and highlighting the importance of 
the MPOA in maternal behaviour control irrespective of the trigger for maternal 
behaviour onset [28].   
1.1.3.2 Amygdala 
Like the BnST, the amygdala is part of the limbic system and is crucially involved in 
the control of emotion [94-97]. As previously described the peri-partum period is an 
intense time of hormonal and physical changes along with new environmental 
demands, i.e. the caring for offspring, thus it is es ential for the emotional state of the 
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mother to be stable. This does not only benefit the mother in her ability to care for the 
offspring but can also have important consequences for the mental and physiological 
development of the offspring as well. Therefore thefunction of the amygdala in 
control of emotion, especially fear and anxiety, could explain why it is linked with an 
important role in the regulation of maternal behaviour regulation.  
Virgin rats are fearful of pups thus it is hypothesis d that the amygdala during 
pregnancy and lactation acts to decrease fear and anxiety to allow maternal behaviour 
[29]. This was deduced because whole amygdala lesions reduced withdrawal from 
pups and fear display in the open field test [79]. Fos activation is also observed to be 
significantly higher in the amygdala following pup exposure in pup-sensitized 
maternal mice [88]. However, the amygdala is composed of many different sub-
regions with various functions. Therefore although w ole amygdala lesions were 
observed to facilitate maternal behaviour it was proposed this was due to the removal 
of the inhibitory stimulus from medial amygdala (MeA) to the MPOA via the BnST 
[79]. Further evidence that the MeA specifically inhibited maternal behaviour was 
that Fos expression was increased in the MeA of pup-exposed non-maternal virgin 
rats compared to pup-sensitized maternal virgins [70].  
The MeA receives a direct input from the OBs and relays the information to 
the MPOA and BnST; anosmia in virgin rats is known to reduce pup-sensitization 
latency, so the MeA is considered to receive these aversive olfactory stimuli from 
pups and inhibits maternal behaviour [30, 70]. MeA l sions not only significantly 
reduce Fos expression in brain areas stimulated in pup-exposed but non-maternal 
virgin rats but, along with lesions of the anterior hypothalamic nucleus and 
ventromedial hypothalamic nucleus, lead to stimulation of maternal behaviour in non-
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maternal virgin rats [98]. Other studies have also observed this disinhibition of 
maternal behaviour, including pup retrieval and general pup interaction, in virgin rats 
following MeA lesions [89, 99, 100]. Thus, the MeA works to inhibit maternal 
behaviour in virgin female rats and this is proposed to be overcome by the hormonal 
changes during pregnancy to allow normal maternal behaviour expression at 
parturition in the lactating rat [9]. 
Nonetheless, Fos expression was also specifically elevated in the MeA in the 
lactating rat re-exposed to pups after 3 days of separation [89]. Anosmia in lactating 
rats resulted in lower Fos expression in the MeA indicating that the MeA may be 
important in the interpretation of olfactory stimuli from pups, and enabling maternal 
behaviour during lactation [89]. 2-DG was positively correlated with Fos in the MeA 
in post-partum rats but negatively in pup-sensitized virgin rats. In pup-sensitized 
virgins, increased Fos activation with decreased 2-DG activity in the MeA suggests 
that the pup-sensitization process decreases the inhibitory input to the MeA thereby 
disinhibiting projections to the MPOA and creating an excitatory input-output 
relationship with the MPOA [28]. In post-partum rats i  is speculated that sensory 
information from uterine contractions during parturition helps overcome this 
inhibitory input to result in an excitatory one [28]. This is because Fos and 2-DG 
activity was significantly increased in post-partum rats in the MPOA, MeA, BnST 
and ventromedial hypothalamus (VMH) compared to controls (non-maternal virgin 
rats) and these areas show higher Fos expression in conjunction with birth canal 
stimulation [28]. Also, hormones are unlikely to bethe cause of the change in the 
input nature because pregnancy-terminated rats, which experience the hormonal 
changes of pregnancy until surgery but not parturition, do not display a change in 2-
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DG activity compared to controls [28]. Therefore, during the virgin state the MeA 
works to inhibit maternal behaviour but once suppressed allows maternal behaviour 
expression at parturition, the MeA appears to help maintain normal maternal 
behaviour during lactation.  
Lesions of the cortical part of the amygdala also di inhibit maternal behaviour 
in virgin rats [89, 99]. Furthermore, olfactory desen itization in the lactating rat 
resulted in lower Fos expression in the cortical amygdala after pup exposure. This 
indicates that that, just like the MeA, the cortical amygdala works to interpret 
olfactory information to help regulate maternal behaviour [89]. 
The olfactory processing by the MeA and cortical amygdala are not the only 
parts of the amygdala that are linked with the regulation of maternal behaviour. The 
basolateral amygdala (BlA) is important for learning, memory and memory 
reinforcement, especially in relation to emotional and olfactory memories [89, 94, 
101-103]. Thus it is suggested that the BlA is important for attainment of maternal 
memories and experience [89]. Fos expression within e BlA is observed to be 
significantly higher in lactating rats following pu interactions compared to lactating 
rats that had social contact with a conspecific or no pup/social interaction [89, 104]. 
Sensory desensitisations (anosmia and ventral desensitization by anaesthesia) lead to 
significantly lower Fos expression in the BlA of lact ting rats during pup interactions 
[89]. Furthermore the level of Fos expression was dependent in the BlA on the type of 
pup interaction the lactating rat experienced; exposure to pups in a box increased Fos 
in dams compared to those who just interacted with the box but highest expression 
was observed in dams that had physical contact with pups [89]. Fos expression within 
the BlA was higher in experienced lactating rats (i.e. that had prior exposure to pups) 
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than inexperienced lactating rats upon re-exposure to pups whether the pups were in 
the cage or a box [104]. No changes in Fos expression were observed in the MeA, 
cortical or central amygdala (CeA) [104]. Therefore th  BlA activation during the 
initial pup interaction is proposed to be essential for the acquisition of maternal 
memory or experience necessary for the following pup exposures to initiate maternal 
motivation to care for the pups.  
One final region of the amygdala important for maternal behaviour regulation 
is the CeA. The CeA, like the BlA, is important in emotional and olfactory memory 
processing as well as memory reinforcement [94, 104]. Sensory desensitization was 
also observed to result in significantly lower Fos activation during pup interactions in 
lactating rats compared to normal lactating rats [104]. This indicates that like the BlA, 
the CeA is important in processing sensory information about pups to create maternal 
memories essential for maternal motivation. However, the CeA is also known to be 
important for the control of emotional behaviour esp cially in short term cue specific 
responses (whereas the BnST is more involved in the long term non cued 
consequences) [84, 105]. Thus, the CeA may also be involved in controlling 
emotional responses, along with the BnST, to enable normal maternal behaviour 
expression. 
The MeA and cortical amygdala therefore work to inhibit maternal behaviour 
in the virgin rats however in the lactating rat theM A, cortical, BlA and CeA work to 
integrate and process sensory and olfactory information for maternal experience or 




1.1.3.3 Paraventricular nucleus  
Situated adjacent to the third ventricle in the anterior hypothalamus is the 
paraventricular nucleus (PVN, see appendix 3). The PVN is an essential region of the 
brain because it is able to produce and control the rel ase of many neuroactive 
substances from its neurones simultaneously [106]. The PVN is made up of thousands 
of cells which can be divided into three main groups, magnocellular, parvocellular 
and ‘autonomic cells’, based on their morphology and projections. The large 
magnocellular cells comprise the hypothalamic-neurohyp physial system (HNS) 
which project to the posterior pituitary where they release OXT and vasopressin 
(AVP) to control and influence multiple functions including blood osmolality and 
physiological stress responses [106-108]. The ‘autonomic cells’ of the PVN carry 
mainly oxytocinergic and some AVP, projections to the brain stem and spinal cord 
which impact upon cardiovascular functions, analgesia, food and water intake, and 
gastrointestinal functions [106, 109-117]. Finally, the parvocellular neurons of the 
PVN produce a number of neuromodulators including corti otropin releasing factor 
(CRF), thyrotropin releasing hormone, vasoactive intestinal polypeptide, 
cholecystokinin, substance P, neurotensin, enkephalin, growth hormone releasing 
factor or angiotensin II [106, 110, 118-122]. Thus the parvocellular neurones of the 
PVN can influence body metabolism, body temperature and food intake [106, 109, 
112-115, 123].  
The parvocellular neurones also project to the median eminence where CRF 
acts on the pituitary corticotrophs to elicit ACTH response, along with AVP from the 
PVN, to initiate the secretion of glucocorticoids from the adrenal cortex into the 
bloodstream [107, 108, 124]. This system is known as the HPA axis and controls the 
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homeostasis of the body response to stress which the PVN, therefore, has a primary 
role in the controlling body’s stress response [107, 125]. The HPA axis was initially 
thought to be dependent entirely on the parvocellular PVN neuron activity but the 
discovery that the magnocellular PVN neurones of the HNS can release OXT and 
AVP from dendrites lead to the indication the HNS can also impact upon HPA axis 
functioning [126-129]. Dendritic OXT or AVP release from magnocellular PVN 
neurones is proposed to influence the HPA axis by affecting both parvocellular and/or 
magnocellular neuron activity either directly or indirectly within the PVN [107]. 
Local release may also be able to diffuse out into the brain and affect other limbic 
brain regions in their response to stressors [107]. The PVN is known to have essential 
actions on nursing behaviour alone, but for the purpose of this thesis the focus will be 
on relating PVN activation to maternal behaviour in general (for reviews on the PVN 
and its role in lactation and parturition specifically please see [130, 131]).  
As the PVN receives input from the MPOA, it was hypothesised to form part 
of the maternal behaviour circuitry [80, 132]. However, no effect on maternal 
behaviour was observed following knife cuts of the lateral PVN connections (i.e. 
destroying the MPOA to PVN pathway) and PVN radiofrequency lesions in lactation 
day 4 rats [133]. These PVN lesions significantly disrupt the milk ejection reflex 
indicating the PVN is important for nursing behaviour, but they are not necessarily 
involved in the pathway that the MPOA acts upon to enable maternal behaviour [80, 
133]. Yet these lesions were made during the lactation period, so the PVN may play a 
role in the initiation of maternal behaviour [80, 133]. Indeed, electrolytic PVN lesions 
performed on pregnancy day 15 prevents the initiation of maternal behaviour whereas 
there is no effect if this is performed on lactation day 4 [134]. Kainic acid lesions on 
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lactation day 2 disrupted retrieving as well as nursing behaviour and these effects 
were probably due to kainic lesions destroying local cell bodies but not affecting fibre 
projections [132]. As only retrieval and nursing behaviours were disrupted, the PVN 
may only play a minor role in the regulation of maternal behaviour [132].  
However the PVN does have a crucial role in the control of the HPA axis 
activity which during pregnancy and lactation is observed to be significantly altered 
[37]. Basal circadian rhythm HPA activity is significantly changed from early 
pregnancy with lower corticosterone and ACTH release in rats [37, 135]. By late 
pregnancy, HPA responses to both physical and emotional stressors are depressed but 
late pregnant rats have an increase in corticosterone release [37, 38, 137-139]. 
However there is also an increase corticosterone biding globulin levels which 
reduces amount of free and therefore active corticoster ne in blood compared to non 
pregnant rats [37, 38, 135-137]. The depression of the HPA axis response during 
pregnancy is proposed to be essential for the fetus in protecting it from harmful 
excess glucocorticoid exposure [36, 138].  
Altered HPA activity remains until late lactation however now basal activity 
is increased with greater secretion of ACTH and corti sterone observed but 
hyporesponsitivity to stressors remains [37, 135, 139]. The increased basal activity is 
induced by pups suckling and hence may be related to the necessicity of  
glucocorticoid actions on cells that produce milk [37]. The hyporesponsive HPA axis 
activity is proposed to be due to change in central p ocessing of a perceived stressor 
rather than stimulation of ACTH and corticosterone release because ACTH and 
corticosterone secretion is still rapidly induced by suckling even after a period of 
separation during lactation period [37, 139]. During the post natal period, this reduced 
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HPA activity is proposed to be result in a reduced f ar and anxiety phenotype 
required to enable maternal aggression (see section 1.2.2.3.1 for further discussion).  
1.1.3.4 Periaqueductal grey 
The PAG, as mentioned in the section on the MPOA and B ST, is directly linked to 
the trigeminal sensory complex which controls motor output of the body [90-92]. 
This important function of the PAG may be essential in regulating the motor output of 
maternal behaviour. The PAG receives direct projections from the MPOA and vBnST 
which show increased Fos activation during maternal behaviour display [90]. Lesions 
of the caudal PAG in the rat have shown to be important for kyphosis (upright 
crouching nursing behaviour necessary for optimal weight gain in pups), which is 
induced by suckling [140]. Fos activation in the caud l PAG is increased in rat dams 
by the suckling stimulus compared to dams anaestheti ed in the perioral area, whereas 
Fos expression increases in the rostral PAG after display of retrieval and licking 
behaviour [140]. Lesions of the rostral PAG did notaffect maternal behaviour or the 
ability to pick up and move pups but did impair theability of the rat dam to release 
pups [140]. Therefore different PAG regions are important for the motor control of 
the specific maternal behaviour components (e.g. nursi g posture) via their ability to 
process sensory information in the rat [140]. 
 The PAG is also important in controlling specific motor responses to different 
forms of stressors, including offensive and defensive reactions [141-145]. Thus the 
PAG may be important for maternal aggression expression in response to an intruder 
which is threatening towards offspring survival (see section 1.2.3.3.3 for further 
discussion).   
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1.1.3.5 Nucleus accumbens 
The nucleus accumbens (NAccs) is, like the BlA and CeA, is involved in the 
formation of emotional memories and associative learning [89, 146, 147]. Fos 
expression is  significantly increased in the NAccs following pup exposure in 
lactating rats regardless of previous maternal experience; hence the NAccs function in 
the maternal behaviour circuitry was proposed to be involved in “maternal memory” 
[89, 148, 149]. Electrolytic lesions of the NAccs shell, but not the core, disrupt 
“maternal memory”, which is defined as the process of retaining maternal experience 
[150]. Further to this Li and Fleming [150] reported that lesions of the shell of NAccs 
extended the time to retrieve all pups. This effect was consistent across a range of 
conditions from length of previous maternal experience, influence of hormones, and 
pre- or post-partum lesion, thus emphasising the importance of the NAccs in pup 
retrieval behaviour [150]. Therefore, owing to the NAccs functions in attention and 
motivational behaviour as well as memory formation, the lesions during the peri-
partum period that disrupt retrieval behaviour could be a result of the lesion affecting 
the NAccs shell to retrieve maternal memories working to motivate the mother to 
perform pup retrieval behaviour [89, 104, 150].  
1.1.3.6 Lateral septum 
The situation of the lateral septum (LS, see appendix 2) means it is a focal point in the 
brain receiving inputs from the prefrontal cortex, entorhinal cortex, hippocampus, 
amygdala, hypothalamus and BnST and projecting to diencephalic and mesencephalic 
regions [151]. Thus the LS is involved in many brain functions including social 
behaviours, HPA activity, cardiac function, thermoregulation, spatial cognition and 
pain [151-166]. The role of the LS in influencing social behaviours means that it has a 
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crucial role in maternal behaviour. It is proposed that the LS regulates behavioural 
functions rather than directly mediating them i.e. t collates the sensory information 
the brain is receiving from various regions, working out its relevance and then relays 
the most relevant information to other regions which then mediate the correct 
behavioural response [151]. This means that the appropriate behaviour response is 
expressed in relation to the surrounding environment [151].     
Lesions of the septum in mice produced profound deficits in maternal 
behaviour whereas lesions of the cingulate cortex or thalamus had little or no effect 
[167]. This was observed not to be a consequence of m tor or motivational 
impairment in performing maternal behaviour but to result from the inability to 
inhibit all maternal behaviour responses other than the required one to deal with the 
pup situation [167]. Similar results were also observed in rats by Flannelly et al [168]. 
However, these lesions affected the whole septum which is made up of many distinct 
sub-regions; each of these may be involved in a more specific aspect of maternal 
behaviour. The LS, for example, is suggested to be critical only for the expression of 
one component of maternal behaviour, specifically maternal aggression, and this will 
be described in more detail in section 1.2.3.2 [67]. 
There are many brain areas involved in maternal behaviour, some with a 
general role, for example MPOA and BnST; others with a specific function in 
controlling exhibition of a specific component of maternal behaviour (e.g. NA and 
LS, see Fig 1.3). However, although these lesion and IEG studies highlight the 
importance of several brain regions in maternal behaviour, they do not provide 
information about what neuromodulators may be activting or inhibiting these brain 
areas to cause the expression of maternal behaviour. Whilst other maternal behaviours 
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can be induced in non-hormonally primed virgin female rats to levels similar to that 
of lactating or hormonally primed rats, maternal aggression is never expressed at 
equivalent levels without hormonal manipulation and therefore provides an excellent 
behaviour to examine if neuromodulators applied to rats are inducing the maternal 
‘state’ [3, 4, 41]. Hence, this thesis decided to focus on maternal aggression and to 



























































































































































































































































Figure 1.3: Schematic of maternal brain circuitry. Based upon Fig. 8 from Numan 
(2007)[9]. Flow diagram depicting how the brain regions linked with maternal behaviour may 
work together to control and regulate the different aspects of maternal behaviour expression. 
Although the functions of some regions in the maternal behaviour circuitry are established 
such as the BlA involvement in maternal memory and the NAccs controlling maternal 
motivation, it still remains unclear how maternal aggression is controlled within the brain 
(indicated by ? on the flow diagram). Also there are still questions about how the brain 
regions linked with controlling fear and anxiety under normal circumstances work during 
lactation to result in a reduced fear and anxiety phenotype. Abbreviations: AOB = accessory 
olfactory bulb, BlA = basolateral amygdala, CeA = central amygdala, MB= maternal 
behaviour, MOB= main olfactory bulb, MeA= medial amygdala, MPOA= medial pre-optic 
area, NAcc= nucleus accumbens, PAG= periaqueductal grey area, PVN=paraventricular 
nucleus, RRF= retrorubral field, SON=supraoptic nucleus, vBnST= ventral part of bed 
nucleus of stria terminalis, VTA= ventral tegmental area. 
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1.2 Maternal aggression 
Maternal aggression was first reported as early as the 1940s when researchers 
described informal observations of wild and laboratry lactating animals of various 
species fiercely defending their offspring from intruders (cited in [169]). However it 
was not until the early 1970s that any systematic research was performed into 
maternal aggression in rodents with unequivocal results, and since then maternal 
aggression has been clearly defined in mice, rats, hamsters and pigs [6, 169-178]. 
Gandelman [169] reported that lactating mice displayed intense aggressive behaviour 
towards novel conspecific intruders of both sexes more than virgin female mice; this 
aggressive behaviour was expressed most strongly during early lactation (days 3-13) 
and had virtually disappeared by lactation day 21. In rats, the same pattern of 
aggressive behaviour display during lactation was ob erved; there was a peak just 
following parturition with a second peak around lactation day 9 before disappearing 
by lactation day 21 [168, 179]. Furthermore, in rats maternal aggression could be 
observed in pre-partum rats on pregnancy day 22 just hours prior to birth; the same 
time as maternal responsiveness is observed [180]. Female rats provide the best 
model (the one used in this thesis) to understand the control of maternal aggression 
for a number of reasons:  
• Female rats are generally sociable and therefore are no mally grouped 
housed in the laboratory with no aggressive behaviour displayed [181]. 
• Maternal aggression is generally only expressed by the rat during the peri-
partum period whereas in mice and hamsters aggressive behaviour is 
observed outside of this period [3, 175]. 
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• Maternal aggression in the virgin rat cannot be induced to lactating rat levels 
by pup-sensitization alone without hormonal manipulation, whereas mice 
only require a short pup exposure time before expressing maternal 
aggression [3, 182]. 
 Research from mice will also be discussed to highlight the point that maternal 
aggression is important for offspring survival but is under diverse control in different 
species [27]. As maternal aggression is expressed during a short time span in the rat, 
normally from late pregnancy until mid-lactation, neural circuitry activation must 
only be temporary and consequently it is proposed that maternal aggression is 
induced by the dramatic hormonal changes that occur during the peri-partum period 
[12]. However, studies have shown that non-hormonal influences are also important 
for maternal aggression. The next sections will describe and discuss the influence of 
the different hormonal and non-hormonal factors on maternal aggression regulation 
and expression. 
1.2.1 Hormonal influences on maternal aggression  
Maternal aggression levels in pup-sensitized virgin female rats are always 
significantly lower than lactating rats; thus it was proposed that, as maternal 
aggression is a component of maternal behaviour, the changes in ovarian hormones 
(estrogen and progesterone) and the pituitary hormone, prolactin, during pregnancy 
are required to induce the full and vigorous display of maternal aggression [3, 173, 
183]. Hence, the hormonal manipulations which induce maternal behaviour 
(discussed in section 1.1.2) could also facilitate maternal aggression. Mayer and 
Rosenblatt [183] showed that maintaining high circulating estrogen levels during late 
pregnancy or elevating estrogen in pup-sensitized non-pregnant rats caused higher 
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maternal aggression than in rats where an estrogen ris  was prevented, whether 
pregnant or not prior to pup exposure. This indicates that estrogen in pregnant rats 
works to heighten aggressive behaviour [56, 173, 183-185]. Furthermore once 
maternal behaviour was initiated (i.e. after rats were exposed to pups), all pregnant or 
pregnancy-terminated rats displayed maternal aggression regardless of whether they 
had done so before pup exposure and were more likely to show maternal aggression 
than pup-sensitized virgin rats [183]. The level of maternal aggression was lower 
prior to pup exposure than after it indicating that ovarian hormones may ‘prime’ the 
rat ready to express maternal aggression, but for a full display of aggression pup 
exposure is also required [183]. However, pregnancy-terminated rats (by 
hysterectomy and ovariectomy) treated with oil were not aggressive until 3-4 days 
following surgery when circulating estrogen levels would be low as a result of 
ovariectomy [183]. Thus other neuromodulators during the pre-partum period must 
have some function in maternal aggression onset; thse could include pituitary 
hormones [183].  
Hypophysectomy in rats on lactation day 4 has no effect on levels of maternal 
aggression observed on lactation day 9 or the normal maternal aggression level 
following pup removal or re-introduction [173]. Also, if hypophysectomy is 
performed earlier (i.e. on post-partum day 2), there is still no reported effect on 
maternal aggression across the entire lactation period [186]. These results suggest that 
circulating pituitary hormones are not necessary for p st-partum stimulation of 
maternal aggression or to help maintain sensitivity to presence of the litter that 
modulates maternal aggression similar to the maintenance of maternal care, but do 
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not rule out a role in ‘priming’ the rat for maternal aggression expression pre-partum 
[173].  
Maternal aggression can be induced in non-pregnant female rats by prolonged 
treatment with estrogen and progesterone, followed by progesterone withdrawal (as 
occurs in late pregnancy) whilst being exposed continuously to pups compared to 
pup-sensitized virgin female rats [56]. (Comparisons were only made between 
hormone treated pup-sensitized female rats and pup-sensitized only female rats, and 
only the attack behaviour was reported so it was not possible to conclude if the 
maternal aggression expression observed was similar to that in lactating rats [56]). 
This is not mediated by circulating pituitary hormones as the maternal aggression 
exhibited was unaltered in hypophysectomised female r ts treated with the same 
hormonal course, and was significantly greater thanin vehicle treated rats [56].  
Progesterone withdrawal during late pregnancy, as for maternal behaviour 
onset, is proposed to be essential in enabling maternal aggression [56]. This was 
hypothesised because in two studies, the timing of the progesterone withdrawal in 
estrogen/progesterone treated in non-pregnant females resulted in different maternal 
aggression levels. Progesterone withdrawal 3 days prior to aggression testing resulted 
in a significant increase in maternal aggression prior to pup exposure but when 
progesterone was withdrawn only 1 day prior to testing no increase in maternal 
aggression was observed [56, 187]. During pregnancy, progesterone levels begins to 
decrease around day 20 (Fig. 1.1), so behavioural testing only one day after removal 
of progesterone may not be long enough for progesterone levels to have dropped fully 
to allow maternal aggression expression [3, 56]. 
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Pregnancy termination on gestation day 19 by hysterec omy and ovariectomy 
did not prevent the ability of the rat to initiate maternal aggression even after delay of 
exposure to pups, however it was observed that maternal behaviour must have 
commenced before maternal aggression was displayed [184]. Thus it appears in the 
rat the ovarian hormonal experience of pregnancy induces long lasting changes which 
prepare the mother for maternal aggression [184]. However, non pregnant rats treated 
with estrogen and progesterone for 16 days to mimic pregnancy do not exhibit 
maternal aggression if pup exposure is delayed. Therefore estrogen and progesterone 
changes throughout pregnancy are not the only factors that prepare dams to be able to 
display maternal aggression and maternal behaviour [184].  
In mice, the control of maternal aggression by ovarian hormones is not as 
crucial. Mice show little maternal aggression during pregnancy but there is a dramatic 
increase in intensity after parturition [188]. Estrogen levels rise immediately 
following parturition in mice before falling again and if mice are subjected to an 
ovariectomy during this time they exhibit more intensive aggression post-partum than 
intact mice therefore estrogen may prevent maternal aggression in mice [188, 189]. 
Furthermore, estrogen treatment in ovariectomised or lactating mice reduces maternal 
aggression thus indicating it is the estrogen surge just following parturition that 
inhibits maternal aggression in mice [188, 189]. Progesterone administration during 
lactation has no effect on maternal aggression in mce but during pregnancy 
progesterone enhances maternal aggression [188, 189]. Thus in mice estrogen works 
to inhibit maternal aggression during lactation whereas progesterone facilitates it 
during pregnancy, this is the opposite to effects ob erved in rats where estrogen is 
required to enhance maternal aggression during lactation and progesterone 
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withdrawal at late pregnancy is required for initiat on of maternal aggression [56, 
173, 183, 184, 186, 189]. In mice, sensory stimulation (as discussed in the next 
section) appears to be more important in inducing maternal aggression rather than the 
ovarian hormonal changes of pregnancy [188].   
1.2.2 Non-hormonal influences on maternal aggression  
Non-hormonal influences, including both sensory andolfactory cues, are important in 
maternal aggression expression in rodents, and the most important of these cues come 
from the pups. In mice, suckling experience for 24-48h is essential before maternal 
aggression develops [6]. Furthermore, pup-sensitized virgin female mice will display 
maternal aggression at levels comparable to lactating mice which is not the case for 
rats [3, 182]. Removal of pups in both rats and mice has been observed to diminish 
maternal aggression intensity [169, 179, 190]. Furthermore, the re-introduction of the 
pups to lactating mice or rats re-instates maternal aggression [6, 179]. Pup cues are 
essential in re-establishing maternal aggression and influence mice and rats very 
differently; for mice olfactory cues for pups are enough to re-instate maternal 
aggression whereas rats require both sensory and olfactory stimulation (for further 
discussion on the influences of pup on maternal aggression expression see the 
introduction for chapter 3).  
Other non-hormonal factors that influence aggression include pup age, 
intruder age and sex and the test arena. Lactating rats who fostered older pups during 
early lactation displayed less maternal aggression tha lactating rats with normal aged 
pups; furthermore if a dam towards the end of lactation was given young pups (aged 8 
days), maternal aggression increased to early lactation levels [191]. However, these 
dams required at least 5 days of fostering before maternal aggression was tested. 
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Therefore it could be that pup independence, rather an age per se, influenced 
changes in maternal aggression intensity [191]. In mice, older juvenile intruders (20-
40 days old) elicited a greater expression of matern l aggression towards them than 
young intruders (1-10 days old) [6, 188]. It was proposed that possibly hair growth, 
an age-related physical change, may be a causative f ctor in eliciting a higher level of 
maternal aggression [6]. Indeed, hairless mice were attacked less often than age-
matched control mice so a change in physical appearance consistent with maturation 
in mice provokes a certain level of maternal aggression [6]. Maternal aggression was 
greater towards adult male intruders aged 35 or 45 days than those aged 55 or 110 
days in lactating rats [192]. This could have been for a number of reasons, one is that 
the older males were much larger and maternal aggression is shown be greater against 
younger and smaller intruders [192, 193]. Another is that older males displayed 
aggressive behaviour towards the lactating rat and this may have decreased maternal 
aggression [192]. Pheromones can also change with age and it may be that older 
intruders produce pheromones that diminish maternal aggression; however, this is 
unlikely to be androgen based as testosterone levels ar  significantly decreased in 55 
day old male rats compared to 110 day old rats, yet they elicit same similar levels of 
maternal aggression [192]. 
Sex of the intruder during early lactation in mice appears unimportant for the 
intensity of maternal aggression; however in later lactation male intruders elicit a 
greater level of maternal aggression displayed towards them than females [6, 169]. 
Primiparous mice and rats are as aggressive as multiparous animals, thus parity has 
no influence on the intensity of maternal aggression expressed [6, 7]. Lactating rats 
are thus far more aggressive in their home cage than in  novel setting hence a novel 
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environment can inhibit aggression but no difference was observed with different 
sizes of home cage [185, 192].  
 Pup-sensitized virgin female rats express low levels of maternal aggression if 
tested 9 days after becoming maternal, however if they are exposed to pups for at 
least 18 days maternal aggression is expressed at similar levels to lactating rats [172]. 
This prolonged exposure resulted in a pseudopregnant st te, so hormone changes 
similar to pregnancy occurred, possibly enabling the display of maternal aggression 
[172]. Another point is that the initiation of maternal behaviour in pup-sensitized rats 
did eventually enable maternal aggression, while oth r studies have also observed an 
increase in maternal aggression in non-pregnant pup-sensitized rats compared to 
nulliparous controls, indicating that the experience of maternal behaviour can 
facilitate the onset of maternal aggression [174, 18 ]. 
The current view for the control of maternal aggression in the rat is that 
pregnancy ‘primes’ the brain ready for expression, but the onset of maternal 
behaviour by pup stimulation is required before the full suite of maternal aggression 
components can be initiated [12, 27, 184]. However, for mice hormonal influences 
appear to be unimportant and it is the suckling experience itself that controls maternal 
aggression onset [188]. 
1.2.3 Neural circuitry of maternal aggression 
Many brain regions are involved in the maternal brain circuitry and they each have a 
complex role in regulating either general maternal behaviour expression or a specific 
maternal behaviour. The roles of specific brain regions in maternal aggression have 
been investigated recently, using the techniques described in section 1.1.3 for the 
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study of maternal behaviour, and the sections below will outline their possible 
involvement.  
1.2.3.1 Medial preoptic area and bed nucleus of stria terminalis 
Interestingly, although there is strong evidence through lesion and IEG studies that 
the MPOA and the BnST are essential for regulating a d instigating the expression of 
most components of maternal behaviour, few studies have examined their effect on 
maternal aggression. Hence little is known about the potential roles of the MPOA and 
vBnST in maternal aggression [67]. Lesions in the MPOA and vBnST cause general 
disruption of maternal behaviour and it is proposed that while maternal aggression is 
primed by the hormonal changes of pregnancy in the rat, maternal aggression requires 
maternal behaviour onset before its initiation [174, 184]. Therefore, if the MPOA and 
vBnST are lesioned and this is observed to disrupt maternal aggression, it would be 
unclear if this was as a result of a direct effect on maternal aggression, or by reducing 
maternal behaviour the lesion indirectly disrupts maternal aggression. However, IEG 
studies demonstrate an elevation in Fos in the MPOA and BnST of the lactating rat 
and mouse during a maternal aggression test [Meddle et al unpublished, [12, 194]. 
The MPOA and BnST are therefore activated during matern l aggression display but 
it is not known if this reflects a role in stimulating maternal aggression. Future 
research examining the role of the MPOA and BnST in maternal aggression is 
therefore required. 
1.2.3.2 Lateral septum 
The LS is important in maternal aggression as Fos expression is observed to be 
significantly higher in the LS following maternal aggression display in lactating rats 
and mice compared to non-maternal virgin controls [12, 188, 194], Meddle et al 
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unpublished]. Lesions of the septal region significantly disrupt maternal aggression in 
lactating mice [168, 188]. However, these lesions al o caused considerable 
impairment to maternal behaviour, hence the diminished maternal aggression could 
be due to no suckling stimulation from pups which is essential for normal maternal 
aggression in mice [168, 195]. Yet, it has been observed that maternal aggression is 
sustained in mice that have had suckling experience followed by the continued 
presence of a non-suckling litter [168]. The mice with septal lesions did have suckling 
experience prior to surgery and their litter present throughout the experiment 
indicating that suckling stimulation alone cannot account for the decrease in maternal 
aggression [168]. Lesions of the septal region or even the LS alone have yet to be 
examined in the lactating rat. 
1.2.3.3 Amygdala, paraventricular nucleus and periaqueductal grey area   
Unlike the brain regions above (MPOA, BnST and LS), there is substantial evidence 
from Fos and lesion studies that the amygdala, PVN and PAG are crucial to the 
regulation of maternal aggression. The reasons these three brain regions may be 
crucial to maternal aggression are related to their essential roles in the control 
emotions and the HPA axis.  
1.2.3.3.1 Paraventricular nucleus 
PVN expression of Fos and Egr-1 in aggression tested lactating mice was both greater 
compared to untested lactating or virgin mice [12, 94, 196]. In lactating rats that 
have undergone an maternal aggression test, Fos synthe is in the parvocellular and 
magnocellular PVN is also significantly greater compared to control lactating rats 
[188], Meddle et al unpublished]. Electrolytic lesions of the PVN in the lactating rat 
significantly impair maternal aggression [197]. The lesion causes no deficits in pup 
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care or in the duration of sniffing the intruder, thus there is no change in ability to 
perform motor actions or social interaction which emphasizes that the disruption is to 
maternal aggression alone [197]. However, PVN kainic acid lesions were observed to 
have no effect on maternal aggression in the lactating rat, indicating it is the 
projections through the PVN which are important in the control of maternal 
aggression [132]. Ibotenic acid administration into the PVN destroys only the 
parvocellular division which projects to limbic and autonomic brain regions [198]. 
Ibotenic acid lesions to the PVN of the lactating rat made during early lactation 
resulted in an increase in maternal aggression, and no change was observed if the 
lesion was performed on lactation day 18 when matern l aggression is normally low 
[198]. This indicates that the parvocellular division of the PVN projections are 
important for maternal aggression inhibitory control during the time period when 
maternal aggression is at its highest [198]. Therefore, the PVN appears to be 
important in the control of maternal aggression early on in lactation but has little or 
no role later on [188, 198]. 
Research has shown that the pre- and post-partum period is generally 
associated with a reduced fear and anxiety profile in the mother [29, 31-33, 138]. The 
PVN has direct influence over the HPA axis, the respon es of which as described in 
section 1.1.3.3 are observed to be down regulated during the peri-partum period [107, 
199-201]. During the postnatal period, the dampening of the HPA axis response was 
thought to reduce fear and anxiety allowing the dams to express maternal behaviour 
towards pups (a fear inducing stimuli to virgin rats) and also provide protection for 
pups to a normally fear inducing stimuli [29, 42, 202, 203]. Evidence of this theory 
was a reduced corticotropin releasing hormone (CRH) activity, which along with 
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AVP normally activates the HPA axis, in the hypothalamus during the peri-partum 
period [202]. Furthermore if CRH is administered ICV to lactating mice levels of 
maternal aggression are significantly decreased [204]. This is also observed if 
urocortin 1 and 3, CRH related peptides, were given ICV to mice [205].  
However, there is substantial inconsistent evidence with this theory. Firstly, a 
reduced fear and anxiety phenotype is not always observed with normal maternal 
aggression expression indicating a reduced fear and anxiety phenotype may not be 
necessary for heightened aggression [15, 206-208]. This could be due to differences 
in laboratory conditions, experimental procedures or strains of species [202]. 
Secondly, the blunted response of the HPA axis is maxi al during the second week 
of lactation when maternal aggression intensity is normally decreasing [137, 202, 
209]. Also adrenalectomy or hypophysectomy, which increase CRH levels in the 
brain, do not affect maternal aggression [173, 202, 210-213]. Finally, maternal 
aggression and anxiety return to virgin rat levels fo lowing removal of pups but the 
blunted HPA axis response requires a far longer period of pup separation to return 
back to normal [188, 209, 210, 214, 215]. Thus, the actions of the HPA axis do not 
link clearly with maternal aggression and extensive research is required to fully 
understand how maternal aggression is controlled and whether it is connected to the 
reduced fear and/or blunted HPA axis phenotypes. One possible theory is that during 
the pre-partum period the blunted HPA axis ‘primes’ the mother to be able to respond 
to her litter which was previously fear inducing on the day of parturition but 
thereafter fear, anxiety and aggression expression in the dam are all controlled by 




Specific regions of the amygdala have been identifid to be involved in maternal 
aggression by IEG studies. Fos expression is greater in the MeA and cortical 
amygdala of lactating mice following the display of maternal aggression [12, 194]. 
Egr-1 expression was observed to be significantly elevated in the MeA, CeA and BlA 
of lactating mice tested for maternal aggression [196]. In lactating rats, Fos 
expression is observed to be greater in the MeA and CeA during maternal aggression 
display than in control lactating rats [188], Meddle et al unpublished]. To my 
knowledge, few if any lesion studies have examined effects of amygdala lesions on 
maternal aggression in lactating rats or mice [188]. Research instead has focused on 
neuromodulator control of maternal aggression in the amygdala which will be 
discussed further in the sections 1.4-1.7 below which outlines the possible roles of 
different neuromodulators in the regulation of maternal aggression. 
Specific regions of the amygdala, as described in section 1.1.2.2, have 
differing functions. The MeA processes olfactory information so could be essential in 
the detection of a threat to the pups and therefore enabling maternal aggression in 
response to an intruder. The amygdala may also indirectly enable maternal aggression 
due to its involvement in the regulation of fear and anxiety. Another way the 
amygdala may indirectly allow maternal aggression is through its direct projections to 
the PVN which are observed to directly influence th HPA axis response to particular 
stressors [124]. The CeA exerts an impact upon the reactions to systemic stressors for 
example body trauma or inflammation whereas the MeA reacts to noise and restraint 
stressors [216-219].  
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1.2.3.3.3 Periaqueductal grey 
Fos, pCREB and Egr-1 all show significantly greater expression in the PAG 
following maternal aggression display in rats and mice [12, 188, 194, 196], Meddle et
al unpublished]. Lesions of the caudal PAG were observed to result in a higher level 
of maternal aggression in lactating dams compared to sham controls [140].  
The PAG is an area crucial to regulation of the strss response, the descending 
pathway of pain and in general sensory processing [141, 220]. In response to 
stressors, different sub-regions of the PAG are essntial in controlling particular stress 
responses. The dorsolateral region of the PAG is important in active physical 
responses (i.e. flight and fight) to psychological but escapable stressful situations and 
thus works to control motor activity, circulatory activity and increased vigilance 
necessary for the response [141-145]. The lateral PAG controls the active physical 
response to physical stressors [141]. The ventrolateral PAG region controls the 
passive emotional coping response in situations where the stressor is inescapable, 
physical or psychological [141, 143-145, 221]. Passive coping strategies include 
decrease motor activity, slowing of the heart rate nd decreased vigilance. The 
passive response controlled by the PAG is also proposed to be important for recovery 
a from the stress response [141, 221]. These defensive reactions controlled by the 
PAG are proposed to be influenced heavily by GABAergic neurotransmission but 
serotonin, opioids, neuropeptides, histaminergic and excitatory amino acids have also 
been observed to have an impact [222]. Thus the PAG, like the PVN, is essential to 
cope with emotional stressful situations especially the motor component. Thus, a 
harmful intruder when looking after young may be a stressor for the dam which 
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requires the action of the PAG to initiate motor aspects of maternal aggression to 
protect her young.  
1.2.3.4 Olfactory bulbs 
The OBs process olfactory information from the animal’s environment. The OBs has 
a clear link with maternal behaviour, as described previously in section 1.1.1, where 
the olfactory information received from pups is relayed through the OBs to the MeA 
to inhibit the expression of maternal behaviour (see Fig 1.4) [4, 30, 70].  
However, the OBs must also play a crucial role in the control of maternal 
aggression. Fos expression is observed to be significa tly greater in the OBs of 
aggressive lactating rats compared to non-aggressive lactating rats [Meddle t al, 
unpublished]. Furthermore, lesioning the OBs or removing the olfactory cues from 
pups or intruders disrupts maternal aggression expression in lactating mice and rats 
(see introduction of chapter 3 for more detail) [181, 188, 223-225]. In virgin rats, the 
olfactory the information works to inhibit maternal behaviour but once maternal 
behaviour is expressed in lactating rats the olfactory information from pups is now 
salient and works to enhance maternal aggression. 
1.2.3.5 Supraoptic Nucleus 
The supraoptic nucleus (SON), along with the PVN, is the brain’s major source of 
OXT and AVP which, as described in sections 1.4 and 1.5 respectively, are two 
important neuromodulators with strong links to maternal behaviour and maternal 
aggression [226-228]. The SON, like the PVN, is alre dy established to be important 
for the normal functioning of lactation physiology [229-236]. However recent studies 
observed that Fos expression within the SON is significa tly greater in lactating rats 
tested for maternal aggression than in controls indicating that the SON does play a 
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role in maternal aggression [Meddle et al unpublished]. Whether this is due to its role 
in systemic OXT and AVP release or a direct influence over behaviour expression 
remains to be established and is the subject of current investigation.  
Although more extensive research is required into how these brain regions 
link or regulate maternal aggression, it is clear that maternal aggression is closely 
linked with the PVN, PAG and amygdala; all of which are involved in fear and 
anxiety circuitry. It is proposed that the decline  fear associated with the postpartum 
period could enable the increased aggression [15, 27, 203, 237-240]. Research is now 
focusing on how these brain areas link together and influence each other through 
neuropeptides and neurotransmitters to allow expression of specific maternal 
behaviours, as discussed in section 1.2.1 it is clear that hormonal changes of estrogen, 
progesterone and prolactin alone do not regulate marn l aggression.  
 
1.3 Neurochemical control of maternal aggression 
Many different neuroactive substances are proposed to be involved in maternal 
behaviour and maternal aggression regulation from neurotransmitters to hormones to 
neurosteroids. The experiments in this thesis focus n OXT, AVP, allopregnanolone 
and GABA. All have different actions in the brain ad the next sections of this 
chapter will examine how their roles in the brain may be linked with maternal 
behaviour, maternal aggression and each other. 
 
1.4 Oxytocin 
OXT is so named after the Greek for ‘quick birth’ because of its involvement in the 
parturition process [131, 227]. OXT is nonapeptide hormone whose structure 
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consisting of a nine amino acid sequence (Cys-Tyr -Ile-Gln-Asn-Cys-Pro-Leu-
GlyNH2) with a sulphur bridge between the two cysteine residues; this is highly 
conserved across phyla suggesting that evolutionarily it is an important neuropeptide 
in the brain [227, 241]. So far only one OXT receptor (OTR) has been  sequenced 
and it is a member of the class 1 G-protein coupled receptor family [131, 227, 242]. 
OTRs are distributed widely throughout the brain; in the rodent OTRs are located 
mainly in the OBs, tubercle, neocortex, endoprirform, hippocampal formation, 
central and lateral amygdala, BnST, NAcc and VMH [227, 243, 244].  
In the periphery, OXT has sexually dimorphic functions; in females it acts 
upon the uterus and mammary gland to control parturition and milk ejection 
respectively [106, 131]. In males, OXT works on theestis muscle to contribute to 
ejaculation [106, 131]. Peripheral OXT also affects the heart and cardiovascular 
system where it reduces heart rate and arterial blood pressure [131, 245, 246]. The 
kidney is another peripheral organ site where OXT acts as a non hypertensive 
natriuretic to regulate blood osmolarity [131, 247-250]. In addition, OXT acts 
directly on the heart to elicit the release of atrial natriuretic peptide [131, 251, 252]. 
Thus, OXT has many crucial functions in both males nd females when secreted into 
the periphery. However once OXT is secreted into the blood it does not easily cross 
the blood-brain barrier therefore blood and cerebrospinal fluid OXT levels can be 
independently regulated, but often central and periph ral secretions reflect each other 
[127, 131].   
In the brain, the main sources of central OXT release re the dendrites and 
somatas of magnocellular neurons of the PVN and SON nuclei uncovered by 
immunohistochemical studies [227]. Dendritic OXT release by the magnocellular 
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PVN neurones occurs in response to a variety of stimuli from dehydration to suckling 
to stressors to drugs [128, 131, 253]. In response to a specific stimulus, the PVN 
magnocellular neurones display a distinct firing pattern to cause a specific pattern of 
OXT secretion [131]. For example, during lactation OXT is secreted in a pusatile 
fashion following each large synchronous burst of firing of OXT neurones, whereas 
hyperosmolarity causes a small increase in firing rate to result in a small rise in OXT 
secretion [130, 131, 254, 255]. OXT is observed to help regulate analgesia, 
thermoregulation, feeding, motor activity, cardiovascular activity and social 
behaviours from sexual to maternal to cognition [109, 131, 152, 200, 227, 256-276]. 
The involvement of OXT in the regulation of so many social behaviours and its 
importance in lactation and parturition highlights why OXT could be essential for the 
control of maternal behaviour, a period of important social interaction between 
mother and child essential for both mother and the future wellbeing of the offspring 
[227, 265, 277]. In the next few sections below, the evidence from rodent and human 
research on the role of OXT in these behaviours, namely affiliation, social memory 
and recognition, anxiety, stress will be discussed an related to the peri-partum 
period.  
1.4.1 Affiliation 
Affiliation is the creation of a bond between two individuals [227, 228]. In the 
laboratory this is generally studied through pair bonding, sexual behaviour or parent-
child interactions [227, 228]. Pair bonding has been particularly studied in voles 
because prairie voles form a monogamous relationship for life allowing comparisons 
to the promiscuous montane vole [227, 228, 265, 277, 278]. Central but not 
peripheral OXT infusions to an ovariectomised female prairie vole facilitates pair 
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bonding formation independent of mating (normally required) whereas pre-treatment 
with an OXT antagonist prevents pair bond development [227, 277-279]. 
Furthermore, the density of OTR is greater in the LS, BnST and NAccs (areas 
involved in the reward circuitry) of the monogamous vole compared to the 
promiscuous vole species [227, 265, 279]. In male prairie voles, central OXT 
infusion also facilitates pair bonding but at a much higher dose than AVP and this 
facilitation can be blocked by an OXT antagonist [278]. OXT administration to male 
prairie voles during their neonatal development period facilitated pair bonding in 
adulthood [280].  
If pair bonding has a similar control mechanism as the parent-child bond, 
then one would expect aggressive expression to be higher in protection of partner 
[265]. Indeed, if female prairie voles cohabit with a male they display more 
aggression and less affiliation towards a novel femal  in a neutral test area [281]. 
Aggression remains high in females ovariectomised prior to cohabitation with males, 
indicating that sexual experience is not required for aggression and that the formation 
of a pair bond alone is enough [281]. Female prairie voles treated with OXT within 
24h of their birth expressed more aggression and less social behaviour towards a 
novel female after cohabitation with a male in adulthood indicating neonatal OXT 
exposure can help the development of the mate-defenc  component of a pair bond  
[282].  
In sheep, unlike rats and mice, ewes will form a specific olfactory memory of 
their young and are able to recognise them within 2h of birth [277]. Central OXT 
infusion in hormonally primed sheep facilitates this bond and OTR mRNA is 
increased in the granule cell layer of the OBs which regulates the formation of 
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olfactory memories [277]. In sheep, therefore, OXT in the brain helps to create a 
strong mother-infant bond by facilitating olfactory memory [277]. In humans, 
mothers are able to recognise the smell of their own infants within 30 min of their 
birth; so far though this has not been linked to OXT [277]. Yet, OXT levels do rise 
within the circulation of a mother whilst she is breastfeeding to cause milk ejection 
indicating there may be a connection [283]. Intranasal OXT administration to 
humans has been observed to increase trust and also decrease stress responses in a 
stressful situation [283]. These results suggest that like in rodents and sheep, OXT is 
important for creating bonds between individuals and therefore could be important 
for the development of the mother-child bond which s essential for offspring 
survival and adulthood social behaviour. 
1.4.2 Social memory and recognition 
Social memory and recognition enable individuals to distinguish between familiar 
and unfamiliar conspecifics allowing the display of appropriate behaviour towards 
them including the formation of social attachment [227, 283]. In rodents, the main 
stimulus for social memory and recognition are olfactory cues, mediated by the 
accessory and main OBs [227, 283]. In primates, auditory and visual cues also play 
important roles [227]. OXT is viewed as important for social recognition in both 
sexes because OXT KO mice, both male and female, display impaired social 
recognition, even after repeated trials [284, 285]. This is not due to olfactory or 
spatial memory impairment as OXT KO mice perform just as well as wild type mice 
in olfactory or Morris water-maze tasks [284]. OXT infusion into the lateral 
ventricles of the male OXT KO mice was able to rescu  their social recognition 
impairment [284]. Moreover OXT antagonist administration to wild type male mice 
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impeded their social recognition abilities [284]. In female mice, administration of 
OTR antisense DNA to the MeA resulted in lower OTR expression and social 
recognition impairment [286]. ICV OXT antagonist infusion to female rats produced 
significantly impaired social recognition compared to vehicle treated females [227, 
287]. OXT infusion into the OBs of male rats was able to facilitate social 
recognition; this effect involves noradrenaline as depletion of noradrenaline by 6-
OHDA administration prior to OXT infusion prevented normal social recognition 
responses [288, 289]. Therefore, in male and female rod nts OXT may facilitate 
social recognition by helping the information to beprocessed to create social 
memories, especially in the amygdala and OBs [227, 84 290].  
This olfactory learning may be taught to the pups by the mother’s maternal 
behaviour during the neonatal period [283]. Paint-brushing, used to simulate 
maternal licking, whilst being exposed to a novel smell, induces pups to remember 
and have preference for that smell even in the absence of ‘licking’ [283]. 
Furthermore, the odour from the mother can be linked to non-social odours 
(peppermint) so that pups prefer the non-social odour when mother is not present 
[283]. ICV OTR antagonist prior to the learning phase of this paradigm prevents 
establishment of the association between the mother’s odour and the non-social 
odour [283]. Thus, during development OXT plays an important role in learning 
social odours which could have important implications for how a rodent reacts in 
adulthood to social stimuli [283].  
OXT administered subcutaneously or directly into the septal region to male 
rats decreased the social investigation time of a familiar juvenile rat during a second 
encounter indicating facilitation of social recognition [291, 292]. However, no effect 
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was observed with OXT antagonist treatment prior to the first encounter, but OXT 
injected into the lateral ventricles of male rats immediately after the first encounter 
facilitated social recognition and OXT antagonist trea ment prevented this, leading to 
the proposal the OXT was important for social memory acquisition not retention 
[227, 292]. OXT in humans has been shown to improve social memory for faces, 
significantly angry or neutral, when administered intranasally in both males and 
females after the learning task [293]. The amygdala has also been implicated in 
control of facial recognition in humans with decreas d amygdala activation 
following OXT administration to male humans when looking at angry or fearful 
faces [227]. OXT therefore in rodents and humans appe rs to be important in 
processing information in the amygdala and OBs to create memories which help with 
social recognition, even during development.  
1.4.3 Stress and anxiety 
All mammals face aversive stimuli which affect their normal homeostasis; in general 
there are two mechanisms which control the animals behavioural, autonomic and 
neuroendocrine responses [107]. These are the sympatho-adrenergic system which 
works to control the immediate active reactions to a threatening stimulus and the 
HPA axis which regulates the long term passive respon es [107]. If there is 
uncontrollable, long lasting stimulation of the HPA axis then a maladaptive response 
may result in emotional disorders such as anxiety or panic [107]. One of the main 
features of the HPA axis is the PVN which is one of the main sources of OXT and 
AVP and research has observed a higher release level of these two neuropeptides 
whilst rodents perform stressful tasks [107]. Rats who experienced social defeat had 
a greater OXT release in the SON but no change in the PVN, however a forced swim 
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test caused a greater release in both the SON and PVN [107, 294-296]. Both of these 
tests are able to activate the HPA axis as demonstrated by increased ACTH and 
corticosterone levels in rats after testing compared to before [107]. Thus the release 
of OXT (and AVP) from the SON and PVN in response to s ressful stimuli can 
modulate ACTH and glucocorticoid release hence they can impact HPA axis 
activation [107, 297]. OXT reduces ACTH and glucocorti id release to negatively 
modulate the HPA axis to decrease the effect of stres ful stimuli, whereas AVP 
works in the opposite way [35, 107, 298, 299].  
 In ovariectomised estrogen-treated female rats, ICV OXT infusion resulted in 
significantly lower plasma corticosterone levels following a noise stress compared to 
saline infused rats [300]. OXT treated female rats spent significantly more time and 
made more entries to the open arms of the EPM, thus displaying reduced anxiety 
behaviour; the same effects were observed in ovariectomised estrogen-treated mice 
[299, 300]. Ovariectomised estrogen-treated female rats infused with OXT prior to a 
restraint stress test showed significantly lower release of ACTH and corticosterone 
and lower Fos expression in the PVN, LS and dorsal hippocampus subregions [298, 
300]. The fact estrogen is required in these paradigms is interesting as towards the 
end of pregnancy estrogen levels rise dramatically (Fig. 1.1), so high circulating 
estrogen levels may potentiate the important anxiolytic effects of OXT around 
parturition especially within the LS where higher OXT binding was correlated with 
estrogen induced anxiolysis [299].  
These anxiolytic effects of OXT are not restricted o females as direct OXT 
administration to the PVN of male rats resulted in more time on and more entries into 
open arms of the EPM thus a lower anxiety profile than vehicle injected rats [301]. 
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OXT release was higher in the CeA of male rats during a forced swim test [302]. 
Furthermore, infusion of OXT into CeA of these male rats reduced floating time and 
increased swimming time suggesting that the activation of OTRs in the CeA works to 
increase a passive stress response [302]. In male mic , ICV OXT administration 
reduced anxiety expression in the four-plate test, EPM and stress-induced 
hypothermia [303]. 
 It is well documented that the peri-partum period results in a lower anxiety 
profile in mothers and during this time the OXT system changes dramatically hence 
OXT may regulate the anxiolysis and lowered stress ponse of motherhood [29, 31-
33, 35, 297, 304-307]. In response to a mild psychological stressor (airpuff), late 
pregnant and parturient rats have significantly attenuated stress-induced release of 
ACTH and corticosterone compared to virgin female rats [35]. However, OXT 
antagonist administration did not alter ACTH or corticosterone release in response to 
a stressor in late pregnant or parturient rats [35]. ICV infusion of OXT antagonist to 
virgin female rats increased basal and stress-induced corticosterone but had no effect 
on the levels in pregnant or lactating rats [40]. Thus during the post-partum period, 
the reduced HPA axis activity to stressors is not mediated by OXT, but OXT does 
modulate anxiety behaviour [40]. Administration of an OXT antagonist reduced 
anxiety behaviour on the EPM in pregnant and lactating rats [40]. In addition 
infusion of OTR antagonist into the caudal PAG of pst-partum rats, where lesions 
are observed to be anxiogenic, significantly reduce th  time spent in the open arms 
of the EPM compared to vehicle treated rats [308]. 
 In humans, OXT has also been linked with emotional disorders including 
depression and personality disorders involving excessiv  aggression [309, 310]. 
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More recently, the OXT system has been linked with autism where there are severe 
deficits in social behaviour including social coping and creating interpersonal 
relationships indicating the importance of OXT for normal social behaviour 
expression [283, 311-313]. 
OXT effects on emotional state are also linked with the post-partum period in 
humans [283, 314]. During breastfeeding plasma OXT levels are higher in mothers 
and these correlate with lower stress experience and negative mood than bottle 
feeding mothers who have lower plasma OXT levels [314, 315].  
1.4.4 Oxytocin, maternal behaviour and maternal aggression 
OXT is proposed to be important for maternal behaviour onset but not necessary for 
its maintenance; this is because ICV OXT administration can induce maternal 
behaviour to virgin female rats and an OXT antagonist given ICV can prevent 
maternal behaviour onset to pregnant rats, but ICV application of an OXT antagonist 
once maternal behaviour has been initiated has no effect [3, 44, 131, 316, 317]. 
Furthermore, OTR expression in the SON, BnST and MPOA significantly increases 
at parturition but within 12h post-partum has returned to virgin rats levels; these 
areas are as important in the regulation of maternal behaviour [307, 318].  
In sheep, prior maternal experience caused higher levels of OTR mRNA 
expression in many brain regions including the PVN at parturition than in 
inexperienced ewes [319]. The higher increase in OTR mRNA in the PVN of 
experienced than in non-experienced ewes may contribute to the onset of maternal 
behaviour as inexperienced ewes take longer to demonstrate maternal behaviour and 
the PVN is the main source of OXT [319]. Thus OXT can contribute to increased 
maternal responsiveness by inducing greater OTR expression in the brain following 
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previous maternal experience [319]. OTR mRNA expression and OXT 
immunoreactivity are also observed to change dynamic lly over pregnancy, 
parturition and lactation in the rat [304, 307].  
 In terms of maternal aggression, there is evidence for an essential role of 
OXT in maternal aggression control, especially within t e PVN; however currently it 
is unclear if OXT inhibits or facilitates maternal ggression. PVN ibotenic acid 
lesions and OXT mRNA antisense (reduces OXT synthesis) inhibited maternal 
aggression on postpartum day 5 [188, 198]. However, neither ICV injections of OXT 
just prior to testing or peripenduncular lesions (preventing suckling-induced OXT 
release) had any effect on maternal aggression [188, 267]. Yet, OXT secretion is 
increased within the PVN during maternal aggression testing in the lactating rat and 
OXT antagonist administration directly to the PVN inhibits maternal aggression 
[320]. Thus research does indicate a role of OXT in maternal aggression and further 
discussion of the importance of OXT in the regulation of maternal aggression can be 
found in the introduction for chapter 4. 
OXT therefore is linked with maternal behaviour and maternal aggression 
although its role in their regulation is not as yetcompletely understood [3, 44, 304, 
307, 314, 316-319]. The many functions of OXT in regulating social behaviour 
suggest OXT may be important during the peri-partum period especially for maternal 
aggression for numerous reasons. OXT is anxiolytic and the ‘maternal’ state is a time 
of reduced anxiety and fear thus OXT may work to enable maternal aggression by 
reducing fear and anxiety [35, 40, 314]. OXT also pr motes affiliation, thus OXT 
may help to create the mother-infant bond enabling the full display of maternal 
behaviour [265, 277, 281-283]. Finally OXT helps with social recognition, therefore 
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in terms of maternal aggression it may enable lactating rat to distinguish intruder as 
foe and therefore express the appropriate behaviour towards them [227, 283, 284, 
290, 293].  
 
1.5 Vasopressin 
AVP is also a nonapeptide and differs from OXT by two amino acids (Cys-Tyr-Phe-
Gln-Asn-Cys-Pro-Arg -GlyNH2) [131, 228]. Like OXT, the structure of AVP is 
highly conserved across phyla, in birds and reptiles vasotocin is its evolutionary 
equivalent [228]. The SON and PVN of the hypothalamic nucleus are the main 
synthesizers of AVP but AVP is also known to be synthesized in the MeA, BnST, 
and suprachiasmatic nucleus (SCN) neurones of the brain [228, 321]. The latter of 
these has projections which terminate in the septal area and release AVP leading to 
its involvement in many brain functions [321]. There are 3 types of AVP receptors 
(V1a, V1b and V2), all of which are seven transmembrane receptors [228]. Although 
all 3 are expressed in different specific areas in the periphery, within the brain 
generally only expression of V1a and V1b receptors are observed [228, 322]. V1a 
receptor autoradiography (examines the location of receptor by allowing binding to a 
radioactively labelled ligand) and ISH has uncovered V1a receptor distribution in 
various brain regions of the rat including the LS, BnST, VTA, PVN, OBs and 
amygdalostriatal (transition area between amygdala and striatum) which are known 
to be part of the maternal behaviour and maternal aggression circuitry [12, 28, 67, 
70, 79, 80, 140, 148, 188, 194, 228, 323, 324]. Binding of V1b receptors in the rat 
brain has yet to be examined due to the lack of a specific radioactively labelled 
ligand [228]. However, ISH studies observe V1b receptor mRNA in many brain 
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regions including those implicated in maternal behaviour or maternal aggression 
circuitry namely the septum, PVN and OBs [228]. 
 AVP has many different actions in both the brain and periphery to control 
multiple functions. Two main stimuli which cause systemic AVP release from 
hypothalamic brain regions are stress and changes in plasma osmolality. AVP is 
released from the PVN magnocellular neurones into the bloodstream via their 
terminals in the posterior pituitary in response to bl od hyperosmolality [107, 108]. 
AVP acts as an antidiuretic agent in the kidney to initiate water retention and return 
plasma osmolality to normal [107, 108]. Stressful stimuli will activate the HPA axis 
causing the release of AVP synthesised in the parvocellular PVN neurons of the 
hypothalamus (along with CRH) resulting in ACTH release and thus glucocorticoids 
from the adrenal glands which controls physiological stress responses of the body 
[107, 108]. Like OXT, once AVP is released systemically, the blood/brain barrier 
prevents re-entry of AVP into the brain so systemic and central AVP levels, although 
they may be linked, can be independent of each other [108, 127].  
Within the brain, AVP is released from the magnocellular neurones of PVN 
and SON through their neuronal somatas and dendrites m aning AVP is able to 
diffuse through the brain in the extracellular fluid and act on regions distal to its 
release point  [108, 126-129]. The parvocellular cells of the PVN are known to 
release AVP centrally as their projections terminate in the PVV, BnST, MeA and 
SCN [228]. Together, these multiple means of AVP release indicate that local brain 
AVP levels can be carefully controlled and this could explain how AVP is involved 
in a wide range of brain functions, from cognition to social behaviour to circadian 
rhythm control in the brain [108, 325] (for full revi w see [228]). In the next 
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sections, AVP links with affiliation, social recognition, stress and aggression will be 
reviewed in the context of how these actions may be important to the peri-partum 
period. 
1.5.1 Affiliation 
Affiliation is clearly linked with AVP [227, 228]. Sexual partner preference is one 
bond research has observed is clearly linked with the AVP system; this has been 
especially studied in prairie voles due to their lifelong monogamous relationships 
they form [228, 326]. In male prairie voles, AVP plays a central role in affiliation 
because ICV AVP administration to males housed with an ovariectomised mate 
enabled formation of pair-bond even though no sexual experience had occurred; 
normally essential for pair bond formation [326]. When sexual experience has 
occurred, ICV infusion of V1a antagonist to male prairie voles was able to prevent 
formation of a pair-bond [326].  OXT and CSF did not have any effect in either 
paradigm [326]. ICV treatment with AVP (or OXT) in male and female prairie voles 
prior to nonsexual cohabitation induced a pair bond, since more time was spent with 
the vole from the cohabitation period than the novel vole during a partner preference 
test [278]. AVP given to male voles at a 1ng dose was more effective than OXT in 
creating this partner bond as OXT only became effectiv  at a dose of 10ng [278]. In 
females, AVP (and OXT) only became effective at the 100ng dose [278]. In this 
experiment the partner preference could be prevented by pre-treatment with an OXT 
or an AVP antagonist in both males and females [278]. This indicates both AVP and 
OXT are important in pair bond formation but in males AVP is more influential. 
The parent-child bond is important to study as abnormal parental care has 
lifelong consequences. Paternal care is not generally observed in the male rodent 
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hence research has focused on the prairie vole and C lifornia mouse, two species in 
which the male is actively involved in the raising of the offspring [228]. Paternal care 
has been attributed in these parental rodents to differences in the central AVP system 
in the brain [228]. In male prairie voles there is higher expression of AVP 
immunoreactive fibres and neurones in the LS and BnST than in female prairie voles. 
Furthermore castration results in lower paternal behaviour and AVP expression in 
these areas, indicating steroid hormones are involved in the regulation of paternal 
behaviour [228, 327].  Administration of AVP to sexually naïve male prairie voles 
can induce paternal care [228]. This was also observed to occur in the non-paternal 
or pup-aggressive meadow voles who are promiscuous and do not normally display 
paternal care [228, 328].  
In California mice, AVP immunoreactivity is higher in the BnST, and V1a 
receptor expression is greater in the LS compared to that observed in the polygamous 
white-footed mouse (a non-paternal species) [329]. Thus for paternal care AVP is 
important for both male voles and mice [228]. For female rodents, the full role of 
AVP is still unclear in maternal behaviour. AVP release in limbic and septal brain 
regions changes dramatically over the peri-partum period but this release has yet to 
be examined in relation to maternal behaviour [228, 330].  
1.5.2 Social recognition  
The central AVP system is important for creating affili tion because of its links with 
social recognition [228, 278]. Brattleboro male rats re unable to naturally synthesise 
AVP and display impaired social recognition [331]. This impaired social recognition 
can be rescued by infusion of AVP into the mediolater l septal region of the 
Brattleboro rats [331]. Furthermore, microdialysis AVP V1a receptor antagonist 
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infusion into the mediolateral septal area of male Long Evans rats (that have normal 
social recognition skills) resulted in an impaired social recognition phenotype similar 
to the male Brattleboro rat under normal conditions [331]. In the Wistar rat (that also 
have normal social recognition abilities), application of an AVP receptor V1a anti-
sense oligonucleotide into the septum reduced AVP binding and resulted in an 
impaired social recognition phenotype [332].  
In the V1a receptor KO male mice, an impaired social recognition phenotype 
is observed but this is not due to an olfactory impairment as both wild type and V1a 
receptor KO mice could become habituated to a scented cotton wool ball [333]. A 
V1a receptor viral vector (to increase AVP binding) was able to rescue the social 
recognition impairment in the V1a receptor KO male mouse and enhance social 
recognition in the wild type if applied directly to the LS but not the MeA [334]. 
These studies indicates that the V1a receptor and LS are important in social 
recognition [334]. Others however have failed to see this social recognition deficit in 
V1a receptor KO mice but observe an olfactory one instead; they suggest that the 
V1a receptor is important in olfactory processing, and because the V1b receptor KO 
mice in their laboratory show social recognition impairment, it is the V1b receptor is 
involved in social memory retrieval for social recognition [228, 290].  
AVP therefore is important in social recognition but again research has only 
focused on males so it is as yet unknown if AVP is as important in females and hence 
necessary to help with bonding during the peri-partum period.  
1.5.3 Anxiety, stress and depression 
AVP also plays a role in the control of anxiety behavioural responses and HPA axis 
functioning, which as described above in the OXT section is essential in controlling 
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the stress response [107, 200, 228, 335]. In male rodents, there is significant 
evidence for AVP in regulating anxiety. In male rats, AVP release within the PVN, 
LS and amygdala is significantly higher following water-maze and forced swim tasks 
respectively [336, 337]. AVP may differentially mediate active and passive 
components of the stress response, as application of a AVP V1 receptor antagonist 
directly into the amygdala and LS resulted in opposite effects on struggling (active) 
and floating (passive) without affecting overall swimming behaviour in the forced 
swim test [337]. AVP application to amygdala increas d struggling but decreased 
floating and vice versa following AVP administration to the LS [337].   
Both the V1a and V1b receptors are implicated in AVP anxiety regulation in 
rats and mice. In adult male rats, septal infusion of AVP V1a receptor antagonists 
resulted a lower anxiety profile on the EPM compared to vehicle or AVP treated 
male rats [321]. No difference in locomotor activity was observed between treatment 
groups therefore the change in anxiety expression was as a result of central AVP 
action [321]. I.p. V1b receptor antagonist administration in male rats also resulted in 
lower anxiety profiles on both the EPM and in the punished drinking paradigms 
[338]. In male mice, V1b antagonist administration also led to a lower anxiety profile 
in the light/dark and EPM (after experience of social defeat stress) compared to 
vehicle treated mice [338].  
There is a difference of opinion about whether AVP affects anxiety 
specifically through V1a or V1b receptors as the antagonists used are not necessarily 
specific to one receptor so cross-reactions can occur [333]. KO mice therefore 
provide a more definitive model to test which receptor mediates AVP actions on 
anxiety [333]. Male V1a receptor KO mice display significantly less anxiety 
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behaviour in the EPM, open field or light/dark box compared to wild type male mice 
[333]. No difference was observed in length of time i mobile during a forced swim 
test between KO and WT male mice indicating a lack of V1a receptors affects 
anxiety but not depression behaviours and the lower anxiety behaviour expression in 
the KO mice was not due to an effect on locomotor activity [333]. In WT male mice, 
V1a receptor overexpression in the LS by direct viral vector injection caused a higher 
anxiety profile on the EPM [334]. However, when V1a receptor KO male mice were 
injected the same V1a viral vector into the LS no change was observed in anxiety 
behaviour on the EPM, open field or light/dark box tests [334]. This could be due to 
the fact that these KO male mice have no experience of V1a receptor throughout 
their development or life and that gene replacement in adulthood in one specific 
brain region is not sufficient to rescue this loss [334]. No difference in anxiety 
behaviour has been observed in male V1b receptor KO mice compared to wild types, 
but V1b receptor antagonist treatment in male rats esulted in less time spent 
immobile (a neophobic behaviour) in the forced swim test [228, 334, 338]. Thus one 
could propose that the V1a receptor mediates anxiety whereas the V1b receptor 
regulates depression.  
Female V1a receptor KO mice do not exhibit a lower anxiety behaviour 
profile on the EPM, open field or light/dark box test [339]. Thus, there may be a sex 
difference in anxiety control, with V1a receptors not being essential in female mice 
for anxiety expression. Although the brain regions in which AVP is released are the 
same in male and female mice, male mice exhibit more AVP positive cells and 
release more AVP in the BnST and MeA [339]. Furthermore male mice have denser 
AVP projections than females to the LS from the BnST and MeA [339]. In female 
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mice, therefore, as discussed above it may be the OXT system which controls anxiety 
[339]. Also implicated are progesterone and its metabolites as being important for 
emotional stability in females and this is reviewed in section 1.6 [339]. However, this 
does not rule out AVP in modulating anxiety in the female as dramatic changes are 
known to occur in AVP release around the peri-partum period and research has as yet 
to investigate fully the relationship between AVP and anxiety and stress in female 
rodents [228, 330, 339]. 
A link between AVP and anxiety and stress disorders in humans has also 
been observed. Plasma AVP levels are higher in depressed patients who have 
increased numbers of AVP positive cells in the PVN [340]. Also a single nucleotide 
polymorphism in the V1b receptor is observed to protect against major depression 
[340]. For anxiety disorders, elevated plasma AVP leve  has been observed in post 
traumatic stress disorder patients compared to trauma or non-traumatized controls 
and obsessive-compulsive disorder patients [340]. Plasma AVP levels were 
correlated with anxiety symptoms in healthy humans following an anxiogenic drug 
challenge [341]. Thus there is evidence for roles of the AVP system in emotional 
disorders in both rodents and humans. Although resea ch in rodents has focused on 
the male it is beginning to examine the significance of AVP in females and its 
possible importance in emotional disorders of the peri- artum period.    
1.5.4 Aggression 
As with most research investigating AVP effects on s cial behaviour, the focus has 
been on male rodents in terms of aggression. Male aggression in rodents generally 
reflects territorial protection or social hierarchy (cited in [342]). AVP in male rodents 
has been linked with excessive aggression, especially when related to alcohol or drug 
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taking paradigms, but aggression development has been linked with early life 
experience [16, 23, 228, 342-345]. In mice, the type of paternal care can influenced 
the development of aggression in their offspring [343, 344]. Cross-fostering of white-
footed male mice pups to male California mice (who display paternal care) results in 
higher aggression than non cross-fostered male white-footed mice [343]. 
Furthermore, male California mice pups cross-fostered to white-footed males display 
lower aggression levels and a lower percentage of positive AVP cells in the BnST 
[343]. If adult California male mice are manipulated to exhibit more retrieval 
behaviour, their male and female offspring are more aggressive and in male offspring 
a higher number of AVP expressing projections in the BnST are observed [344]. It is 
unknown if the change in female aggression is correlated with change in AVP 
expression as this was not investigated, but these r sults do highlight the ability of 
the type of parental care to influence and programme adulthood aggressive behaviour 
in mice [343, 344].  
Maternal behaviour has also been linked with adulthood aggressive behaviour 
display in males and females [14-17]. Prolonged matern l separation affects 
adulthood anxiety the same way in males and females, however it causes a decreased 
in intermale aggression but an increase in maternal aggression [16]. Furthermore, 
these different aggressive behaviour displays could be linked with changes in the 
neuropeptides, OXT and AVP; in maternally separated f male mice OXT 
immunoreactivity was lower in the PVN whilst AVP remained unchanged, whereas 
in maternally separated males AVP immunoreactivity was higher in the PVN but 
OXT was unaltered [16]. Thus, as before these two neuropeptides are sexually 
dimorphic in their actions on social behaviours [16, 339]. It is important to remember 
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that there may be strain or species as well as gender differences in response to 
negative and positive maternal behaviour influences [16]. 
 AVP, like OXT, has many links with social behaviours important for the peri-
partum period such as anxiety, social recognition and ffiliation [228, 290, 330, 333, 
334, 339]. However the effects of AVP on these behaviours have yet to be 
investigated comprehensively in female rodents around the time of birth. Thus, there 
is a new focus of research on trying to understand how AVP works with or in 
balance to OXT to help maintain and regulate maternl behaviour. 
 
1.6 Progesterone and Allopregnanolone 
1.6.1 Are the effects of progesterone on maternal behaviour mediated by 
progesterone alone? 
Changes in progesterone levels in the brain through pregnancy and parturition have 
important implications for maternal behaviour and maternal aggression (Fig. 1.1) [3, 
27, 44, 45, 50, 180, 346-349]. The specific effects of progesterone on the 
development of maternal behaviour and maternal aggression were discussed in 
sections 1.1.2 and 1.2.1 respectively. The question presently being asked by 
researchers is how is progesterone is acting in the brain to prevent the onset of 
maternal behaviour and maternal aggression?  
Progesterone can act in two main ways to cause change in cell or neural 
functioning; the first is to activate intracellular progesterone receptors (hormone 
dependent transcription factors) by binding to them and hence influence genomic 
actions [350]. The second is to affect cellular functioning by progesterone itself or its 
metabolites binding to a membrane receptor [350, 351]. Dynamic changes in 
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progesterone receptor expression in the brain during pregnancy and lactation have 
been observed with higher progesterone receptor expession in the anteroventral 
periventricular nucleus of the preoptic area, MPOA and VMN regions on pregnancy 
day 21 than pregnancy day 3 in Charles River CD rats [350]. By post-partum day 3, 
progesterone receptor expression was significantly lower in the AVPV, MPOA, 
VMN and ARC than pregnancy day 15 or 21 [350]. In Sprague Dawley (SD) rats, 
higher progesterone receptor expression was observed in the MPOA of pregnant and 
parturient females compared with virgins in proestrous [352]. Progesterone mRNA 
receptor expression was significantly higher in the MPOA, hypothalamus and 
temporal cortex on pregnancy day 15 in SD rats compared with pregnancy day 21 
[353]. These areas, MPOA and hypothalamus especially, are proposed to be involved 
in the maternal behaviour circuitry, therefore progesterone may act at one or more of 
these sites to inhibit maternal behaviour [350]. The low levels of progesterone 
receptor in these brain regions post-partum (day 3 and 7) may explain why 
progesterone no longer inhibits maternal behaviour d ing the lactation period 
because there are fewer intracellular progesterone ec ptor for progesterone to act 
upon in brain regions critical for maternal behaviour expression [350].  
Application of RU486, an intracellular progesterone receptor antagonist, 
prevents progesterone from inhibiting maternal behaviour development in estrogen 
and progesterone-treated pregnancy-terminated rats [350]. Systemic administration 
of RU486 to mice also caused mild to moderate disruption of maternal behaviour 
[350, 354]. Although these studies seem to only highlight the importance of the 
intracellular progesterone receptor as the mechanism by which progesterone 
manipulates maternal behaviour, there is evidence that this is not the whole story. 
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RU486 application in estrogen only treated pregnancy-terminated rats had no effect 
on maternal behaviour onset latency [350]. This could be a RU486 dosage issue but 
this seems unlikely as doses lower than 5mg (used in this study) are effective in 
terminating pregnancy indicating progesterone may act through another mechanism 
other than via intracellular progesterone receptors  inhibit maternal behaviour 
[350]. RU486 also affects glucocorticoid receptors, so to be certain that the effects 
are via the progesterone receptor, experimentation with ZK28299; an antagonist 
specific only to intracellular progesterone receptor is warranted [350].  
In the MPOA between 50 and 95% of its cells synthesize GABA [352]. 
During maternal behaviour more than 50% of GAD containing cells in the MPOA 
exhibited Fos suggesting GABA functioning may be important in this region for 
maternal behaviour control [355]. This may indicate he involvement of 
allopregnanolone (AP), the progesterone metabolite, as one of its most potent 
functions is to facilitate the inhibitory action of GABA acting via the GABAA 
receptor [356-358]. It was observed that the actions f progesterone in preventing 
early birth may be mediated by AP as the SON OXT neurones are influenced by the 
inhibitory actions of GABA controlled allosterically by AP [352]. It is important to 
note that the MPOA is not the only brain area where progesterone may act to inhibit 
maternal behaviour, as progesterone implants alone in the MPOA were ineffective in 
preventing maternal behaviour, thus progesterone may act at multiple sites to inhibit 
maternal behaviour [347, 350, 352]. For example, it is suggested that progesterone 
may inhibit maternal behaviour by decreasing MPOA functioning and increasing 
VMN functioning [350]. Also, maintaining high levels of progesterone in pregnancy-
terminated rats also results in lower Fos expression in the MPOA, LS and BnST 
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indicating progesterone may prevent maternal behaviour by inhibiting neural activity 
in the all or one of these regions [347]. However, it is important to note that these 
changes in maternal behaviour or Fos expression only ccur in rats who express 
maternal behaviour, therefore the lack of pup contact, meaning no olfactory and 
sensory input, in non-maternal mothers could be the cause of lower maternal 
behaviour or Fos expression [347]. 
1.6.2 Allopregnanolone in the brain 
AP is derived from peripherally sourced progesteron r cholesterol through the 
actions of the enzymes, 5α-reductase and 3α-hydroxysteroid dehydrogenase, which 
are available extensively throughout the brain (see Fig. 1.4) [359-361]. AP is 
described as a neurosteroid due to its ability to be allosterically modulate the GABAA 
receptor in the presence of GABA resulting in manipulation of many behavioural and 
physiological functions [362]. AP has little or no affinity for the intracellular 
progesterone receptor, therefore any impact AP has on behavioural or physiological 
outputs are due to modulation of GABAA receptor functioning which causes 
increases in the Cl- influx, channel opening and efficacy of other positive GABAA 
receptor modulators e.g. benzodiazepines [342, 351, 9  363, 364]. The enzymes, 
5α-reductase and 3α hydroxysteroid dehydrogenase, responsible for AP production 
are generally found in the primary output neurones and glia in the brain, therefore AP 
may impact upon the GABAA receptor in one of three main ways (1) AP may be 
released by the cell to act in a paracrine fashion on a distal cell; (2) AP may act on 
the GABAA receptors of the same neuron in which it was synthesised after being 
released i.e. an autocrine fashion; (3) AP may work on intracellular sites of the 
GABAA receptor in the cell it was synthesised in, accessed by lateral diffusion 
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through the plasma membrane [359]. Research is linking changes in AP levels with 
many emotional disorders possibly due to AP causing dysfunction in GABA 
neurotransmission [342, 365, 366].  
1.6.3 Progesterone, allopregnanolone and anxiety 
Maternal aggression is closely linked with fear and anxiety and progesterone is 
known to be anxiolytic in rodents [15, 27, 203, 237-240]. Furthermore, it was 
uncovered that these anxiolytic actions of progesteron  are mainly due to its 
conversion to the metabolite, AP [27]. ICV AP administration to proestrous rats 
resulted in lower anxiety-like behaviour display onthe EPM than vehicle-treated 
proestrous rats [367]. This effect could be blocked by picrotoxin, a GABA-gated Cl- 
blocker [367]. Rats in proestrous display less anxiety behaviour in the open field test 
 
Figure 1.4: Neurosteroidogenesis pathways in the brain. Modified from Stoffel-Wagner 
(2003) and Mellon et al (2002). P450scc, scc=side chain cleavage, P450c11as = 
mitochondrial aldosterone synthase,  3β-HSD = 3β Hydroxysteroid dehydrogenase, 17β-
HSD = 17β hydroxysteroid dehydrogenase, 5α-R = 5α-reductase, 3α-HSD = 3α 
hydroxysteroid dehydrogenase, 21-H = 21 hydroxylase, DHEA = dehydroepiandrosterone, 
DHEAS = dehydroepiandrosterone sulphate, 5α-DHP = 5α-dihydroprogesterone, 3α, 5α-
THP = 3α, 5α-tetrahydroprogesterone, DOC = deoxycorticosterone, 5α DHDOC = 5α 




and forced swim test than diestrous or male rats normally; this could be due to the 
higher levels of AP in the hippocampus normally seen during proestrous [368]. 
Furthermore intrahippocampal or systemic finasteride a ministration, a 5α reductase 
inhibitor, to reduce hippocampal AP levels in proestrous rats prevented lower anxiety 
behaviour profile in the open field and forced swim test [368]. In ovariectomised 
rats, lower anxiety behaviour was displayed on the EPM following systemic 
progesterone administration in conjunction with enhanced Cl- flux mediated by 
GABA [369]. Systemic progesterone application also caused an increase in AP levels 
in the cortex and blood serum of the ovariectomised rats indicating that the anxiolytic 
effect of the progesterone administration are actually mediated by its metabolite, AP 
[369]. These anxiolytic effects of progesterone andAP are not restricted to cycling 
females.  
Progesterone withdrawal in pseudopregnant rats by ovariectomy increased in 
anxiety exhibited on the EPM compared to control and pseudopregnant rats [370]. 
Administration of a 5α reductase (MK-906) inhibitor to a pseudopregnant rt causes 
an increase in anxiety on the EPM [370]. This increased anxiety was linked with a 
decrease in GABA receptor functioning which could be as a result of an observed 
increase in the α4 subunit of GABAA receptor; however this increase was only 
examined in the hippocampus [370]. Thus if the dramatic changes in AP and 
progesterone levels around parturition are not ableto be normalised then this could 
result in increased anxiety, a major symptoms of postnatal depression and 
postmenopausal dysphoria disorders; but also provides an excellent model of how to 
study this further as the progesterone that the pseudopregnant rats experience is from 
an endogenous source [370]. In males, treatment with progesterone or pregnanolone 
 71 
increased time in the open arms of the EPM, decreased nxiety behaviour in a 
defensive burying paradigm, and prevented inducement of anxiogenic behaviour on 
the EPM by an inescapable electric shock [371, 372]. Pregnanolone also works in the 
brain by positively modulating the GABAA receptor, showing that in males and 
female rats it is the ring A reduced metabolites (see Fig. 1.5), AP and pregnanolone, 
which mediate the anxiolytic effects of progesteron [371].  
New research is beginning to focus on how AP is involved in modulating the 
effects of progesterone on maternal behaviour including maternal aggression during 
the peri-partum period; the time when a mother’s emotional state is not only 
important for her ability to care for her offspring but also the offspring’s future 
mental well being [14-17]. 
Progesterone
Allopregnanolone Pregnanolone  
Figure 1.5: Structure of progesterone and its ring A metabolites. Diagram depicts the 
structure of progesterone. The ring A structure is highlighted in red. The reduction of this 
structure forms pregnanolone and allopregnanolone which are proposed to be the structures 




GABA is the main inhibitory neurotransmitter in the brain where it appears in 
roughly one third of neurones [373-375]. GABA is synthesised from glutamate, the 
major excitatory neurotransmitter, by the rate limiting enzyme, glutamic acid 
decarboxylase (GAD) of which there are two isoforms GAD 65 and 67 [375]. GABA 
has two types of receptor it acts upon to cause a change in ion flow and thus cell 
activity, the ligand gated ion channel GABAA and the G-protein coupled GABAB 
receptors [376]. The GABA receptor works to manipulate the flow of chloride ions 
across the cell membrane; during development GABA acts in an excitatory manner 
but its action changes to inhibitory in adulthood [377]. The actions of GABA on its 
GABAA receptor will be the focus in this thesis because of the ability of AP to 
modulate GABAA receptor functioning to impact upon anxiety and aggression as 
discussed above [361]. GABAA receptors are also well established in mediating 
aggressive behaviour in rodents, especially heightened male aggression [342, 378-
380]. Finally, recent research has linked changes in GABAA receptor functioning 
facilitated by progesterone or its metabolite AP in premenstrual tension and other 
disorders connected to the menstrual cycle or the peri-partum period [361, 381]. 
1.7.1 GABA and aggression 
Female aggression has many behavioural similarities to the different forms of male 
aggression, hence neurotransmitters controlling linked with male aggression may 
also play the same role in regulating maternal aggression [378]. There is substantial 
evidence for GABA neurotransmission in the control of male aggression [342, 373]. 
Direct manipulations of GABA receptors by injecting GABA agonist inhibit 
aggression in male mice [342, 373, 382, 383]. Low leve s of GABA correlate with 
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higher aggressive behaviour in mice and hamsters [384-386]. Furthermore, male 
GABA transporter subtype 1 (which controls GABA reuptake) KO mice display 
reduced aggression compared to wild types, so prolonged GABA neurotransmission 
prevents aggressive behaviour [374]. However, it is al o well established that 
positive GABAA receptor modulators, including ethanol, benzodiazepines and AP 
work to heighten aggressive behaviour displayed in males under a range of 
conditions [342, 378]. Furthermore, benzodiazepine a tagonists, specific for the α1 
subunit of the GABAA receptor, are able to prevent increases in aggressive behaviour 
which may explain why not all GABA receptor positive modulators work to 
decrease aggression because they need to act on specific GABAA receptor subunits 
[378, 380]. Hence GABA under certain conditions canwork to escalate aggression or 
prevent it; one possibility is that GABA acts differently on different types of 
aggressive behaviour, it may be stimulatory to offensive but inhibitory to defensive 
[342, 373, 378].  Only recently has GABA been investigated in relation to maternal 
aggression even though evidence links GABA neurotransmission with disorders of 
the estrous cycle and the peri-partum period [361, 370, 381, 387]. Inhibition of 
GABAA receptors within the LS resulted in significant reduction in maternal 
aggression expression in lactating mice [387]. Furthermore, GABA transmission has 
been implicated in the control of OXT release, which may modulate HPA axis 
activity during basal and stressful situations [107, 388]. Thus, evidence is starting to 
build that GABA neurotransmission may have an important role in the regulation of 




1.7.2 GABA transmission and anxiety 
GABA neurotransmission in rodents has been observed to be linked with anxiety and 
depression behaviour [361, 375, 389]. Application of bicuculline, a GABAA receptor 
antagonist, to proestrous rats increases anxiety behaviour display on the EPM and 
open field test [389]. In GAD 65 KO mice, increasing GABA levels during 
development were delayed compared to wild type controls [375]. Furthermore they 
display a higher anxiety profile in the forced swim and light/dark tests and lower 
aggression in an intermale aggression test [375]. Hence GABA synthesis controlled 
by GAD65 is important for the control of emotional behaviour [375].  
 GABAA receptor activity links GABA transmission with premnstrual tension 
disorders and possibly postnatal depression [361, 38 ]. During the oestrous cycle of 
rats, there are changes in the GABAA receptor subunit composition that coincide with 
the rise and fall of progesterone levels [381]. Furthermore these subunit alterations 
cause different GABA receptor functioning; for example in the PAG during late 
diestrous the change in GABAA receptor subunits results in reduced GABA activity 
and hence increased PAG activity, an area closely linked with emotional behaviour 
[42, 140, 381, 390]. Thus it is proposed that the plasticity of these changes within 
women may be the cause of some the symptoms of premenstrual tension [381]. This 
plasticity of the GABAA receptor has also been implicated in postnatal depression 
where lack of the GABA receptor δ subunit throughout pregnancy in mice resulted 
in poor maternal care and depression behaviour expression post-partum [361]. In the 
heterozygous KO GABA receptor δ subunit mouse, administration of a GABAA 
receptor agonist, THIP, alleviated poor maternal care to result in greater pup survival 
[361]. Thus, ability to regulate GABAA receptor expression and activity during the 
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peri-partum period is important to maintain normal behaviour expression and 
manipulation of GABAA receptor δ subunit activity or expression provides one 
model to study how post-partum depression may occur and a potential therapeutic 
target [361]. 
 GABA neurotransmission therefore is not only important in the control of 
aggressive behaviour, especially in males, but alsonxiety and depression which 
may be related to maternal aggression expression [361, 371, 375, 381, 389]. GABA 
neurotransmission is also closely correlated with many emotional disorders that 
could be mediated by changes in progesterone or itsme abolite levels, which change 
dramatically during pregnancy and parturition [361, 381, 389]. Hence research is 
starting to focus on how GABA transmission may contr l behaviour during this 
period and indicate possible targets for drugs. 
 
1.8 The aim of this thesis  
The aim of this thesis is to understand and gain knowledge into the control and 
regulation of maternal behaviour, specifically one aspect; maternal aggression. 
Maternal aggression is the focus of this thesis because it is hard to induce aggression 
in non-maternal rats and maternal aggression is expressed specifically only during 
the post-partum period. Therefore there is a short time period where the behaviour is 
switched on and off. Thus manipulation of neuromodulators that may result in 
changes to maternal aggression that can be readily observed. During the peri-partum 
period when maternal aggression is expressed, therear  numerous changes occurring 
in the female. Hormone levels are rising and falling, alongside changes in receptor 
expression and functioning to maintain normal behaviour expression. If these do not 
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occur normally, not only may they result in disorders in the mother but they can also 
have lifelong consequences for the offspring [14-17]. Hence the importance of 
understanding what changes are occurring and what part they play in the maternal 
behaviour circuitry that organises maternal aggression. 
 For studies in this thesis it was decided to explore the effects of OXT and 
AVP on maternal aggression because there is substantial evidence for these 
neuropeptides being involved in numerous social behaviours, including affiliation, 
social memory and aggression, all which are important during the post-partum period 
for offspring survival [3, 44, 227, 228, 290, 304, 307, 314, 316-319, 330, 333, 334, 
339]. Also investigated were roles of GABA and AP, because AP can modulate 
GABA neurotransmission by potentiating the action of GABA at the GABAA 
receptor [342, 359, 362]. Furthermore this effect has been linked with emotional 
disorders especially those which are related to changes in progesterone levels [361, 
370, 381]. During pregnancy progesterone levels, and consequently AP, change 
dramatically, so these changes may be linked pregnancy nd post-partum disorders if 
GABA neurotransmission is dysregulated when the levls of AP and progesterone 









Chapter Two: Materials and methods 
2.1 Animals 
Virgin female Sprague-Dawley rats (Charles River) weighing between 200 and 250g 
were used in all studies. The rats were group housed (n = 5/cage) prior to 
experimental setup and fed on normal rat chow diet (RM1). One week prior to 
mating rats were moved onto breeding rat chow diet (T klad 2019) and housed 
overnight with a male until the presence of a seminal plug (Pregnancy day 1) was 
detected. Once pregnant, rats were caged individually for the duration of the 
experiment. Rats were housed under standard laboratory conditions (12h light/dark 
cycle: lights on at 7:00, off at 19:00; temp (19-21oC); humidity (50-55%) and ad 
libitum access to food and water). Virgin females rats were group housed (n = 
5/cage) for the length of the experiment under standard laboratory conditions as 
detailed above. Animal care and use protocols were approved by the University of 
Edinburgh and under UK Home Office Licence guidelins and regulations.  
 
2.2 Injections and sampling 
2.2.1 Subcutaneous (s.c.) 
Subcutaneous injections were either performed at the base of the neck or on the back 
close to the hind legs. An injection was made into the centre of a fold of lightly 
pinched skin.  
2.2.2 Intraperitoneal (i.p.) 
The rat was held on its back and the skin around the s omach area was gently lifted 
and the needle inserted into the body cavity. The ne dle was pulled back slightly 
before injection.  
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2.2.3 Vaginal smears 
To collect vaginal cells, 1-2ml of physiological saline (0.9% w/vol) was gently 
flushed in and out of the vagina using a plastic pipette. The saline containing the 
cells was expelled onto a glass microscope slide an left to air dry. Once the smear 
was dry, cells were fixed in acetic alcohol fixative (AAF) for about 10 sec, drained 
and dipped into toluidine blue (1%; ~10 sec) drained and coverslipped with glass 
coverslips (VWR) using DPX mountant (BDH, Poole). 
Cell morphology was examined under a light microscope with a 20X 
objective mountant to determine the phase of the oestr us cycle (see table 2.1 for 
diagrams and descriptions of cycle phases). 
2.2.4 Blood sampling using tail tipping 
The rat was gently restrained by being wrapped in a towel with the tail was exposed. 
A small nick was then made about 2.5cm from the tip of the tail using a sterile 
surgical blade (Swann Morton). The tail was then getly massaged to encourage 
blood flow. The blood was collected in heparinised capillary tubes (Hawksley, 
Sussex), transferred to sterile Eppendorf tubes which were spun in a centrifuge at 
2000xg for 3-5 min. The plasma was decanted by pipette into a fresh labelled sterile 
Eppendorf tube and stored at -20oC until radioimmunoassay for levels of circulating 
progesterone. 
2.3 Surgery 
2.3.1 Intracerebroventricular (ICV) cannulation 
SD rats on day 2 of lactation, weighing 276±7.6g (number of rats = 23), were 
anaesthetised with isoflurane (Dunlop; 0.5-1L/min) mixed with nitrous oxide 
(2L/min) and oxygen (2L/min). Fur was shaved from the op of the head with  
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Table 2.1: Vaginal smear cycle phase morphology. Modified from table 6-1 in The 
Laboratory Rat by Mark A. Suckow, Steven H. Weisbroth and Craig L. Franklin [391]. 
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clippers. The rat was then placed into a stereotaxic frame, making sure the head was 
securely positioned by the ear bars. During this time, a nose cone supplied a constant 
flow of anaesthetic to the rat. 
The rats head was sterilized with povidone-iodine antiseptic solution 
(Vetasept) and a 2cm midline incision made with a sterile surgical blade (Swann 
Morton). Blood was cleaned from the skull with sterile cotton wool buds. Bregma is 
the point where the sagittal suture crosses the coronal suture and is used a place of 
reference on the skull to position a hole for implanting cannula into specific brain 
regions [392]. Bregma is used as a point of reference because in all rats, from 
juvenile until mature, bregma is consistently positi ned above the most forward 
crossing fibres of the anterior commisure [392]. Bregma was located and a hole was 
drilled above the right ventricle (1.6cm lateral to the midline, 0.6cm posterior to 
bregma) using a hand held electrical drill (Precision PCB/modal) with 2.3mm shaft 
drill bit (Fine Science Tools). Two further holes were drilled for screws to be 
implanted; one right rostral and one left caudal to the hole for the cannula. Two 
screws (1.6x3mm cheese head A2; Precision Technology Supplies Ltd) were inserted 
into the holes adjacent to the cannula and acrylic dental cement (Kemdent) was used 
to secure the cannula to the skull. Rats received 1ml of physiological saline (i.p.) to 
correct for dehydration during surgery and a 4mg/kg injection of Rimadyl 
(Carprofen; Dunlop) s.c. for pain relief prior to waking up. Rats were allowed to 
recover on a vet bed heating pad (Vet Tech Solutions Ltd). 
2.3.2 Bilateral microdialysis using cannulation 
The surgery was performed as above until the point of finding bregma. Polyethylene 
cannula tubing (outer diameter 0.97mm, inner diameter 0.58mm; Plastics One) about 
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5cm long was attached to the outflow end of the microdialysis probe (3mm 
membrane length u-shaped; University of Regensburg, Germany). The microdialysis 
probe was checked for any faults and leaks by slowly injecting Ringer’s solution 
(composed of [in mM] 147.1Na+, 2.25Ca2+, 4K+ and 155.6Cl- at pH 7.4; Fresenius, 
Bad Hamburg, Germany) before attaching it to a holder on the stereotaxic frame. The 
probe was positioned vertically in the holding frame and its tip located positioned 
over bregma before it was moved to coordinates for implantation into the designated 
specific brain region (from bregma PVN -1.6 anterior/p sterior, ±1.8 lateral, +9.1 
depth; BnST -0.7, ±1.5, +6.5; LS +0.2, ±2.3 +6.0; MeA -2.0, ±3.5, +9.0 and SON -
0.6, ±1.8, +9.4). In order to avoid major blood vessel , injections into the PVN and 
LS required the probe to be inserted at an angle (PVN o10, LS o20). The first probe 
was inserted in the left hand side of the brain and fixed into place by attaching it to 
one the screws with dental cement (Kemdent) which was set hard by exposure to a 
bright light (KL 1500 Compact, Schott AG, Mainz, Germany). This process was 
repeated for the second probe which was inserted into the right hand side of the 
brain. Again this probe was fixed in place using dental cement (Kemdent) to attach it 
firmly to the second screw and the skull. Once the cement was dry, cannula tubing 
6cm long was attached to the inflow end of each probe. Ringer’s solution (0.5ml) 
was flushed through gently to make certain the probe was still patent and intact. 
Dental cement was then used to firmly attach the tubing to the probes. Coloured tape 
was attached to the inflow (black tape) and outflow (white tape) tubing of each probe 
to keep them together and provide a means of identification of the direction of flow. 
Rats were injected s.c. with 0.03ml of antibiotic (enrofloxacin 3 mg/0.03 mL; 
Baytril, Bayer, Germany) and left to recover in their home cage for one day. 
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2.3.3 Microdialysis Sampling 
At 08.00h on the day of behavioural testing, a syringe filled with sterile Ringer’s 
solution, mounted on a microinfusion pump, was connected with polyethylene tubing 
(30-40cm long) to the inflow tubing of each individual microdialysis probe. To the 
outflow tubing a 1.5ml Eppendorf was attached via a 5cm length of polyethylene 
tubing for sample collection. For 2h prior to the first sample collection, the 
microdialysis probes were perfused with Ringer’s soluti n at a rate of 3.3µl/min. 
Five successive 30 min samples then were collected from each rat. The first two 
samples were taken under basal conditions i.e. the rat was left undisturbed in her 
home cage. Sample 3 was collected during a 10 min maternal aggression test (as 
described below). Samples 4 and 5 were taken following the aggression test with the 
rat left undisturbed. The microdialysates were immediat ly frozen on dry ice and 
stored at -20oC until they were analysed for levels of OXT or AVP by 
radioimmunoassay at the Max Plank Institute, Germany, by Prof Rainer Landgraf. 
 
2.4 Behavioural Testing 
2.4.1 Sensitization of virgin female rats to pups 
On day one of pup-sensitization, 3 pups (aged between 2 and 8 days) were placed 
into the corner opposite the sleeping nest of the virgin female in her home cage. For 
the first 15 min, the rats were observed and any behaviour directed towards the pups 
(sniffing, licking, picking up or retrieving pups) was noted. Spot checks were then 
made at 30, 45 and 60 min after the start of the test with the position of the virgin and 
pups recorded each time. At the end of the observation (60 min), the pups remained 
with the virgin for 24h after which they were removed and 15 min later replaced with 
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3 recently fed pups from a different litter. This protocol was repeated daily until the 
virgin rat displayed full maternal behaviour or 13 days had passed. Rats were defined 
as being fully maternal (i.e. pup-sensitized) when they sniffed, licked and retrieved 
all 3 pups back to the nest within 15 min of the start of the observation test.  
2.4.2 Maternal aggression test 
A novel virgin female intruder (weighing between 200-250g which has been housed 
in a different room) was marked with black pen on its back to allow for identification 
and placed into the home cage of a lactating rat in the presence of her pups (8-18) for 
a specific period of time (either 10 or 30 min). Behaviour was recorded via a digital 
camcorder and later analysed for defensive, offensiv  and maternal behaviours using 
Noldus Observer Video Pro (see appendix 3 and 4 for m re detail). Following 30 
min exposure to the resident, the female intruder was removed and returned to her 
home cage. No female intruder was used more than once per day. 
2.4.3 Maternal behaviour test 
The behaviour of lactating rats in their home cage with their pups present (8-18) was 
digitally recorded for 30 min. 
2.4.4 Pup retrieval task 
Prior to behavioural testing, the entire litter was removed from a lactating rat and the 
pups were covered in bedding to keep them warm in a sep rate cage out of earshot of 
the lactating rat. After 1h of separation, eight of the litter were randomly scattered 
around the home cage. Behaviour was digitally recorded until all eight pups were 
retrieved and returned to the nest or after 30 min. The rest of the litter was then 
returned to the dam in the home cage. The digital recording was analysed for latency 
to approach the pups or sniff the first pup, latency to retrieve the first pup back to the 
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nest, latency to retrieve the first four pups to the nest and latency to retrieve all eight 
pups to the nest.  
2.4.5 Elevated plus maze test  
An EPM consists of four horizontal arms coming out at 90o to each other from a 
central area at the 48.5cm from the floor. Two of the arms are enclosed by walls (at a 
height of 38cm and length 127cm; closed arms) and two arms have no walls (length 
127cm; open arms). Rats were placed into the centre section of the four arms of the 
EPM and allowed to move freely whilst being digitally recorded from above for 5 
min. The behavioural recording was later analysed using Noldus Ethovision for 
latency to enter open/closed arms, time spent in each arm and total distance moved 
(see appendix 4 for more detail). 
2.4.6 Behavioural analysis  
The behavioural videos were uploaded onto Noldus Oberver Video Pro Version 5 or 
XT 7.0 for maternal aggression or maternal behaviour analysis or Ethovision for 
EPM test analysis. Appendix 4 shows the graphical user interface for each program. 
The behavioural videos of the females were analysed for all behaviours. For a 
maternal aggression test, offensive (latency to attack, number of attacks, biting, 
rearing, sniffing), defensive (immobility), normal maternal behaviours 
(grooming/licking, pup carrying, nursing) and normal behaviours (eating, drinking, 
exploring; see appendix 3) were all examined.  
 
2.5 Transcardial Perfusion for Fixation 
The rat was given a lethal overdose of anaesthetic (2.8ml/kg sodium pentobarbital; 
i.p.) 90 min after the start of behavioural testing and perfused via the left ventricle 
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with heparinised saline (250ml) and then fixed with 4 % paraformaldehyde (300ml) 
using a peristaltic pump. The brains were carefully removed from the skull using 
scissors and bone rongeurs, put into a 4% paraformaldehyde and 15% sucrose 
solution and stored at 4-5oC until the brain had sunk (usually overnight). The brain 
was then placed in a 30% sucrose in 0.1M phosphate buff r at 4-5oC for 1-2 days. 
Once sunk in this solution, the brain was removed, the excess solution dried off with 
a paper towel, and divided by coronal cuts with a blade (Fischer Scientific) into thick 
slices including the OBs (cut just prior to the later l septum), main brain (preoptic 
regions and hypothalamus) and hind brain (cut just into the cerebellum) sections. 
Each section was frozen on foil on dry ice and then wrapped in foil before being 
placing into labelled plastic bags and stored at -70 oC. 
 
2.6 Immunocytochemistry 
2.6.1 General principles 
Immunocytochemistry (ICC) is a sensitive and adaptable method for ascertaining the 
specific molecular components of a tissue or cell via an antigen-antibody reaction 
marked by a visible tag [393, 394]. There are several methods for detection varying 
in speed and sensitivity. The method used in this tesis was the Avidin-Biotin 
Complex (ABC) method which has excellent sensitivity and specificity and the 
process can be performed quickly. The ABC method involves application of an 
unlabelled primary antibody specific to the molecul intended for detection. Next, a 
biotinylated secondary antibody raised against the primary is used. Thirdly the 
avidin-biotin complex, where avidin has bound to a biotinylated peroxidase due its 
extremely high affinity for biotin, is applied (Figure 2.1). This is then visualised 
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using diaminobenzidine tetrachloride (DAB), a substrate of peroxidase, forming a 
visual brown tag (with the addition of nickel ammonium sulphate the reaction 
product turns black) enabling visualisation of the labelled molecule under a light 
microscope and allowing quantifiable analysis.  
 Figure 2.1: Avidin-Biotin complex method for immunocytochemistry. 
Immunocytochemistry is used to identify molecules in tissues by an antigen-antibody binding 
mechanism. In this figure, the primary antibody (green) binds to the molecule within the 
tissue. A biotinylated secondary antibody (blue and red) is applied and binds to the primary. 
Finally the avidin-biotin complex is used consisting of avidin bound to a biotinylated 
peroxidase (black, red and yellow). The tissue can then be washed with a substrate of 
peroxidase such as diaminebenzidine tetrachoride which provides a visual tag for the 
molecule. Non-specific binding blocked by using normal serum (blue) during the procedure. 
Modified from Figure 2.3, Immunocytochemistry Practical Applications in Pathology and 
Biology, Polak and Van Noorden (1983). 
 
2.6.2 Gelatinization of slides 
Slides were slowly dipped (to avoid air bubbles) 2 to 3 times in the filtered slide 
gelatinization solution and then left to dry overnight at room temperature (appendix 
5). 
2.6.3 Immunocytochemistry for the immediate early gene (c-fos) Fos protein 
Brains were sectioned at 52 µm on a freezing microtome and sections were collected 
into 0.1M PB. Sections were then washed in 0.1M PB with 0.2% Triton X-100 
(4x15min, PB-T) and once in 0.1M PB (5 min). Endogenous peroxidase was blocked 
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with 0.3% H2O2 in 0.1M PB for 15 min following which sections were insed with 
0.1M PB-T (3x10min). Non-specific immunoreactivity was blocked by incubating 
sections with 1% normal sheep serum in PB-T for 30 min. Sections were then 
incubated with Ab-2 Fos antibody (1:1000, Rabbit Polycl nal; Calbiochem, UK) in 
1% normal sheep serum in PB-T for 48h in sealed labelled vials at 4oC during which 
sections were gently agitated daily.  
After 48h, sections were washed in 0.1M PB-T (3x10min) before being 
incubated in biotinylated anti-rabbit Ig (1:1000) and normal sheep serum (1:100) in 
0.1M PB-T (Vectastain ABC Elite Kit PK6100; Vector Labs) for 1h. Sections were 
washed in 0.1M PB-T (3x10min) before incubation for1h in the Avidin DH and 
biotinylated horseradish peroxidase complex (both 1:500 in  0.1M PB-T; Vectastain 
ABC Elite Kit PK6100; Vector Labs). Sections were then rinsed with 0.1M PB-T 
(2x10min) and 0.1M sodium acetate (5min) before visuali ation with DAB 
(0.25mg/ml) and nickel sulphate (0.025g/ml) with 0.3% H2O2 for up to 10 min. This 
reaction was terminated by immersion in 0.1M sodium acetate and then 5 washes of 
0.1M PB. Sections were then serially mounted onto gelatinized microscope slides 
(Menzel-Glaser) and left to dry overnight before goin  through a series of 
increasingly concentrated ethanol solutions (70%, 90%, 95%, 100% and 100%; each 
for 5 min). Sections were then cleared in xylene (2x5min) before being coverslipped 
with glass coverslips (25mmx60mm; VWR) using DPX mountant (BDH, Poole).  
2.6.4 Double labelling immunocytochemistry 
2.6.4.1 Oxytocin receptor (OTR) 
Rats whose brains were to be processed for OTR ICC were perfused with the OTR 
fixative (see appendix 6 for recipe). Once the brains were collected, they were 
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sectioned coronally and processed for Fos ICC as describ d above. Following 
visualisation, sections were washed with 0.1M PB (2x5min) and then 0.1M PB-T 
(2x5min). Any unreacted peroxidase was blocked with 0.3% H2O2 for 15 min and 
then by washing in 0.1M PB-T (2x10min) before being i cubated in the OTR 
antibody (1:1000, rabbit polyclonal; kindly donated by Dr Fred Van Leeuwen from 
Maastricht University, Netherlands) for 48h in labelled vials at 4oC. Sections were 
then rinsed in 0.1M PB-T (3x10min) before being incubated in biotinylated anti-
rabbit Ig (1:1000) and normal goat serum (1:100) in 0.1M PB-T for 1h. Sections 
were washed again in 0.1M PB-T (3x10min) before incubation for 1h in the Avidin 
DH and biotinylated horseradish peroxidase complex (both 1:500 in 0.1M PB-T; 
Vectastain ABC Elite Kit PK6100; Vector Labs, UK). Sections were rinsed with 
0.1M PB-T (2x10min) and the cytoplasmic OTR was visualised with DAB without 
nickel for 7-10 min resulting in a brown reaction product. This reaction was then 
terminated with several washes in 0.1M PB. Sections were mounted and 
coverslipped as previously described above. 
2.6.4.2 Double labelling for Fos and glutamic acid decarboxylase (GAD) 65/67 
The double labelling ICC method was followed as described above for OTR but 
using standard 4% paraformaldehyde fixative and rabbit anti-GAD 65/67 polyclonal 
antibody (Chemicon International; 1:2000 dilution).  
2.6.5 Methyl green counterstain 
To record the location of cannula or microdialysis probe placement in the brain, 
coronal sections were cut at 52 µm on a freezing microtome and mounted onto 
gelatinized slides. They were then rinsed in distilled water and methyl green solution 
(0.5% methyl green in 0.1M sodium acetate, pH 4.2; Sigma) was applied. Slides 
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were left at room temperature for 5 min before being r sed with distilled water and 
then dipped 10 times in 95% ethanol followed by 100% ethanol (twice). Finally, they 
were cleared in xylene (5 min) before being coverslipped as described above using 
DPX mountant (BDH, Poole).  
2.6.6 Quantification technique 
Slides were coded so the experimenter was blind to which treatment group they 
belonged to and examined under a light microscope (bjective 20X or 40X). For Fos 
ICC only, cells with black or dark grey nuclei (see Fig. 2.2a for examples) were 
counted in the specific brain area of interest defined using The Rat Brain in 
Stereotaxic Coordinates by G. Paxinos and C. Watson ( ee appendix 2 for more 
detail on brain areas examined) [392]. For double ICC, only cells with a clear dark 
brown nucleus and brown cytoplasmic staining were counted (Fig. 2.2b). 
 
Figure 2.2: Examples of Fos and double labelled positive cells from 
immunocytochemistry. Fos positive cells (black arrows; A) and a Fos positive cell too pale 
to be included in the count (red arrow; A) in the supraoptic nucleus of an aggression tested 
rat. A cell was only counted as double labelled if it had a distinctive dark brown nucleus 
surrounded by a paler brown but clearly stained cytoplasm as shown in figure B which is an 
example of double labelled Fos and oxytocin receptor cell (black arrow; B) in the olfactory 




2.7 In Situ Hybridisation 
2.7.1 General principles 
In situ hybridisation (ISH) is an extremely sensitive method enabling detection of 
specific mRNA sequences in certain tissue or cell groups [395, 396]. The method 
uses a probe, made from radioactively labelled single strands of DNA or RNA 
complementary to the specific cellular mRNA, to hybridise to mRNA strand of 
interest under particular conditions to form a stable complex. The radioactive signal 
is then detected by autoradiography where liquid emulsion or autoradiographic film 
is applied to the slides and then left for a defined exposure time before developing. 
The probe used here was a 396 bp riboprobe complementary to the sequence 
encoding the fifth to the midseventh transmembrane regions of the V1a receptor 
kindly donated by Dr Stephen J. Lolait from the University of Bristol. 
2.7.2 Brain sectioning 
Brains were serially sectioned at 15 µm using a cryostat and were collected onto 
labelled polysine microscope slides (4 sections per slide; VWR). Six polysine slides 
were cut as a series, with every 7th section being collected onto a gelatinized 
microscope slides (Menzel-Glaser) to act as a marker slide. Once four sections had 
been collected onto each slide, the 6 polysine slide  n labelled order were put into a 
slide box with a silica gel bag and kept at -25oC. Once the box was full, the slide box 
was sealed with tape and stored at -80oC with the silica gel bag still inside to reduce 
condensation ice damage to the tissue at this temperatur . The 7th slide in each series, 
or marker slides, was dipped into AAF fixative for 10 sec, the excess drained off and 
then dipped into 1% methyl violet. The excess was whed off under running water 
and the slide left to dry. The marker slides were stored at room temperature and used 
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to identify the location of each brain section with reference to the Rat Brain in 
Stereotaxic Coordinates by G. Paxinos and C. Watson,  that slides with brain 
regions of interest could be removed from storage as necessary. 
2.7.3 Plasmid linearization  
On ice, the anti-sense (signal), sense (control) and double digest template 
construction solutions were made up in Eppendorf tubes according to the amounts 
listed below: 
Anti-Sense (100µl digest) Sense (50µl digest) Double Digest (25µl digest) 
20µl DNA   20µl DNA  5µl DNA 
4µl Anti-sense Restriction 4µl Sense Restriction 2µl Anti-sense Restriction  
Enzyme   Enzyme  Enzyme 
       2µl Sense Restriction Enzyme 
10µl Buffer   10µl Buffer  10µl Buffer 
66µl DEPC-H20  66µl DEPC-H20 33µl DEPC-H20  
     
These were then vortexed and incubated in a 37oC water bath for 2h (they were 
vortexed again after 1h in a water bath). Following incubation, 100µl of 
phenol:chloroform isoamyl alcohol (Sigma) was added, the Eppendorf tube was then 
vortexed and centrifuged for 5 min at 16250xg. The top layer was decanted into a 
fresh Eppendorf tube and an equal volume of chloroform:isoamyl alcohol (Sigma) 
was added. The plasmid was vortexed and centrifuged for 5 min at 16250xg again. 
The top layer was removed to a fresh Eppendorf to which 1/10 of its volume 5M 
NaCl (Sigma) and 2x the total volume (i.e. the volume of NaCl and the DNA 
containing solution) of absolute ethanol was added. The plasmid was then frozen on 
dry ice for 10 min, defrosted and centrifuged for 15 min at 16250xg. The supernatant 
was carefully decanted, taking care not to include the DNA pellet, and discarded. 
The DNA pellet was left to air dry for at least 60 min. Once dry the DNA pellet was 
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resuspended in TE buffer (15µl for anti-sense and 8µl for sense) and then stored at -
20oC. 
2.7.4 Gel electrophoresis of linearised plasmid fragments 
Gel electrophoresis was used to check correct linearization of the plasmid. The gel 
separates the plasmid fragments according to size; the shorter (in base pair) the 
length of the fragment, the further it will move through the gel. A DNA ladder was 
also included so that a scale of known lengths from which the length of the anti-
sense, sense and double digest templates could be approximated and checked against 
expected values.  
1g of agarose was added to 100ml of 1XTBE and dissolved gently. 10µl of 
DNA safe stain (Cybersafe) was added and the solution poured into the tray with 
comb in place making sure there were no bubbles. The gel was then left to set for 
about 60 min. Once set, the gel was then placed into the chamber and enough 1X 
TBE was added to completely cover the gel (by at lest 1 mm). On ice, 2µl loading 
buffer and 8µl DEPC-H2O was mixed with 2µl of the antisense or sense template. 
For the double digest, 5µl was added to 1µl loading buffer and 4µl DEPC-H2O.  The 
solutions were then added to the wells as laid out below: 
DNA Ladder  / Anti-sense          / Sense          / Double Digest / DNA ladder  
(10µl)   / Template (10µl) / Template (10µl)  / (10µl)              / (5µl) 
 
The voltage was set at 120V and the gel set to run for 60 min. Once run, the gel was 
imaged using Genescan and GeneSnap Program. The plasmid was expected to be 
about 400 bp long. 
2.7.5 Radioactively labelling the linearised plasmid 
To sterile Eppendorfs the following were added: 
 4µl 5X transcription buffer 
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 2µl ATP 
 2µl GTP 
 2µl CTP 
 1µl 100mM DTT 
 2µl template (anti-sense or sense) 
 0.8µl RNase, ribonuclease inhibitor 
 8µl S35-UTP (for sense only 4µl) 
 2µl RNase polymerase (SP6 for anti-sense, T7 for sense) 
 
These were then incubated in water baths (40oC for antisense and 37oC for sense) for 
2h. After 2h, 2µl of DNase was added to digest the template and the Eppendorfs 
vortexed before being returned to water baths at the same temperatures as above for a 
further 15 min.  
2.7.6 Purification of labelled probe 
The anti-sense and sense labelled probes were purified using NICK columns 
(Sephadex). The solution at the top of the NICK column was discarded and 1 ml of 
TE buffer added, shaken and also discarded. 3ml of TE buffer was then added to the 
NICK column and allowed to completely elute into the waste pot. The probe was 
then applied to the top of the column followed by 400µl TE buffer and left to elute 
entirely. Another 400µl TE buffer was added to the column and once the first drop 
had been discarded, the probe was collected into a fresh sterile labelled Eppendorf. 
2µl of each eluted probe was pipetted into individual scintillation vials with 3.5ml of 
scintillation fluid and then counted using a Beckman beta counter. This was to check 
two things, firstly that the probe was radioactively labelled and secondly to get a 
value of probe activity (i.e. counts per min per µl of probe) required for the 





2.7.7 Tissue preparation and fixation 
Slides with the section of interest, taken directly from storage at -70oC, were put into 
racks and placed into 4% paraformaldehyde in PBS for 10 min and rinsed in 2 
washes of 1X PBS (each for 5 min). They were then incubated in 300ml 
triethanolamine (Sigma) with 0.75ml acetic anhydride (Sigma) for 10 min to reduce 
background. Slides were rinsed again with 2 washes of 1X PBS (each for 3 min) 
before being dehydrated through increasing concentrations of ethanol (70%, 80% and 
95%) for 2 min each and left to air dry for about 30 min. 
2.7.8 Pre-hybridisation 
In a humidifying box, blotting paper (2 layers thick) was placed to fit the bottom of 
the box and covered with 20ml of box buffer (4ml 20X SSC, 6ml DEPC- H2O and 
10ml deionised formamide). To each slide, 200µl of prehybridisation solution (50% 
prehybridisation solution with 50% deionised formamide) was applied and gently 
spread over. Slides were then laid in the humidifying box on a glass or perspex plate, 
ensuring that they were level, and incubated for 2h at 50oC. 
2.7.9 Hybridisation 
The volumes required for the hybridisation solution were calculated using the 
formulae below.  
2.7.9.1 Formulae for Hybridisation Solution Calculation 
Total Hybridisation = Volume of Hybridisation Solution required per slide 
Solution Volume  (200µl) x Number of Slides 
 
Volume of Deionised = 50% of Total Hybridisation Solution Volume 
Formamide 
 





Volume of Probe   =  Radioactivity required (Total Hybridisation Solution  
     Volume x 10 x 106 cpm/ml)  
Probe Activity 
 
Volume of   = Total Hybridisation Solution Volume – (Volume of  
Hybridisation Buffer  Probe + Volume of DTT + Volume of Deionised  
    Formamide) 
 
Once calculated the hybridisation buffer and deionised formamide (Sigma) were 
added together, vortexed and incubated at 70oC for 10 min. The mixture was cooled 
on ice for 1 min and the DTT (Sigma) added before again vortexing the solution. 
Slides were removed from the oven and 200µl of hybridisation solution was applied 
to each after draining off as much as possible of the prehybridisation solution. Slides 
were then returned to the humidifying box as before and incubated at 55oC for 16-
18h. 
2.7.10 Post hybridisation washes 
Slides were removed from the oven, drained and placed into slide racks and taken 
through 3 washes of 2X SSC (each 5 min) at room temperature. 
2.7.11 RNase incubation 
In a RNase humidifying box, one layer of blotting paper was placed in the bottom 
and 20ml of box buffer added. Following washes, 200µl of RNase solution (1µl 
RNase/2ml box buffer) was applied to each slide. Slides were then incubated in the 
humidifying box for 60 min at 37oC. 
2.7.12 Post RNase treatment washes 
Following incubation, slides were returned to racks and washed in 2X SCC at room 
temperature for 30 min. They were then rinsed in 0.1X SSC twice at 65oC; the first 
being 90 min and the second 60 min with the solution being left at room temperature 
to cool. A fourth wash was for 60 min in 0.1X SSC in solution that had been left to 
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cool to room temperature. Slides were then put through a series of increasing 
concentrations of ethanol (50%, 70% and 90%) in 0.3M ammonium acetate (each for 
2 min) and left to dry overnight.  
2.7.13 Application of autoradiographic emulsion 
In a dark room with the lights off and the red light on, a bottle of emulsion (Ilford) 
was placed in a black box in a 40oC water bath and left for 2h to melt. Again with the 
lights off and the red light on, the emulsion was poured into a glass slide dipping 
container carefully to ensure that no air bubbles formed in the emulsion. The slides 
were then dipped and left to dry in a light proof bx overnight. Once dry (again with 
lights off and the red light on), slides were transferred into a slide box with a silica 
bag to reduce moisture, sealed with tape, wrapped in foil and sealed in a black bag 
again with tape. They were then stored at 4oC for the desired exposure time. Extra 
test slides were always included and developed at intervals to ensure optimum 
exposure time. 
2.7.14 Development of autoradiographs 
In the dark room with the lights off and red light on, slides were removed from the 
slide box and put into slide racks. Next the slides w re dipped in fresh developer for 
10 min (Kodak D19, 80g in 500ml water). Slides were th n dipped in distilled water 
and then placed into fixer (2x10min, Ilford Hypam rapid, 100ml in 400ml water), 
followed by two 5 min rinses in distilled water. Slides were then processed for 
haematoxylin and eosin background tissue staining. They were put into Shandon 
Harris haematoxylin (acidified, 100%; Thermo Electron Corporation) for 5 min 
before being rinsed with water. Then slides were dipped twice in acid alcohol, rinsed 
with water again and left in Scott’s tap water substitute (STWS; see appendix 5 for 
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details) for 3 min. Slides were then washed in water (running) for 3 min before being 
dipped into eosin solution (1%) for 3 min. They were rinsed with water dipped into 
potassium aluminium solution (5%; see appendix fourr details) for 3 min. Finally 
slides were rinsed again in water before being taken through a series of increasing 
concentrations of ethanol (70%, 90%, 95%, 100% and 100% for 5 min each), cleared 
in xylene (two 5 min washes) and coverslipped (25x60mm, VWR) with DPX 
mountant (BDH Poole). 
2.7.15 Quantification technique 
Slides were coded so the experimenter was blind to treatment group. The silver grain 
density of neurons within the area of interest were quantified under a light 
microscope (objective 40X) aided by a computer image nalysis system (Open Lab; 
Improvision Lexington MA). Three measurements were taken per area of interest 
using a fixed shape and three background measurements w re collected from tissue 
close to the area of interest which exhibited little or no signal. Background 
measurements were then averaged for each rat and the average subtracted from each 
area of interest measurement for the same rat. The average silver grain density of the 
area of interest for each rat was then calculated. 
 
2.8 Receptor Autoradiography  
2.8.1 General principles 
Whilst ISH and ICC provide detailed and important iformation about the cellular 
and tissue location of specific receptors or molecules, they cannot inform us about 
the functional binding affinity of these locations. Receptor autoradiography, on the 
other hand, has poor cellular resolution but can provide the binding site location of 
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specific receptors. Receptor autoradiography involves applying a radioactively ligand 
specific to the receptor of interest to fixed tissue section [397, 398]. The ligand will 
then bind to the receptor binding site and the radio ct ve signal from the bound 
ligand can then be detected by autoradiographic methods, in this study by using 
films. Together these methods, ISH, ICC and receptor autoradiography enable a good 
understanding of the origin, distribution and location of a specific receptors and 
hence, of their physiological functioning [397]. An I125-orithine vasotocin analog 
(I125-d(CH2)5[Tyr(Me)
2,Thr4,Orn8)(125I)Tyr9-NH2];
 Perkin Elmer) or the linear I125 
AVP-A tracer (I125-d(CH2)5[Tyr(Me)]-AVP; Perkin Elmer) was used for the OXT 
and AVP receptor binding studies respectively.  
2.8.2 Method  
Slides with unfixed coronal brain sections of interest were removed from storage at -
80oC, left at 4oC for 30 min and for a further 30 min at room temperature. They were 
then put into glass troughs and fixed for 2 min in 0.1% paraformaldehyde followed 
by rinses in 50mM tris buffer (Sigma; 2x10 min). Next, slides were incubated for 60 
min in 50mM tris buffer with 10mM MgCl2 (Sigma), 0.1% BSA (Sigma) and 
radioactive tracer (2000cpm/10µl; Perkin Elmer). Slides were rinsed with tris MgCl2 
buffer (4x5 min) followed by a 30 min spinning wash in tris MgCl2 buffer. Finally 
they were dipped into distilled water before being dried with cold air (from a 
hairdryer). In a dark room with a red light on, the slides were arranged onto a 
cassette and film (Kodak BioMaxMR) laid on top. The cassette was then closed and 




2.8.3 Quantification Technique 
Receptor binding was quantified using the NIH Image program (Image J 1.31; 
National Institute of Health) as grey density minus background for specific brain 
areas of interest (see appendix for definition of these areas). Deduction of 
background means the measurement reflects specific binding only. Means were 
calculated for each individual rat using brain slices with areas of interest comparable 
to each other (4 sections per rat). 
 
2.9 Progesterone Radioimmunoassay (RIA) 
2.9.1 General principles 
This assay enables accurate measurement of serum progesterone concentrations by 
using a radioactively labelled antigen (I125 labelled progesterone in this case) which 
will compete with a non-radioactively antigen for a specific number of antibody 
binding locations. Once free and bound antigens have been separated by decanting, 
the amount of radioactively bound antigen can then b  measured using a gamma 
counter and is inversely proportional to the concentration of non-radioactive antigen 
present in the sample. The assay sensitivity is 0.12ng/ml. 
2.9.2 Method 
Prior to performing the assay, standards and control solutions were reconstituted by 
adding 0.5ml of deionised water to each, except standard A which required 1 ml. 
Standards and controls were included in each assay run. The values from the 
standards were used to form a standard curve from which the concentration of 
progesterone in unknown samples was read (an example of a standard curve is in 
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figure 3). Controls were included in order to check the validity of the standard curve 
formed. 
Two plain tubes were labelled for total counts and the anti-progesterone-
coated tubes were labelled in duplicate for standards, controls and samples. To each 
appropriately labelled tube, 25µl of standard, control or sample was pipetted to the 
bottom. Immediately, 500 µl of progesterone (I125) reagent was pipetted into each 
tube and the rack gently shaken before incubating all tubes at 37 oC for 70 min. All 
tubes were decanted, except total counts, and after being blotted on absorbent paper, 
left inverted to drain completely for 2 min. Once drained, all tubes were counted 
using a gamma counter for 1 min.  
Progesterone (ng/mL)




















Sample Standard Curve for Progesterone Radioimmunoassay
 
Figure 2.3: Example of a standard curve for progesterone radioimmunoassay. Values 
used are from the data given by Diagnostics Systems Laboratories as typical Active 




Chapter Three: Maternal aggression and pup removal 
3.1 Introduction 
Maternal aggression is an important maternal behaviour generally defined as 
the protection of the offspring from a harmful intruder [169, 175, 176, 180, 399]. To 
this end there must be some balance in expressing maternal aggression between 
protecting the offspring and harm that may come to the mother during the aggressive 
encounter [54].  
In lactating mice, maternal aggression is significantly decreased if pups are 
removed for at least 5h but maternal aggression can be re-instated by the re-
introduction of pups for as little as 5 min [6, 169]. Similar findings have been 
reported for lactating rats where pup removal for 4h significantly decreased attack 
and bite number and significantly increased attack l tency [179, 190]. By 24h after 
pup removal maternal aggression was entirely eliminated in rats [179, 190]. As in 
mice, it was observed that maternal aggression could be reinstated if lactating rats 
were re-exposed to pups although the time period requir d was substantially longer 
(at least 1h) [179]. Studies in hamsters however, have shown that 6h of pup removal 
had little or no effect on maternal aggression [175]. It was suggested that this was due 
to the fact that lactating hamsters were tested in their home cage and therefore the 
olfactory cues remaining from pup odour on the bedding meant maternal aggression 
did not diminish [175]. However, this seems unlikely as both mice and rats in the 
studies described above were also tested in their home cages [6, 169]. Until further 
experiments are performed a better hypothesis to test would be that for maternal 
aggression in the hamster, pup cues do not play such an important role in reinforcing 
maternal aggression as they do in rats and mice [175]. In support of this is the 
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observation that maternal aggression in lactating hamsters does not diminish as the 
lactation period progresses in contrast to rats and mice, for which research has shown 
tactile and olfactory cues from pups are essential in maternal aggression regulation 
[188].  
Nulliparous mice that have undergone thelectomy (surgical removal of 
nipples) prior to mating or parturition (i.e. pre-partum) exhibited significantly reduced 
maternal aggression compared to mice given post-partum thelectomy after 48h of 
suckling experience [195]. This indicates that suckling experience (of at least 48h) is 
essential in mice for the initiation but not maintenance of maternal aggression [195]. 
It is olfactory, visual and auditory cues from the pups which are important for 
maternal aggression maintenance as lactating mice whose pups were present behind a 
mesh wire (i.e. no physical contact between mother and pups) still exhibited normal 
maternal aggression levels towards a novel conspecific intruder [6]. Olfactory cues 
also appear to help with identification of the intruder. Studies have shown no 
maternal aggression is displayed to a male if the resident lactating mouse has 
previously been exposed to this individual behind a wire mesh (again preventing 
physical contact) for at least 7 days (lactation days 2-7) [6]. It may be advantageous 
not to attack a familiar male as in the wild it has been observed that mice communally 
rear offspring [6].  
In the rat, suckling does not appear to be as important for the initiation of 
maternal aggression. Pre-partum thelectomy does not affect maternal aggression at 
late pregnancy or postpartum, however suckling must provide some important 
sensory stimulation necessary for maternal aggression as complete anaesthesia of the 
nipple and surrounding skin severely reduced or abolished maternal aggression in the 
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Long Evans strain of rat [183, 190]. Olfactory cues for rats, as in mice, are important 
in the regulation of maternal aggression. Complete r moval of the olfactory bulbs 
(BOBX) results in abolishment of maternal aggression but this may be a consequence 
of poor maternal behaviour rather than an inability to detect olfactory cues [225]. 
However BOBX does not allow distinction between volatile and non volatile 
(pheromonal) olfactory cues, if lactating rats are subjected to ZnSO4 application 
which eliminates only volatile cues by destroying the olfactory epithelium. In this 
case little or no effect is observed on maternal aggression unless tested later in 
lactation where it significantly reduces maternal aggression [181, 188, 225]. It has 
been proposed that maternal aggression during earlylactation is regulated by both 
hormones of the peri-partum period and sensory cuesfrom pups. As the lactation 
period progresses and hormonal levels normalise, the primary maternal aggression 
drive is from pup chemosensory cues [181, 184]. Nevertheless the reduction in 
maternal aggression observed in both rats and mice following pup removal does 
highlight the point that maternal aggression is not entirely regulated by the hormonal 
changes of the peri-partum period; it must also rely on reinforcement from pup cues, 
both somato- and chemosensory. 
It has been established that it is possible to induce maternal behaviour and 
maternal aggression in virgin female rats by exposing them to pups for 24h a day for 
at least 7 days without any hormonal manipulations [10]. However although the level 
of maternal behaviour is similar to lactating rats, the level of maternal aggression is 
never as high [3, 173, 400]. In contrast, virgin female mice are observed to express 
maternal behaviour towards 1 day old pups spontaneously [182]. Further to this, these 
pup-sensitized mice also display maternal aggression towards a novel conspecific 
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[182]. If pups are removed from these pup-sensitized virgin female mice, maternal 
aggression diminishes in the same manner as in lactating mice although within only 
1h compared to the 5h separation required by lactating mice [182]. As in mice, pup-
sensitized ovariectomised rats show maternal aggression towards a conspecific male 
[174]. These studies provide evidence that the expression of maternal behaviour, and 
hence learning to interact with pups and interpret up signals, is important in the 
development of maternal aggression as well as hormonal influences.  
Mapping of both Fos and pCREB expression has been reported with increases 
in many specific brain areas following the display of maternal aggression in both 
mice and rats [12, 67, 188, 194]. In lactating mice, th  number of Fos positive cells 
was observed to significantly increase in the claustrum, BnST, MPOA, PVN, MeA 
and cortical amygdala following maternal aggression [12]. pCREB expression in 
lactating mice which displayed aggression during a m ternal aggression test was 
reported to significantly increase only in the ventrolateral PAG and LS compared to 
non aggressive lactating mice [12]. These results are in concordance with Hansen and 
Gammie (2005, [194]) who observed significant increases in Fos expression in the 
BnST (dorsal and ventral), PVN, amygdaloid complex (central, basolateral and 
medial), MPOA, cingulate cortex and OBs (mitral and granular call layers) in 
aggression tested lactating mice compared to virgin females. Furthermore, 
examination of early growth response factor expression (Egr-1) showed significantly 
increased activation in the PVN, lateral PAG, MeA, CeA, BlA, anterior, lateral and 
ventromedial hypothalamus in aggression tested lactating mice compared to untested 
mice [196]. Aggression tested lactating rats similarly showed increases in Fos 
expression in the BnST, PVN, MeA and PAG regions [188]. Together these results 
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provide evidence for the brain regions important in the regulation of maternal 
aggression and highlight the neural circuitry of maternal aggression. 
Lactating rats not only display fierce aggressive behaviour but have also been 
extensively reported to exhibit reduced anxiety on the EPM, in conflict tests and open 
field paradigms [29, 31-33]. They also express a reduc d fear response to a sudden 
noise [42]. However, little is known of the effect of maternal aggression on the 
display of anxiety, as most studies have examined both separately but never in 
relation to one another.  
In this chapter, the first aim was to clearly defin the changes to specific 
maternal aggression behavioural components following pup removal for increasing 
duration in lactating rats. The second aim was to discover whether the level of 
activation in specific brain regions correlates with the expression of specific maternal 
aggression behavioural components. This was done by examining Fos expression in 
specific brain regions linked to maternal aggression in the rats from the pup removal 
experiment and testing if the number of Fos positive cells correlates with the duration 
of a specific maternal aggression behavioural component. Pup-sensitized virgin 
female rats were also tested in these paradigms to allow us to compare the effects of 
hormone and pup stimulation versus pup stimulation only on maternal aggression 
expression and brain activation. This experiment was done with the assistance of 
Honours student, Kathryn Cruickshank. The final aim was to examine whether the 
lactating rat being in the aggressive state results in a lower anxiety behaviour profile. 
This was investigated by observing the behaviour of lactating rats on the EPM 
following the exhibition of aggressive behaviour.  
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3.2 The effect of pup removal on the expression of maternal aggression in 
lactating and pup-sensitised virgin female rats  
3.2.1 Method 
For lactating rats (Dam), their entire litter of pups was left (n=8) or removed from 
their home cage 2 (n=7), 6 (n=7) or 24h (n=8) prior to a 30 min maternal aggression 
test. Virgin female rats (Virgin) underwent the pup-sensitization process (described 
in chapter 2). On the day after virgins were defined as ‘fully maternal’, they were 
randomly assigned to one of two groups. The pup-sensitization observation was 
performed for both groups as before and one group was then immediately exposed to 
a 30 min maternal aggression test (n=7). The other group had all donor pups removed 
immediately after the pup-sensitization test and 2h later was subjected to a 30 min 
maternal aggression test (n=9). Ninety min following the start of the maternal 
aggression test, rats were anthaesthetised and perfused with 4% paraformaldehyde. 
The brains from perfused rats were collected and processed for Fos ICC. 
The number of Fos positive cells were counted in the LS, BnST, MPOA, 
SON, MeA, CeA, PVN and PAG according to the ICC quantification technique 
described in chapter 2. 
3.2.1.1 Statistics 
A one way ANOVA was performed to compare the effects of treatment (0, 2, 6 or 
24h pup removal) on the all groups for behaviour and Fos expression in the LS, 
BnST, MPOA, SON, MeA, CeA, PVN and PAG with a Holm-Sidak post hoc test to 
determine which groups were statistically significantly different. If data were not 
normally distributed a one way ANOVA on ranks was performed using a Dunn’s test 
post hoc instead. When p≤0.05, data were defined as significantly different.  
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3.2.2 Results  
3.2.2.1 Pup-sensitization  
A total of 26 virgin female rats began the pup-sensitization procedure. One rat 
immediately killed the pups in the first day of testing and was subsequently removed 
from the whole experiment. Of the remaining 25 virgin rats, 9 did not express any 
maternal behaviour after 13 days of testing and were r moved from the study. The 
other 16 became maternal within an average of 7.37±0.7days so 61.5% of virgin 
female rats that started the pup-sensitization process were successfully pup-
sensitized. There was no significant difference in latency to become maternal 
between the two groups chosen for the pup removal experiment (p=0.15, t1.53). 
Another virgin female rat that became maternal following the pup-sensitization 
procedure was removed from the study because during maternal aggression testing 
this rat and the intruder killed the pups. 
3.2.2.2 Aggressive behaviour  
Attack behaviour expression in lactating rats changed dramatically following 
removal of pups (Fig. 3.1). The latency to attack was significantly decreased 6h (dam 
6h; p<0.001, H5=31.99) and 24h (dam 24h; p<0.001, H5=31.99) following pup 
removal compared to dams with pups present (dam PP) but not by 2h (dam 2h; 
p>0.05, H5=31.99; Fig. 3.2). Time spent displaying attack behaviour and attack 
number were also significantly lower in the dam 6h (attack duration - p<0.001, 
H5=30.67; attack number – p<0.001, H5=29.65) and dam 24h (attack duration - 
p<0.001, H5=30.67; attack number – p<0.001, H5=29.65) groups compared to dam 
PP but not dam 2h group (Fig. 3.2 and 3.3).  
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 Pup sensitized virgin rats displayed significantly fewer attacks (p<0.001, 
H5=29.65) and longer attack latencies (p<0.001, H5=31.99) whether pups remained 
present (virgin PP) or had been removed for 2 hours (vi gin 2h) compared to the dam 
PP group but no other dam group. Both groups also spent a significantly shorter time 
attacking the intruder compared to the dam PP group (p<0.001, H5=30.67).  
For other aggressive behaviours, the duration of biting behaviour was 
significantly reduced in the dam 2h (p<0.001, H5=22.11; Fig. 3.3), dam 6h (p<0.001, 
H5=22.11; Fig. 3.3) and virgin 2h (p<0.001, H5=22.11; Fig. 3.3) groups but not the 
dam 24h (p>0.05, H5=22.11; Fig. 3.3) or virgin PP (p<0.001, H5=22.11; Fig. 3.3) 
groups compared to the dam PP group. Furthermore, although rearing duration was 
significantly lower in the dam 6h and virgin PP groups (vs dam PP; p=0.002, 
H5=19.32), no change was observed in the dam 24h or virgin 2h groups vs the dam 
PP group (p>0.05, H5=19.32; Fig. 3.3). Expression of pinning down (p=0.003, 
H5=17.86) behaviour was only significantly lower by 24h following pup removal in 
the lactating rat compared to the dam PP group; but in the pup sensitized virgin 
group both the virgins with pup present and virgin with pups removed for 2h 
displayed significantly lower pinning down behaviour compared to the dam PP group 
(p=0.003, H5=17.86). No significant difference was observed in clawing behaviour 
across all groups (p=0.052, H5=10.97; Fig. 3.3). Duration in lunging behaviour was 
significantly different between all groups (p=0.010, H5=15.11) but post hoc analysis 
was unable to determine between which specific groups.  
3.2.2.3 Sniffing behaviour 
Duration of sniffing was observed to be significantly different between all groups 
(p<0.001, F(5,42)=5.85; Fig. 3.2). Two hours following pup removal, time spent 
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sniffing was significantly less than the dam PP group (p=0.005, F(5,42)=5.85). This 
remained so for the dam 6h (p=0.004, F(5,42)=5.85) and dam 24h (p=0.004, 
F(5,42)=5.85) groups compared to the dam PP group. Pup-sensitiz d virgin spent 
significantly less time sniffing whether pups were pr sent (p=0.003, F(5,42)=5.85) or 
2h after removal (p=0.004, F(5,42)=5.85) compared to the dam PP group. 
3.2.2.4 General behaviour 
There was a significant difference in the duration of general behaviours between the 
all groups (p<0.001, F(5,40)=13.88) with the dam PP group spending significantly less 
time displaying general behaviour than the dam 2h, 6h and 24h and virgin 2h groups 
(Fig. 3.4). The virgin PP group also displayed signif cantly less general behaviour 
than the dam 2h, 6h, and 24h groups but not the virgin 2h group (Fig. 3.4). 
Expression of exploring behaviour was higher in dam 24h and virgin 2h group 
compared to the dam PP group only (p=0.002, H5=19.43). Duration of grooming self 
behaviour was significantly higher in the dam PP group compared to the dam 2h and 
24h groups only ((p=0.048, F(5,41)=2.47; Fig. 3.4). 
3.2.2.5 Maternal behaviour 
The virgin PP group exhibited significantly more nesting behaviour than dam PP 
group (p=0.006, T(7,8)=79; Fig. 3.4). 
3.2.2.6 Response to aggression behaviour by the resident 
There was a significant difference between all groups in duration of response to 
aggression behaviours (p=0.044, H5=11.40; Fig. 3.4) but a Dunn’s post hoc test was 




3.2.2.7 Fos expression 
Fos expression was observed to change significantly following different duration 
after pup removal in lactating rats. By 2h following pup removal, Fos expression was 
significantly lower in the BnST (p<0.001, F(5,38)=28.01), PVN (p=0.029, 
F(5,38)=2.82), MeA (p=0.001, H5=19.93) and SON (p<0.001, F(5,32)=8.87) compared 
to the dam PP group and remained so in the dam 6h and 24h groups (Fig. 3.5). 
However, although Fos expression in the PAG (p=0.015, H5=14.01) was 
significantly lower than the dam PP group in the dam 6h, no significant difference 
was observed in the dam 24h group (Fig. 3.5). After 24h of pup removal, Fos 
expression within the LS (p<0.001, H5=26.60), and CeA (p<0.001, H5=22.53) was 
significantly lower than in the dam PP group (Fig. 3.5). 
 Fos expression in the BnST (p<0.001, F(5,38)=28.01), LS (p<0.001, 
H5=26.60), SON (p<0.001, F(5,32)=8.87) and CeA (p<0.001, H5=22.53) was 
significantly lower in both the pup sensitized virgin rat group with pups present and 
after 2h of pup removal compared to the dam PP group. Interestingly, only the pup 
sensitized virgin rats whose pups had been removed for 2h had significantly lower 
Fos expression in the PVN (p=0.029, F(5,38)=2.82) and MeA (p=0.001, H5=19.93) but 
only when compared to the dam PP group and not to the virgin PP group.  
Significant difference for Fos expression was observed within the MPOA across all 
the dam groups (p=0.034, H5=12.08; Fig. 3.5), but post hoc analysis was unable to 
determine between which specific groups.  
3.2.2.8 Correlations of Fos expression with aggressive behaviour 
Significant correlations between Fos expression in specific brain regions and 
duration of different components of aggressive behaviour were observed. Table 3.1 
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depicts the p values and r coefficients for each brain egion against each specific 
behaviour (see appendix 6 for graphs). The BnST is one area highlighted as 
important in the aggression circuitry as almost all correlations were significant 
(positively with attack number, attack/biting/clawing/lunging/pinning down duration 
and negatively with attack latency; Table 3.1, Figs. 3.6-3.13); only clawing duration 
was not significant. Similarly, Fos expression within the LS, MeA and PAG were 
significantly correlated with most aggressive behaviours (positively with attack 
number, attack/biting/clawing/lunging/pinning down duration and negatively with 
attack latency; Table 3.1; see appendix 6) but not rearing or lunging for the LS, and 
not clawing or lunging for the MeA and PAG. The SON, PVN and CeA are also 
implicated as significant positive correlations were observed between Fos expression 
and lunging, Fos expression and attack/biting/pinning down duration or Fos 
expression and attack number/attack/pinning down respectively (Table 3.1;s. 
appendix 6). Fos expression in the SON, PVN and CeA was also negatively 
correlated with attack latency (Table 3.1; appendix 6). In the MPOA, Fos expression 
was not significantly correlated with any specific aggressive behaviour (Table 3.1; 
appendix 6).  
Sniffing duration was also examined and significant positive correlations 
were observed with Fos expression within the BnST, LS MeA, CeA and PAG 







Figure 3.1: Mean percentage of total time spent exhibiting different behaviours by the 
resident rat during a maternal aggression test following pup removal. Virgin female rats 
were sensitized to donor pups until confirmed as expressing ‘full maternal behaviour’. Pup-
sensitized virgin and lactating rats were then subjected to a 30 min maternal aggression test 
with their pups present (Virgin PP, n=7; Dam PP, n=8) or 2h (Virgin 2h, n=9; Dam 2h, n=7), 
6h (Dam 6h, n=7) or 24h (Dam 24h, n=8) after pups were removed. The average percentage 
of the total time of the 30 min maternal aggression test spent by the resident rat exhibiting 
aggressive (including attacks, bites, lunging), maternal (including pup moving and nursing), 
response to aggression (including freezing) and general (including exploring, eating and 
drinking) behaviours. In the groups where pups removed, maternal behaviour was defined as 
the digging in the nest or searching the cage for pups. As expected one can see in the dam 
PP group spent the greatest percentage of time exhibiting aggressive behaviour and sniffing 
behaviour which reflects investigation of the intruder. As duration of pup removal increases 
the percentage of time spent expressing aggressive behaviour lowers in the dam groups. 
Note that the percentage of time expressing aggressive behaviours in the dam 6h is 
comparable to the virgin PP and 2h groups indicating maternal aggression is diminishing 
following removal of pups. One other important feature to note is the higher percentage of 
maternal behaviour expression in the virgin PP group compared to the dam PP group 
confirming maternal behaviour is being expressed but pup-sensitization alone has not 
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Figure 3.2: Average number of attacks, attack latency and duration of sniffing by the 
resident rat during a maternal aggression test following pup removal. Virgin female rats 
were sensitized to donor pups until confirmed as expressing ‘full maternal behaviour’. Pup-
sensitized virgin and lactating rats were then subjected to a 30 min maternal aggression test 
with their pups present (Virgin PP, n=7; Dam PP, n=8) or 2h (Virgin 2h, n=9; Dam 2h, n=7), 
6h (Dam 6h, n=7) or 24h (Dam 24h, n=8) after pups were removed. The average number of 
attacks (A) and latency to attack (B) exhibited by the resident rat towards a novel intruder are 
depicted. The average duration (secs) the resident rat spent sniffing the intruder rat during 
the 30 min maternal aggression test is shown in C. A one-way ANOVA was used to compare 
groups followed by a Holm-Sidak post hoc test. If data were not normally distributed, a one-
way ANOVA on ranks was performed followed by a Dunn’s post hoc test. Data are 
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Figure 3.3: Average duration of specific aggressive behaviours expressed by the 
resident rat during a maternal aggression test following pup removal. Virgin female rats 
were sensitized to donor pups until defined as expressing ‘full maternal behaviour’. Pup-
sensitized virgin and lactating rats were then subjected to a 30 min maternal aggression test 
with their pups present (Virgin PP, n=7; Dam PP, n=8) or 2h (Virgin 2h, n=9; Dam 2h, n=7), 
6h (Dam 6h, n=7) or 24h (Dam 24h, n=8) after pups were removed. The average duration 
(secs) of attack (A), biting (B), clawing (C), rearing (D), lunging (E) and pinning down (F) 
behaviour exhibited by the resident rat towards a novel intruder are depicted. A one-way 
ANOVA was used to compare groups followed by a Holm-Sidak post hoc test. If data were 
not normally distributed, a one-way ANOVA on ranks was performed followed by a Dunn’s 
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Figure 3.4: Average duration of specific general, maternal or response to aggression 
behaviours expressed by the resident rat during a maternal aggression test following 
pup removal. Virgin female rats were sensitized to donor pups until defined as expressing 
‘full maternal behaviour’. Pup-sensitized virgin and lactating rats were then subjected to a 30 
min maternal aggression test with their pups present (Virgin PP, n=7; Dam PP, n=8) or 2h 
(Virgin 2h, n=9; Dam 2h, n=7), 6h (Dam 6h, n=7) or 24h (Dam 24h, n=8) after pups were 
removed. The average duration (secs) of general (A), grooming self (B), exploring (C), 
nesting (D) and freezing (E) behaviour exhibited by the resident rat during a 30 min maternal 
aggression test. A one-way ANOVA was used to compare groups followed by a Holm-Sidak 
post hoc test. If data were not normally distributed, a one-way ANOVA on ranks was 
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Figure 3.5: Average number of Fos positive cells in specific brain areas of the resident 
rat during a maternal aggression test following pup removal. Virgin female rats were 
sensitized to donor pups until defined as expressing ‘full maternal behaviour’. Pup-sensitized 
virgin and lactating rats were then subjected to a 30 min maternal aggression test with their 
pups present (Virgin PP, n=7; Dam PP, n=8) or 2h (Virgin 2h, n=9; Dam 2h, n=7), 6h (Dam 
6h, n=7) or 24h (Dam 24h, n=8) after pups were removed. The number of cells expressing 
Fos was counted in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial 
preoptic area (MPOA), supraoptic nucleus (SON), medial and central amygdala  (MeA and 
CeA respectively), paraventricular nucleus (PVN) and periaqueductal grey (PAG) of the 
resident rat following a 30 min maternal aggression test after pup removal for increasing time 
lengths. A one-way ANOVA was used to compare groups followed by a Holm-Sidak post hoc 
test. If data were not normally distributed, a one-way ANOVA on ranks was performed 
followed by a Dunn’s post hoc test. Data are represented as mean + SEM.*p≤0.05. 
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Table 3.1: The p values and r coefficients for correlations between Fos expression 
within specific brain regions and specific behaviours of a lactating and pup-sensitized 
rat following a maternal aggression test. Virgin female rats were sensitized to donor pups 
until defined as expressing ‘full maternal behaviour’. Pup-sensitized virgin (n=16) and 
lactating (n=30) rats were then subjected to a 30 min maternal aggression test with their 
pups present. The purpose of these correlations was to compare expression of a specific 
aggressive behaviour with Fos synthesis in specific brain regions linked with maternal 
aggression hence the data of pup-sensitized virgin and lactating rats was combined. The 
differences seen in behaviour and Fos expression between pup-sensitized virgin and 
lactating rats in Figs 3.1-3.5 therefore should be reflected in the correlations. It would be 
expected that less time spent expressing a specific aggressive behaviour would correlate 
with less Fos expression in specific brains regions. Abbreviations lateral septum (LS), bed 
nucleus of stria terminalis (BnST), medial preoptic area (MPOA), supraoptic nucleus (SON), 
medial and central amygdala (MeA and CeA respectively), paraventricular nucleus (PVN) 



























































































































































































































































3.3 The effect of maternal aggression on the performance of a lactating rat in 
the elevated plus maze 
3.3.1 Method 
Between lactation days 3 to 7, SD rats were subjected to a 10 min maternal 
aggression test immediately followed by 5 min exposure to an EPM task (n=9) or a 
cage disturbance (as a control) 10 min prior to exposure to the EPM for 5 min (n=9). 
Lactating rats were anaesthetised and perfused with 4% paraformaldehyde 90 min 
after the start of maternal aggression test and the brain collected and processed for 
Fos ICC. Fos expression was counted and quantified in the LS, BnST, MPOA, SON, 
MeA, CeA and PVN brain regions using the technique described in chapter 2. 
3.3.2 Results  
3.3.2.1 Aggressive behaviour 
The aggressive behaviour displayed by the aggression tested lactating rats was 
comparable to the level of aggression observed in lactation day (LD) 3-7 rats the 
experiment in which from maternal aggression was studied through pregnancy, 
parturition and lactation (chapter 4). The average number of attacks in 10 min was 
2.11±0.8 (LD4-7 3.80±0.6; p=0.18, t12=-1.43) and the average latency to attack was 
252.14±61.7 secs (LD 3-7 146.1±42.2 secs; p=0.27, t(5,7)=25.0). 
3.3.2.2 Behaviour on the elevated plus maze 
Aggression tested (AT) rats made significantly more entries into either open or 
closed arms overall (p=0.022, t16=2.54; Fig. 3.6). They were significantly more likey 
to enter the open arms of the maze (p=0.031, t16=2.37; AT=5.50±0.9 entries, non 
aggression-tested rats (NAT)=2.88±0.6 entries) althoug  there was no significant 
difference in the number of entries into the closed arms (p=0.17, t(8,10)=60.0; Fig. 
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3.6). The AT group also spent significantly more time in the open arms of the maze 
(p=0.019, t(8,10)=49.0; AT=47.84±8.9sec, NAT=18.10±4.0sec) and significantly less 
time on the closed arms (p=0.008, t16=-3.03; AT=230.68±10.7sec, 
NAT=271.58±7.0sec) than the NAT group (Fig. 3.6). Locomotion (cm/s) in the open 
arm was significantly increased in the AT group compared to the controls (p=0.043, 
t16=2.20; AT=7.03±0.5cm/s, NAT=5.13±0.7cm/s) although there was no significant 
difference in the closed arms (p=0.23, t16=1.25; Fig. 3.6). The total distance travelled 
(cm) was also significantly increased in the AT group overall (p=0.012, t15=2.86) and 
in the open (p=0.002, t(8,9)=40.0) but not in the closed arms (p=0.399, t(8,9)=66.0) 
when compared to the NAT group (Fig. 3.6). 
There were no significant differences between the groups in the latency to 
enter either open (p=0.27, t16=-1.15) or closed arms (p=0.40, t16=0.87; Fig. 3.6). No 
significant difference in time spent displaying rearing (p=0.46, t16=0.75) behaviours 
between the two groups was observed, although therewas a trend for the NAT group 
to spend more time grooming themselves (p=0.054, t16=-2.08) than the AT rats in the 
closed arms (Fig. 3.7). Neither group displayed these behaviours in the open arms.  
3.3.2.3 Fos expression 
Fos expression was significantly higher in AT rats in the BnST (p=0.023, t16=2.51), 
LS (p=0.046, T(8,10)=53.0), MPOA (p=0.007, t13=3.18) and MeA (p=0.002, 
t(8,9)=40.0) compared to NAT rats (Fig. 3.8). There was no significant difference in 
Fos expression in the SON (p=0.93, t(3,10)=22.0), CeA (p=0.13, T(8,10)=58.5) or PVN 
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Figure 3.6: Number of entries, latency to enter, duration and mean velocity on an 
elevated plus maze by a lactating rat following a maternal aggression test. The 
average number of entries into the open and closed arms by a lactating rat during a 5 min 
test on an elevated plus maze (EPM). The aggression tested group (AT; n=9) received a 10 
min maternal aggression test with a novel intruder in their home cage with their pups present 
prior to the EPM test, the non-aggression tested group (NAT; n=9) had a cage disturbance 
and were then left undisturbed 10 min prior to the test on the EPM. The mean duration 
(secs), average velocity (cm/s) and distance moved (cm) in the open and closed arms for 







































































































Figure 3.7: Average time spent by a lactating rat spent exhibiting different behaviours 
on an elevated plus maze following a maternal aggression test. The mean time (secs) 
for a lactating rat spent grooming (A) or rearing (B) in the closed arms on an elevated plus 
maze during a 5 min test. The aggression tested group (n=9) received a 10 min maternal 
aggression test with a novel intruder in their home cage with their pups present prior to the 
EPM test, the non-aggression tested group (n=9) had a cage disturbance and were then left 























































































































































































































































































































































































































































































































Figure 3.8: Average number of Fos positive cells in specific brain areas of a lactating 
rat following a maternal aggression and elevated plus maze test. Fos positive cells were 
quantified in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic 
area (MPOA), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and supraoptic nucleus (SON) in a lactating rat following a maternal 
aggression and elevated plus maze (AT; n=9) test compared to a lactating rat that only 




In this study, it is observed that maternal aggression gradually diminishes in dams 
with lengthening separation from pups. From our study, pup removal for at least 6h 
is required for the most aggressive behaviour, attack, to be significantly reduced. 
Attack number, latency and duration were exhibited at levels similar to dams with 
pups present in dams 2h after their pups were removd. By 6h after pup removal 
attack number, latency and duration were all signifcantly lower suggesting there is a 
switch occurring in the control of the maternal aggression circuitry. Other studies 
have observed a significant decrease in maternal aggression 4h after pup removal in 
Long Evans female rats which would further narrow the ime window in which this 
switch occurs [179]. Thus results from this and previous studies demonstrate that 
between 4h and 6h after pup removal, the attack component of maternal aggression is 
switched off. It is important to note that it was not until 24h following pup removal 
that most components of aggressive behaviour were expressed for significantly less 
time than by dams with pups present, similar to levels observed in lactation day 21 
rats (chapter 4) and previous studies [190]. These behavioural results reveal that 
maternal aggression changes dramatically after the removal of pups and that the 
somatosensory and/or chemosensory cues from pups are essential in the maintenance 
of maternal aggression in lactating rats.  
 Examination of Fos expression in the brain and its correlation to aggressive 
behaviour highlighted the main brain regions involved in the maternal aggression 
control circuitry. The BnST was one region implicated as important in the maternal 
aggression circuitry; Fos expression was significantly lower in the maternal 
aggression test 2h after pup removal along with significant correlations between the 
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level of Fos expression within the BnST and duration of most aggressive behaviours 
(except for clawing). Significant correlations were also observed with attack latency 
and number. Fos expression within the BnST has already been observed to be 
significantly higher following maternal aggression testing in both mice and rats but 
this is the first study to show the level of activaon is positively correlated with more 
aggressive behaviour display [12, 188, 194, 196]. Lesions of the MPOA which 
include the ventral BnST impair maternal behaviour, and OXT administration to the 
BnST impairs maternal aggression [56, 67]. However no study has examined the 
effect of a specific BnST lesion on maternal aggression and the results of the present 
study plus previous would lead to the hypothesis that a direct lesion of the BnST 
would significantly attenuate maternal aggression [12, 56, 188, 194, 196].  
Fos expression within the PVN, SON and MeA was alsosignificantly lower 
by 2h following pup removal compared to dams with pups present. The PVN is 
important in the control of fear and anxiety expression which during pregnancy and 
lactation is significantly reduced compared to non-maternal female rats; thus this 
along with the strong positive correlations observed b tween Fos expression and 
aggressive behaviour expression adds further evidence to the hypothesis that the 
reduction of fear and anxiety controlled by this region around the peri-partum period 
enables maternal aggression [12, 31-34, 188]. The PVN along with the SON is one of 
the main sources in the brain of OXT, which is signif cantly linked to maternal 
aggression control; hence lower Fos activation in the PVN and SON following 2h of 
pup removal may reflect the lower demand for OXT to drive the maternal aggression 
circuitry [188, 198, 227, 265, 267]. Microdialysis sampling of the PVN and the SON 
(chapter 4) in the lactating rat shows an increase in OXT during maternal aggression 
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expression hence future studies should examine OXT release in the PVN and SON in 
lactating rats following pup removal during a maternal aggression test to determine if 
pup cues are essential in contributing to the releas  of OXT necessary for activation 
of the maternal aggression circuitry [320]. The MeA is an important brain region in 
the relay olfactory information so the lower Fos expression after as little as 2h pup 
removal may be a reflection of the significantly less time spent sniffing the intruder 
these dams display [70, 401-403]. Indeed there is a significant positive correlation 
between MeA and sniffing duration. As reduction in Fos activation in these 4 areas 
(BnST, PVN, MeA and SON) is observed as little as 2h after pup removal it could be 
proposed that these areas are highly sensitive to pup cues for their actions in maternal 
aggression regulation.  
Fos activation after the maternal aggression test wa  only significantly lower 
in the LS and CeA after pup removal for 24h. However correlations of Fos and 
aggressive behaviour expression did highlight that t ese regions may be influential in 
the maternal aggression circuitry (Table 3.1 and appendix 6). The LS has been 
implicated as being important only in the control of maternal aggression as lesions of 
the septal region decrease maternal aggression and have no effect on other maternal 
behaviour [67, 404]. Also, all studies examining IEG activation following a maternal 
aggression test have observed an increase in activation of the LS [12, 194]. In this 
study, significant positive correlations were observed for Fos expression within the 
LS with attack number/latency, attack/biting/clawing/pinning down duration. This 
may implicate an important role of the LS in maternal aggression but not control as 
Fos activation in the LS was only lowered once all aggressive behaviour expression 
had been diminished. The level of Fos expression within the CeA was also 
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significantly correlated with attack number/latency, attack/pinning down duration 
thus demonstrating these two areas are also important in the maternal aggression 
circuitry. The CeA is another brain region important in the control of fear and may 
link with the PVN and PAG to reduce neophobia and fear of the intruder to enable 
maternal aggression [105, 405].  
Fos expression after the maternal aggression test wa  only lower after 24h of 
pup removal within LS and CeA compared to dams with pups present therefore it 
could be proposed these areas are more sensitive to n ur modulators (such as OXT, 
GABA, estrogen and progesterone) in their role in maternal aggression control. 
However, as mentioned above, it could also reflect tha they are more involved in 
enabling maternal aggression rather than its direct con rol. One way this could be 
investigated would be to examine Fos expression in rat brains following maternal 
aggression testing at specific lactation time points. It has been inferred that during 
the early stages of lactation, maternal aggression is under the influence of the 
dramatic ovarian hormonal changes postpartum and as these return to normal (i.e. 
during the later stages of lactation) maternal aggression regulation is more influenced 
by pup stimulation [56, 181]. Therefore one would exp ct that areas (BnST, PVN, 
MeA and SON) where Fos activation after the maternal aggression test was 
significantly reduced after 2h pup removal there would be no change in expression as 
the lactation period progresses, but in the other ar as (LS, and CeA) Fos expression 
would be expected to decrease to levels observed in untested lactating rats. Another 
experiment that would help elucidate whether the hormone and pup cues influence 
activation of specific brain regions differently for maternal aggression would be to 
examine Fos expression within virgin female rats, exposed to the maternal 
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aggression test, who have undergone hormone treatment imicking pregnancy and 
parturition. If hormones were important for activaton of the LS and CeA, one would 
expect higher Fos expression in hormone treated virgins compared to vehicle treated 
non pup-exposed virgins, whereas little or no change would be observed within the 
BnST, PVN, MeA or SON. 
Fos expression within the PAG was only significantly lower after 6h of pup 
removal but no different after 24h. Thus the involvement of the PAG in the maternal 
aggression circuitry remains unclear although it is implicated as having a role as 
significant positive correlations were observed betwe n specific maternal aggression 
components and the number of Fos positive cells in the PAG. As mentioned in the 
general introduction the PAG can be divided in different specific regions, each with 
individual functions hence further research examining the specific areas of the PAG 
in connection to maternal aggression may be able to more clearly determine the role 
of the PAG in the maternal aggression circuitry. 
Interestingly there was no change in Fos expression observed in the MPOA 
between dams with pups present or dams whose pups had been removed for 2, 6 or 
24h. Furthermore, no significant correlations were observed between the level of Fos 
expression within the MPOA and display of any specific aggressive behaviour 
component. The MPOA is the area considered to link the unique circuitries of all 
maternal behaviour, as MPOA lesions here disrupt all m ternal behaviours examined 
so far [67]. However, studies have yet to examine if the MPOA is critical for 
maternal aggression, as most lesion studies have only investigated other maternal 
behaviours [67]. The drawback in investigating the effects of MPOA lesions and 
maternal aggression is that it would be hard to distinguish whether impairment of 
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maternal aggression was due to a direct effect on maternal aggression or an indirect 
one through the disruption of the other maternal behaviours caused by the lesion. 
Also, although IEG studies highlight that the MPOA is activated after an maternal 
aggression test, this does reflect how the MPOA may be working in the maternal 
aggression circuitry i.e. the MPOA may work to inhibit expression of other maternal 
behaviours allowing the primary output to be maternal aggression [9, 67, 69, 88, 89]. 
Further research that examines direct infusions of neurotransmitter antagonists to the 
MPOA which excite or inhibit maternal aggression would demonstrate if the MPOA 
is essential in maternal aggression as well as most other maternal behaviour. 
However, the results of our study indicate that the MPOA is more critical for other 
aspects of maternal behaviour such as nursing, grooming, pup retrieval and nest 
building and further evidence of this is observed in the pup-sensitized virgin female 
rats (discussed below).  
 In the pup-sensitized virgin female rats with pups present, reduced or no 
aggressive behaviour was observed in comparison to dams with pup present. No 
attack behaviour was displayed by any pup-sensitized virgin rat; however display of 
all other aggressive behaviour components was observed. Thus the suite of 
aggressive behaviours (apart from attack) which make up maternal aggression can be 
induced partly by stimulation by the presence of pups as observed in previous studies 
[174]. However these aggressive behaviours are only displayed at levels similar to 
dams following 24h pup removal and lactation day 21 rats and never at the high 
levels seen in rats during the first week of lactation, similar to results observed in 
pup-sensitized ovariectomised rats [174]. It appears therefore that for normal 
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maternal aggression levels to be expressed in a non-pregnant rat hormonal 
manipulation is required.  
Mayer and Rosenblatt [183] demonstrated that in non-pregnant 
hysterectomised and ovariectomised rats (to reduce cir ulating ovarian hormones and 
cause a switch in the levels of estrogen and progesterone similar to changes at the 
end of pregnancy), treatment with estrogen could induce aggressive behaviour like 
maternal aggression even without expression of matern l behaviour (i.e. exposure to 
pups). Once maternal behaviour was initiated in these rats, no further change was 
observed in maternal aggression. Yet rats that were estrogen treated following 
pregnancy termination and then exposed to pups to initiate maternal behaviour, were 
significantly more likely to exhibit maternal aggression than pregnancy-terminated 
rats without pup exposure and sensitized non-pregnant sham-hysterectomised and 
ovariectomised rats [183]. Also, a higher percentage of pregnancy-terminated rats 
that initiated maternal behaviour displayed maternal aggression than if they were just 
pregnancy-terminated and estrogen treated [183]. This emphasizes the importance of 
hormonal influences on the control of maternal aggression and especially the 
experience of pregnancy hormonal changes (i.e. the rise of progesterone followed by 
the switch in the estrogen:progesterone ratio at term) for full maternal aggression 
expression. These hormonal changes together with constant stimulation by pups 
result in the greatest display of maternal aggression as removal of pups from dams 
gradually diminishes maternal aggression. It is possible therefore to propose that the 
importance of hormonal influence is for maternal aggression initiation but possibly 
not for maternal aggression maintenance. One way to investigate this would be to 
examine expression of maternal aggression following pup removal after maternal 
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behaviour initiation in hormonally manipulated pregnancy-terminated rats. If pup 
stimulation is essential for maternal aggression maintenance and not hormonal 
influences, one should observe a decrease in maternal aggression similar to that in 
the study performed in this chapter.  
 Fos expression was significantly lower in most brain areas (SON, BnST, LS, 
and CeA) of pup-sensitized virgin rats with pups present following maternal 
aggression testing compared to dams with pups present. Fos or pCREB expression is 
also significantly higher in these areas when aggressiv  mice or rats compared to non 
aggressive following a maternal aggression test [12, 188, 194]. This indicates the 
results we observed here are a reflection of the higher aggression displayed by dams 
compared to virgins. Further evidence of this is provided by the correlation data, 
where higher Fos expression in these brain regions was positively correlated with 
higher maternal aggression. Interestingly, in the MPOA, Fos expression appears to 
be increased following maternal aggression testing i  pup-sensitized virgins 
compared to dams but this is not significant. However, this could be a result of the 
observed increase in nesting behaviour in pup-sensitized virgins compared to dams 
with their pups present. Thus, with further research this may show that the MPOA is 
crucial in the regulation of other components of maternal behaviour but possibly not 
maternal aggression.  
In two brain regions, the PVN and PAG, there was no significant difference 
in Fos expression between dams and pup-sensitized virgins after the maternal 
aggression test. As described above these two areas important in the circuitry for 
fear and anxiety, which are known to be reduced throughout the peri-partum period 
[335]. No differences in Fos expression in these aras between dams and pup-
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sensitized virgins with pups present during maternal aggression testing adds further 
evidence that the state of motherhood involves anxiolysis, and that pup cues are 
important in controlling the actions of these areas on reducing fear and anxiety to 
allow maternal behaviour. Previous studies have obsrved that pup-sensitized virgins 
display reduce anxiety in the EPM and decreased freezing response to auditory noise 
[42, 174, 406]. They have also shown these changes requires the constant presence of 
pups, which is supported by the present study as expression of freezing behaviour 
was significantly higher in virgins after 2h pup removal compared to virgins with 
pup present [390]. The presence of pups may also be important for the dam’s anxiety 
state to as Fos expression in the PAG and PVN was significantly lower in dams as 
little as 2h after pup removal although no differenc  was observed in freezing 
behaviour (discussed above). Examination of anxiety b haviour before and after pup 
removal in lactating rats would add further evidence that the presence of pups was 
important for a dam’s reduced anxiety.  
Interestingly, there was also no significant difference in Fos expression 
between virgin pup-sensitised rats with the pups pre ent compared to dams with pups 
present even though sniffing duration of the intruder was significantly lower. Instead 
this expression of Fos in the MeA may reflect activation of the MeA by olfactory 
cues from the pups to induce the expression of matern l behaviour in the virgin rats.  
The non-pregnant rat therefore remain a useful tool in advancing our 
knowledge about how peri-partum hormonal changes and/or cues from pups regulate 
specific brain areas involved in the neural circuitry of maternal aggression. This is 
because these rats can be induced by specific hormone anipulation, or exposure to 
pups without the influence of ovarian hormones (by hysterectomy and ovariectomy), 
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to express maternal behaviour. Future research using these models examining 
application of hormones to specific brain regions and their effect on maternal 
aggression and other elements of maternal behaviour will help define the specific 
roles of these hormones and peptides in maternal aggression regulation. There is a 
wide range of hormones and peptides currently implicated as being involved in 
maternal aggression and maternal behaviour control, from the neuropeptides OXT 
and AVP, which are investigated and discussed in chapter 1 and 4, to ovarian 
hormone derivatives such as AP (chapter 1 and 5), to neurotransmitters such as 
GABA, which was examined in chapter 6.  
The main other factors currently being researched in the control of maternal 
aggression are CRH, prolactin and serotonin [188]. CRH is involved in the HPA axis 
to activate fear and anxiety; during lactation the HPA axis is hyporesponsive so 
lower central release of CRH may prevent activation of fear and anxiety behaviour to 
enable maternal aggression. This is supported by evidence that application of CRH 
and related peptides, Urocortin 1 and 3, lower matern l aggression in lactating mice 
[188, 204, 205, 407]. Prolactin, as described in chapter 1, is essential for maternal 
care but links with maternal aggression are currently unclear, though centrally 
released prolactin is indicated as possibly being involved [188]. In males, the link 
between aggression and serotonin is well established with high serotonin levels 
inhibiting aggression and low level facilitating aggression [188, 378, 408-413]. 
However, in females the picture is still unclear as elevated serotonin has been 
correlated with lower maternal aggression, but studies examining the effects of 
serotonin antagonists have also observed lower maternal aggression in lactating 
rodents [177, 188, 414-416].  
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 Following a maternal aggression test, aggressive lactating rats display 
significantly reduced anxiety behaviour. They make more entries into the open arm 
and spend significantly longer in the open arms compared to non-aggressive lactating 
rats. However, caution should be applied when interpreting the results because 
aggressive rats moved much faster on the open arms nd travelled a further overall 
distance. Thus these results may actually reflect an increase in vigilance against 
intruders, or searching for pups that would be expected during the lactation period. 
Yet it has been proposed that the EPM is an excellent model to assess state anxiety as 
demonstrated by extensive research examining the effects of a prior stressful 
challenge upon anxiety state on the EPM [417]. For example, experience of restraint 
stress or social defeat prior to placement of the EPM reduces time spent in the open 
arms, indicating an increased anxious state [418-422]. Therefore it could also been 
concluded that a lactating rat in an aggressive state shows reduced anxiety. Virgin 
rats are normally fearful of pups and actively avoid them; however constant exposure 
to pups will induce expression of maternal behaviour [10, 29]. It also, as discussed 
above, induces a reduced anxiety state, hence it is the state of motherhood not 
aggression that reduces anxiety, so the lower anxiety profile on the EPM most likely 
reflects the increased vigilance of the lactating rat in an aggressive state [174, 406]. 
 To conclude, this chapter has emphasized that maternal aggression is not only 
reliant on the dramatic hormonal changes of the peri-partum period but for full 
maternal aggression display it requires cues from pups. It has also demonstrated that 
the BnST, MeA, PVN and SON brain regions involved in maternal aggression may 
be more sensitive to pup cues to control maternal aggression than the LS and CeA in 
lactating rats. Fos expression within the PVN and PAG after maternal aggression 
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testing was not different between lactating and pup-sensitized virgin rats with pups 
present, indicating that the state of motherhood, whether hormonal or pup-induced, 
influences the anxiety and fear circuitry in the brain. Furthermore, we have also 
demonstrated that following a maternal aggression test the lactating rat exhibits a 




















Chapter Four: Maternal aggression and the neuropeptides, Oxytocin and 
Vasopressin. 
4.1 Introduction  
Maternal aggression as discussed in chapter 1 and 3 is an important behaviour only 
expressed around the peri-partum period in rats [168, 79, 181]. The peri-partum 
period is a time where expression of social behaviours, such as attachment and 
bonding between mother and offspring, are essential to ensure survival. It is therefore 
unsurprising, research is uncovering substantial evidence for the involvement of 
OXT and AVP in the regulation of maternal behaviour especially maternal 
aggression because these two neuropeptide are essential in the control of many 
different social behaviours [23, 25, 107, 152, 227, 228, 266, 277-279, 284-286, 298-
300, 315, 331-334, 345, 423-425].  
In late pregnancy, disinhibition of GABAA receptors just prior to parturition 
causes a dramatic rise in OXT levels both peripherally and centrally [307]. The 
peripheral OXT release from the posterior pituitary gland is important to drive 
parturition and the milk ejection reflex [130, 131, 07, 316]. During parturition, in all 
mammals (where it has been investigated) higher levels of OXT secretion are 
observed along with an increase in uterine responsive ess to OXT [316]. This is as a 
consequence of an increase in OXT receptor (OTR) expression in the uterus, along 
with increases in uterine contractility, so OXT is a powerful uterotonic agent 
important for allowing parturition to progress normally [130]. Further evidence of 
OXT’s crucial role in parturition is when an OXT ant gonist injected intravenously 
not only disrupts the onset of birth, but if it is administered after the start of 
parturition (i.e. after birth of second pup) subsequent pup births will be delayed in 
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mice [426, 427]. In humans, this powerful effect of OXT antagonist administration 
means it is now used in clinical practice to prevent preterm labour [427].  
However, creation of OXT knock out (KO) mice has recently brought into 
question how essential these OXT actions on parturition and maternal behaviour are, 
as these OXT KO mice are able to give birth and express maternal behaviour 
normally [316]. Therefore it is now considered that there is some redundancy in the 
need for the effects of OXT on parturition and maternal behaviour [316]. In terms of 
the milk ejection reflex however, the OXT KO mice further highlight the 
indispensable role of OXT in controlling this function as they are unable to transfer 
milk to their young [316]. However, although OXT has been knocked out in these 
mice, AVP is still present and because of a similar structure to OXT, AVP can act 
upon OTRs [200]. Thus this ability of OXT KO mice to give birth and express 
maternal behaviour may be due to activation of OTRs by AVP. Also, as OXT in 
these KO mice is deleted from birth, it is unknown hat the long term effects of the 
absence of OXT there are on behaviour. Furthermore, OXT expression is absent 
throughout the brain and OXT may have differing functions in different brain regions 
where it might inhibit one area but activate another o result in a specific behavioural 
output. Future research involving OXT KO mice should try to focus on enabling 
researchers to delete OXT at a specific time point and in specific brain regions to 
help elucidate more clearly the actions of OXT on maternal behaviour including 
maternal aggression [428]. 
 Peripheral OXT secretion has clear functions at term in control of parturition 
and lactation however very little of peripherally secreted OXT is able to cross the 
blood brain barrier. Hence it is proposed that centrally released OXT is important for 
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the actions of OXT on maternal behaviour including maternal aggression [318]. It 
was first hypothesised that OXT was essential for initiation and maintenance of 
maternal behaviour, as ICV OXT administration to nulliparous ovariectomised rats 
could induce maternal behaviour whereas infusion of an OXT antagonist ICV in rats 
was able to prevent maternal behaviour expression [131, 316, 317]. However it was 
later observed that once maternal behaviour was initiated, OXT antagonist 
administration had no effect on maternal behaviour [316]. This implies that OXT is a 
requisite for the onset of maternal behaviour but no its maintenance [316]. 
Immediately following parturition in the rat, significant increases in OTR mRNA 
expression is observed in the SON, BnST and MPOA (areas closely linked with 
maternal behaviour) [9, 67, 80, 82, 83, 90, 148, 188, 307]. These increases are 
probably a result of the uterine contraction, cervical and vaginal distension at 
parturition or physical and olfactory and sensory stimuli from pups [318]. OTR 
expression in these specific brain areas rapidly decreases by 12h postpartum to virgin 
rat levels; this is further evidence that OXT may only be necessary for maternal 
behaviour commencement and not its continuation [318].  
 Research also suggests that OXT plays an important p rt in the control of 
maternal aggression, however the literature is conflicti g and its precise role is as yet 
unclear. In rats, administration of antisense oligonucleotide to OXT mRNA (to 
reduce OXT synthesis) or ibotenic acid (which damages neurons that express 
glutamate receptors) into the PVN results increased maternal aggression expression 
whereas electrolytic lesions of the PVN causes a decrease in maternal aggression 
[269, 429]. The difference between these two studies is hard to reconcile as both 
were in the same species of rat, surgery was performed at the same time point and 
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behavioural testing occurred at the same time point [227]. More recently though, it 
has been observed that OXT release is increased more within the PVN in high 
anxiety behaviour (HAB) compared to low anxiety behaviour (LAB) rats during a 
maternal aggression test [320]. Lactating HAB rats re far more aggressive than 
lactating LAB rats hypothesised to be due to the evn higher level of OXT secretion 
in HAB rats during a maternal aggression test [36, 20, 430]. Furthermore, if an 
OXT antagonist is administered centrally to a lactating HAB rat maternal aggression 
is reduced, whereas administration of OXT to a lactating LAB rat will increase levels 
of maternal aggression [320]. This indicates that OXT within the PVN acts to 
increase maternal aggression; however disparities sll remain and further research 
needs to be performed to confirm OXT actions in the PVN on maternal aggression.  
By contrast, the role of OXT within the CeA is more cl arly defined. In the 
rat, OXT injections directly into the CeA (and also the BnST) decrease maternal 
aggression [431]. In agreement with this, direct infusion of an OXT antagonist into 
the CeA increases aggressive behaviour in the lactating rat [432]. In the lactating 
hamster, however, direct injection of OXT into the CeA increases maternal 
aggression [268]. These differences in OXT effects on aggression in the CeA could 
be as a result of a species difference. The CeA is an area known to be a key regulator 
in the control of fear [265, 266]. OXT transmission within the CeA has been shown 
to increase the inhibitory GABAergic action on the AVP fear-inducing neurons of 
the CeA, thereby reducing fear expression [265, 266]. Thus, there is clear evidence 
for OXT to have an important role in the control of maternal aggression and the main 
conclusion currently is that OXT works by modulating fear and anxiety to allow the 
expression of maternal aggression [265].  
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 Whereas the actions of OXT around the peri-partum period are clearly 
characterised especially on parturition, lactation and maternal behaviour, the role of 
AVP is still relatively unknown [424]. Even though AVP is closely related to OXT 
and can act on OTRs, it appears to have little or no effect on parturition or lactation 
[200, 316, 433]. Despite this, research has observed an increase in AVP mRNA 
expression in the PVN and significant changes in central AVP secretion around the 
peri-partum period [297, 330, 424]. Thus these changes and the importance of AVP 
in social behaviour would lead to the proposal that AVP in the peri-partum period 
could have a role in maternal behaviour. Infusion of an AVP antagonist into the 
MPOA inhibits the onset of maternal behaviour but this could be due to the ability of 
AVP to activate OTRs [434]. More recently though, infusion of an antisense AVP-R 
oligonucleotide into the MPOA to down regulate AVP receptors resulted in 
decreased maternal behaviour, specifically reduced fr quency of arched back 
nursing, time the lactating rat spent on pups and impa red pup retrieval. These 
findings imply a direct role for AVP, within the MPOA, for the regulation of 
maternal behaviour after its initiation [424]. Interestingly, these changes in AVP 
receptor expression did not alter the anxiety behaviour expressed on the EPM 
suggesting that AVP actions on maternal behaviour are independent of its role in 
stress and anxiety [424]. Although it is important to note these manipulations of 
AVP-R expression only occurred locally within the MPOA, and there are other areas 
linked with maternal behaviour, such as the PVN andCeA, where AVP expression 
and its control over stress and fear are more clearly stablished [90, 132, 194, 266].  
Administration of an AVP V1a receptor antagonist into the MeA of lactating 
rats disrupted maternal memory providing further evid nce that AVP is important in 
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controlling maternal behaviour; maternal memory is the ability of postpartum rats to 
express maternal behaviour to foster pups after a period of separation from their own 
pups [435]. AVP therefore appears to have an important role in the maintenance of 
maternal behaviour, especially maternal care; however little research has focused on 
its role in maternal aggression even though AVP is already directly linked with other 
forms of aggressive behaviour especially in males. 
 Research has shown that AVP has an important role in intermale aggression 
in hamsters especially when acting on the anterior hypothalamus (AH) [16, 23, 25, 
436]. Social isolation of male hamsters was observed to increase aggression as well 
as increasing the number of V1a AVP receptors in the AH [436]. A V1a receptor 
antagonist applied to the AH was able to inhibit aggression [436]. In rats, AVP has 
been linked with play fighting among juvenile males following maternal separation 
[23]. Early life stress, modelled in Veenema et al (2008, [23]), by separating males 
from their mothers (termed maternal separation), is a risk factor for later social and 
behaviour problems. Veenema et al (2008, [23]) observed that maternal separation in 
the first few days of life increased AVP mRNA expression in the PVN as well as 
offensive play fighting in juvenile males, a precursor for aggressive behaviour later 
in life. These increases in AVP mRNA in the PVN were also observed in adult male 
rats and mice along with increased aggressive behaviour suggesting early life 
experience can determined the ability in later life to deal with social situations [23, 
345]. In relation to maternal aggression however, administration of an AVP V1a 
receptor antagonist to lactating rats was observed to cause an increase in maternal 
aggression [437]. Ibotenic lesion studies have alsoobserved AVP inhibiting maternal 
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aggression in lactating rats [269]. This suggests AVP may act in an opposite way to 
its actions on male aggression and inhibit the expression of maternal aggression.  
 In this chapter, one aim was to build a clear and detailed picture of the 
changes in different aggressive behaviours through the peri-partum period by 
quantifying maternal aggression at specific time points during pregnancy, parturition 
and lactation. This information can then be used to relate specific hormonal changes 
to different behavioural changes during the peri-patum period. The second aim was 
to investigate the hypothesis that OXT and AVP both have regulatory roles in the 
exhibition of maternal aggression. This is examined in a series of studies. The first 
study examined the changes in OTR and AVP receptor binding and AVP V1a 
mRNA receptor expression throughout the peri-partum period and investigated if any 
changes observed correlate with the variation in the level of maternal aggression 
expressed from the study above. The second study examined OXT and AVP 
secretion in specific brain areas during a maternal aggression test at specific time 
points through the peri-partum period when there is large variance in levels of 
maternal aggression. The specific time points for gr ups to be tested were selected 
from the results of the first study examining maternal aggression through the peri-
partum period. The brain areas selected were those which were highlighted as 
important in the maternal aggression circuitry in previous Fos studies (Meddle et al 
unpublished [12, 194, 196]) and the study examining OXT and AVP binding. 
Finally, it was investigated if activation of the maternal aggression circuitry results in 
activation of OXT sensitive cells by examining double labelled Fos and OTR cells in 
the brains of lactating rats following a maternal aggression test at the time of the 
highest maternal aggression. The microdialysis, receptor autoradiography and insitu 
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hybridisation experiments were done in collaboration with Dr Oliver Bosch and his 
students, Johanna Pfortsch and Steffi Kaha at the University of Regensburg, 
Germany. 
 
4.2 Maternal aggression through pregnancy, parturition and lactation in the rat 
4.2.1 Method 
On day 16, 19, 20 or 21 (PD16, n=7; PD19, n=7, PD20, n=7; PD21, n=8) of 
pregnancy, day of parturition (1h after birth of last pup, PD; n=7) or days 4-7 (LD4-
7; n=12), 14 (LD14; n=8), 21 (LD21; n=9) of lactation, SD rats were subjected to a 
10 min maternal aggression test followed by immediat  decapitation. The brain was 
carefully removed and frozen on dry ice for storage t -80oC until required for OXT 
or AVP autoradiography or AVP V1a receptor ISH. 
4.2.2 Results 
4.2.2.1 Aggressive behaviour 
Aggressive behaviour changed dramatically over the peri-partum period. The number 
of attacks changed significantly, with increases fir t seen on PD21 (p<0.001 vs 
PD16, PD20 and LD21, H7=52.16; Fig. 4.4) and then the highest display observed on 
LD4-7 (p<0.001 vs PD16, PD19, PD20 and LD21, H7=52.16; Fig. 4.4). The latency 
to attack showed similar changes with a significantly lower levels observed first on 
PD21 (p<0.001 vs LD 21, H7=43.05) which continue through PD (p<0.001 vs PD16 
and LD21, H7=43.05) until LD4-7 (p<0.001 vs PD16, PD20 and LD21, H7=43.05; 
Fig. 4.4). Duration of attacks (secs) was significantly higher on PD21 (p<0.001 vs 
PD16, PD20 and LD21, H7=51.81; Fig. 4.2).  
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Although significant changes are observed in the display of attack behaviour 
as early as PD21, the amount of time spent expressing all aggressive behaviours is 
only significantly higher on LD4-7 when LD4-7 aggression tested rats spend a 
significantly higher percentage of total time displaying aggressive behaviour than 
PD16, PD20, LD14 and LD21 aggression tested rats (p<0.001, H7=38.69; Fig. 4.1). 
Furthermore, LD4-7 rats spent significantly more time expressing attack (p<0.001 vs 
PD16, PD19, PD20 and LD21, H7=51.81), clawing (p<0.001 vs LD21, H7=28.03) 
and pinning down (p<0.001 vs PD16, PD19, PD20, LD14 and LD21, H7=39.20) 
behaviours (Fig. 4.2). Interestingly, the duration f biting, one specific aggressive 
behaviour, was significantly higher only on PD (p<0.001 vs PD16, PD20 and LD21, 
H7=32.84) whereas there was no significant difference on LD4-7 compared to any 
group (Fig. 4.2). The duration of sniffing was significantly higher on LD4-7 
(p<0.001 vs PD, LD14 and LD21, F(7,58)=5.08) whereas it was significantly lower on 
PD (p<0.001 vs PD20 and LD4-7, F(7,58)=5.08; Fig. 4.4).  
There were no significant differences in the duration of rearing (p>0.05, 
H7=21.30) or lunging (p>0.05, H7=22.67) behaviour throughout the peri-partum 
period (Fig. 4.2).  
4.2.2.2 Maternal behaviour 
Maternal behaviour was significantly higher on PD compared to LD4-7 and LD21 
(p<0.001, H3=21.22; Fig. 4.1 and 4.4).  This included a significant increase in the 
time spent nesting and nursing compared to all lactating tested groups (p<0.001 vs 




4.2.2.3 General behaviour 
Duration of general behaviours was significantly lower on PD (p<0.001, 
F(7,58)=19.22) and LD4-7 (p<0.001, F(7,58)=19.22) compared to all other groups (Fig. 
4.1). There was significantly greater time spent displaying general behaviour on 
LD21 compared to LD14 (p<0.001, F(7,58)=19.22; Fig. 4.1). A significant decrease in 
time spent exploring was observed in the PD (p<0.001 vs PD16, PD19, LD14 and 
LD21, H7=39.64) and LD4-7 (p<0.001 vs PD16, PD19 and LD21, H7=39.64) but no 
significant difference was observed in grooming self b haviour expression across all 
groups (p=0.058, H7=13.63; Fig. 4.3). 
4.2.2.4 Response to aggression behaviour by the resident 
There was no significant change by resident rats in the duration of response to 







Figure 4.1: Average percentage of total time spent exhibiting different behaviours by 
the resident rat during a maternal aggression test. The average percentage of the total 
time of the 10 min maternal aggression test spent by the resident rat (pregnancy day 16, 
n=7; pregnancy day 19, n=7; pregnancy day 20, n=7; pregnancy day 21, n=8; day of 
parturition [PD], n=7; lactation day 4-7 [LD4-7], n=12; lactation day 14 [LD14], n=8 and 
lactation day 21 [LD21], n=9) exhibiting aggressive (including attacks, bites, lunging), 
maternal (including pup moving and nursing), response to aggression (including freezing) 
and general (including exploring, eating and drinking) behaviours. The rats in the parturition 
day group were tested 1h after the birth of the final pup. For PD, LD 4-7, LD14 and LD21, the 
pups were present during the maternal aggression test. One should note that towards the 
end of pregnancy aggressive behaviour starts to increase. This level of aggression remains 
on the day of parturition even with the demand for an increase in maternal behaviour. The 
peak in aggressive behaviour display occurs during the first week of lactation and is 




Figure 4.2: Average percentage of total aggression time spent exhibiting different 
aggressive behaviours by the resident rat during a maternal aggression test. The 
average percentage of the total aggression time spent by the resident rat (pregnancy day 16, 
n=7; pregnancy day 19, n=7; pregnancy day 20, n=7; pregnancy day 21, n=8; day of 
parturition [PD], n=7; lactation day 4-7 [LD4-7], n=12; lactation day 14 [LD14], n=8 and 
lactation day 21 [LD21], n=9) exhibiting attacking, biting, clawing/punching, rearing, pinning 
down, lunging or sniffing behaviours towards a novel female intruder during a 10 min 
maternal aggression test. The rats in the parturition day group were tested 1h after the birth 
of the final pup. For PD, LD 4-7, LD14 and LD21, the pups were present during the maternal 
aggression test. One should note that attack behaviour significantly is only first seen on 
pregnancy day 21. The pie charts also highlight that specific aggressive behaviours are 
exhibited at specific time points, on parturition day biting behaviour is mostly expressed 




Figure 4.3: Average percentage of total general time spent exhibiting different general 
behaviours by the resident rat during a maternal aggression test. The average 
percentage of the total general time the female lactating resident rat (pregnancy day 16, n=7; 
pregnancy day 19, n=7; pregnancy day 20, n=7;pregnancy day 21, n=8; parturition [PD], 
n=7; lactation day 4-7 [LD4-7], n=12; lactation day 14 [LD14], n=8 and lactation day 21 
[LD21], n=9) exhibited eating, drinking, exploring, grooming self or general (defined as 
wandering around cage) behaviours during a maternal aggression test. The rats in the 
parturition day group were tested 1h after the birth of the final pup. For PD, LD 4-7, LD14 
and LD21, the pups were present during the maternal aggression test. The important feature 




























































































































































































































Figure 4.4: Average number of attacks, latency to attack sniffing and maternal 
behaviour duration during a maternal aggression test by the resident rat.  A) The 
average number of attacks during a 10 min maternal aggression test by the resident rat 
(pregnancy day 16 (PD16), n=7; pregnancy day 19 (PD19), n=7; pregnancy day 20 (PD20), 
n=7; pregnancy day 21 (PD21), n=8; day of parturition (PD), n=7; lactation day 4-7 (LD4-7), 
n=12; lactation day 14 (LD14), n=8 and lactation day 21 (LD21), n=9) in her home cage 
towards a novel virgin female intruder rat. Rats tested in the PD group performed the test 1h 
after birth of the last pup. For rats in PD, LD4-7, LD14 and LD21 groups, they were tested 
with their pups still present. B) The average latency (secs) for a resident rat to attack a novel 
virgin intruder. The average time (secs) a resident spent sniffing a novel female intruder (C) 
or exhibiting maternal behaviour (D) during a maternal aggression test. Data are presented 





4.3 Oxytocin binding throughout the peri-partum period: comparison to 
aggressive behaviour 
4.3.1 Method 
Brains which had been collected from the rats in the first experiment of chapter 4 
were serially sectioned using a cryostat (for details see chapter 2) and then processed 
and quantified for OXT autoradiography in the LS, BnST, MPOA, SON, MeA and 
CeA using the method described in chapter 2. Films were left to expose in the dark 
room for 6 days before being developed.  
4.3.1.1 Statistics 
A one way ANOVA was used to compare the groups in each experiment. If data was 
not normally distributed a Kruskal-Wallis One Way Analysis of Variance on Ranks 
was performed. For analysis pregnancy day 16, 19 and 20 groups were combined as 
there little or no difference in behaviour expressed during the 10 min maternal 
aggression test (see results of first experiment above). Data was deemed statistically 
significant when p≤0.05. 
4.3.2 Results 
4.3.2.1 Oxytocin receptor binding 
OTR binding was significantly higher in the LS of the lactation day 4-7 (LD4-7) 
group compared to the day of parturition (PD; p=0.042, F(5,85)=2.96), lactation day 14 
(LD14; p=0.031, F(5,85)=2.96) and 21 (LD21; p=0.018, F(5,85)=2.96) groups (Fig. 4.5). 
No difference on OTR binding in the LS was observed b tween the pregnancy day 
16/19/20 (PD16/19/20; p=0.053, F(5,85)=2.96) or 21 (PD21; p=0.067, F(5,85)=2.96) 
group and the LD4-7 group. Within the BnST, OTR binding significantly increased 
in the PD21 group compared to the LD21 group (p=0.014, F(5,88)=3.19; Fig. 4.5). 
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There was no significant difference between any other groups (p>0.05, F(5,88)=3.19; 
Fig. 4.5). Interestingly, in the MPOA there was a significant increase in OTR binding 
in the PD group compared to the LD14 (p=0.016, F(5,86)=3.61) and LD21 (p=0.006, 
F(5,86)=3.61) groups; no difference was observed with betwe n other group (p>0.05, 
F(5,86)=3.61; Fig. 4.5). For the PD16/19/20, PD21 and PD groups, there were not 
enough SON areas per rat to be able to compare OTR binding. There was no 
significant difference in OTR binding observed in the SON of the lactation day 
groups (p=0.40, F(2,19)=0.97; Fig. 4.5). No statistical difference was also observed in 
the MeA (p<0.05, F(5,84)=3.15) and CeA (p=0.382, H5=5.29) for OTR binding 
















































































































































Figure 4.5: Average oxytocin receptor binding in specific brain regions of rats through 
pregnancy, parturition and lactation following a maternal aggression test. All rats 
performed a 10 min maternal aggression test followed by immediate decapitation. Brains 
were collected and frozen on dry ice before being processed for oxytocin receptor (OTR) 
binding using receptor autoradiography. OTR binding was examined in the lateral septum 
(LS), bed nucleus of stria terminalis (BnST), medial preoptic area (MPOA), supraoptic 
nucleus (SON), medial and central amygdala (MeA and CeA respectively) of rats tested on 
pregnancy day 16, 19, 20 (PD16/19/20, n=21) or 21 (PD21 n=7), day of parturition (PD, 1h 
after birth of last pup; n=7) or lactation day 4-7 (LD4-7, n=6), 14 (LD14, n=7) and 21(LD21, 
n=8). Data are represented as mean +SEM. *=p<0.05 
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4.4 Correlation of maternal aggression with central oxytocin secretion  
4.4.1 Method 
All rats, pregnant and lactating, underwent bilaterl microdialysis cannulation 
surgery two days prior to behavioural microdialysis te t (for details of method please 
refer to chapter 2). Pregnant rats performed a matern l aggression test on either 
pregnancy day 19 or 21 (PD19 or PD21). A third group was allowed to continue until 
full term and tested on lactation day 4 (LD4). Microdialysis cannulas were placed 
into the BnST (PD19, n=8; PD21, n=7; LD4, n=8), PVN (PD19, n=8; PD21, n=6) LS 
(PD19, n=8; PD21, n=9) or SON (LD4, n=8) brain regions. One day after testing, all 
rats were euthanized and their brains collected and frozen on dry ice. Brains were 
then serially cut on a cryostat and the microdialyss probe placement determined.  
The collected microdialysates were sent to Prof Rainer Landgraf at the Max Planck 
Institute and analysed for OXT levels by radioimmunoassay. 
4.4.1.1 Statistics 
A one way ANOVA was used to compare behavioural data between groups. For 
microdialysis, samples 1 and 2 for each group were averaged and defined as 100% 
basal value. The percentage change in OXT (or AVP) of all samples from the 100% 
basal value were calculated and used in further analysis. A one way repeated 
measures ANOVA was used to compare values for samples across a single group. If 
data was not normally distributed a Friedman Repeated Measures Analysis of 
Variance on Ranks test was performed. A change in the release of OXT (or AVP) 
was defined as significant when sample 3 was statistically different from sample 2. A 
t-test or one way ANOVA was used to compare the sample from different groups 
collected during the maternal aggression test (i.e. sample 3). If data was not normally 
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distributed then a Mann-Whitney Rank Sum Test or Friedman Analysis of Variance 
on Ranks test was performed. When p≤0.05, data was defined as statistically 
significant. 
4.4.2 Results 
4.4.2.1 Behaviour during maternal aggression test 
LD4 rats spent significantly longer time sniffing the ano-genital region of the 
intruder rat compared to the PD19 (p<0.001, H2=22.96) and PD21 groups (p<0.001, 
H2=22.96; Fig. 4.6). Less time was spent exploring in the LD4 group compared to 
the PD19 (p<0.001, H2=20.73) and PD21 (p<0.001, H2=20.73; Fig. 4.6) groups. No 
significant difference was observed in number of attacks (p>0.05, H2=7.30) or time 
spent self grooming (p>0.05, H2=7.14) between any groups (Fig. 4.6). 
4.4.2.2 Oxytocin secretion  
OXT secretion within the PVN was found to significantly increase during a maternal 
aggression test for both PD19 (p=0.001, x2=17.69) and PD21 groups (p=0.05, 
x2=9.47; Fig. 4.8). A significant in the release of OXT during a maternal aggression 
test was also observed within the BnST of the PD19 (p=0.004, x2=15.43) and LD4-7 
(p=0.002, F(7,28)=8.70) groups; it was not found to significantly change in the PD21 
group (p=0.08, x2=8.34; Fig. 4.7). OXT release was also observed in the SON for the 
LD4-7 where a significant increase was observed during the maternal aggression test 
(p=0.002, x2=16.50; Fig. 4.8). For PD19 (p=0.21, x2=5.90) and PD21 (p>0.05, 
F(8,32)=5.48) no significant change in OXT release within t e LS was observed during 
the maternal aggression test (Fig. 4.7). There was no ignificant difference in OXT 
secretion during the maternal aggression test between PD19 and PD21 groups in the 

























































































































































































































Figure 4.6: Average number of attacks, time spent sniffing, self grooming and 
exploring for the resident rat during a maternal aggression test. Bilateral microdialysis 
surgery was performed two days prior to maternal aggression testing on all pregnant and 
lactating rats. On the day of testing, rats were connected to microdialysis pumps and left to 
acclimatize for 2h, five dialysates were then collected every half an hour. The first two were 
collected whilst the rat was left undisturbed in her home cage. The third sample was 
collected during 10 min maternal aggression test whilst behaviour was digitally recorded. 
The final two samples were collected with the rat again left undisturbed in her home cage. All 
dialysates once collected were immediately frozen on dry ice until quantification for oxytocin 
by radioimmunoassay. The average number of attacks or time spent exhibiting sniffing, self 
grooming or exploring behaviours during the 10 min maternal aggression test for resident 
rats (pregnancy day 19 [PD19 n=14] or 21 [PD21 n=14] and lactation day 4 [LD4 n=19]). 
*p≤0.05. Data are represented as mean + SEM. 
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Figure 4.7: Oxytocin release within the lateral septum and bed nucleus of stria 
terminalis of the resident rat during a maternal aggression test. Bilateral microdialysis 
surgery was performed two days prior to maternal aggression testing on all pregnant and 
lactating rats. On the day of testing (pregnancy day 19 [PD19] or 21 [PD21] or lactation day 
4 [LD4]), rats were connected to microdialysis pumps and left to acclimatize for 2h, five 
dialysates were then collected every half an hour. The first two were collected whilst the rat 
was left undisturbed in her home cage. The third sample was collected during a 10 min 
maternal aggression test. The final two samples were collected with the rat again left 
undisturbed in her home cage. All dialysates once collected were immediately frozen on dry 
ice until quantification for oxytocin by radioimmunoassay. Microdialysis probes were 
implanted into the lateral septum (LS; PD19 n=8, PD21 n=9) or bed nucleus of stria 
terminalis (BnST; PD19 n=8, PD21 n=7, LD4 n=8).  *=p≤0.05 when sample 3 compared to 
sample 2. Data are represented mean + SEM.  
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SON in LD4 rats
Sample Number





























































Figure 4.8: Oxytocin release within the paraventricular nucleus and supraoptic 
nucleus of the resident rat during a maternal aggression test. Bilateral microdialysis 
surgery was performed two days prior to maternal aggression testing on all pregnant and 
lactating rats. On the day of testing (pregnancy day 19 [PD19] or 21 [PD21] or lactation day 
4 [LD4]), rats were connected to microdialysis pumps and left to acclimatize for 2h, five 
dialysates were then collected every half an hour. The first two were collected whilst the rat 
was left undisturbed in her home cage. The third sample was collected during a 10 min 
maternal aggression test. The final two samples were collected with the rat again left 
undisturbed in her home cage. All dialysates once collected were immediately frozen on dry 
ice until quantification for oxytocin by radioimmunoassay. Microdialysis probes were 
implanted into the paraventricular nucleus (PVN; PD19 n=9, PD21 n=6) or supraoptic 
nucleus (SON; LD4 n=8). *=p≤0.05 when sample 3 compared to sample 2. Data are 
represented mean + SEM.  
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4.5 Mapping maternal aggression neural circuitry containing oxytocin sensitive 
cells  
4.5.1 Method 
Between lactation days 3 to 7, rats either performed a 30 min maternal aggression 
test (n=9) or were left undisturbed (n=8) in their home cage with their pups present 
(8-18). Lactating rats were perfused 90 min after th  start of the maternal aggression 
test. The behaviour of aggression tested rats was digitally recorded and later analysed 
to ensure aggression was displayed at levels observed in previous experiments. The 
brains were collected and processed for Fos and OTRICC. Fos and OTR positive 
cells were counted and quantified in the LS, BnST, MPOA, SON, MeA, CeA, PVN, 
PAG, OBs and VMH, brain areas previously linked with maternal aggression, using 
the technique described in chapter 2. 
4.5.1.1 Statistics 
A t-test was performed to compare data between the aggression and non aggression 
tested lactating rats. Data was deemed to be significa tly different when p≤0.05. 
4.5.2 Results  
4.5.2.1 Aggressive behaviour 
Aggressive behaviour in aggression tested rats was comparable to levels observed in 
vehicle treated lactating rats from the AP and matern l behaviour study (chapter 5). 
The average latency to attack was 194.0±63.6 secs (vehicle group for AP and 
maternal aggression experiment was 167.1±38.8; p=0.86, T(9,9)=88.0) and average 
number of attacks was 10.0±2.3 (vehicle group for AP and maternal aggression 
experiment was 8.2±1.7; p=0.57, T(9,9)=92.5). 
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4.5.2.2 Activated oxytocin sensitive cells expression in aggression tested lactating 
rats 
The average number of double labelled Fos and OTR positive cells was significantly 
higher in aggressive lactating rats in the LS (p<0.001, T(8,9)=36.0; NAT=21.01±4.8, 
AT=46.21±12.8; Fig. 4.9 and 4.11), BnST (p<0.001, T(8,9)=37.0; NAT=13.98±3.7, 
AT=18.97±2.7; Fig. 4.9 and 4.10) and the MeA (p=0.001, T(8,9)=37.5; 
NAT=7.13±1.1, AT= 18.82±2.6; Fig. 4.9 and 4.12) compared with non aggressive 
lactating rats (Fig. 4.9). 
There was no significant difference in the number of double labelled Fos and OTR 
positive cells in the CeA (p=0.96, T(8,9)=73.0; NAT=19.59±3.9, AT=19.21±4.8), 
PAG (p=0.70, t15=0.39; NAT=56.10±7.4, AT=52.00±7.3), SON (p=0.74, t-0.34; 
NAT=12.42±1.3, AT=13.03±1.2), OBs (p=0.60, t0.54; NAT=113.30±5.9, 
AT=108.71±6.2), Parvocellular PVN (p=0.09, T(8,9)=90.0; NAT=11.59±0.8, 
AT=10.16±0.8), Magnocellular PVN (p=0.91, t-0.11; NAT=18.48±2.5, 
AT=18.90±2.8) or MPOA (p=0.57, T(8,9)=74.0; NAT=86.55±10.0, AT=82.88±11.6) 






























































































































































































































































































































































































































































































































































































































































































Figure 4.9: Average number of Fos and oxytocin receptor double labelled cells in 
specific brain regions of lactating rats following a maternal aggression test. Lactating 
rats either performed a 30 min maternal aggression test or were left undisturbed in their 
home cage with their pups present, 90 min after the start of testing lactating rats were 
perfused and their brains collected for immunocytochemistry. Expression of Fos and OTR 
positive cells was examined in the lateral septum (LS), bed nucleus of stria terminalis 
(BnST), medial preoptic area (MPOA), supraoptic nucleus (SON), medial and central 
amygdala (MeA and CeA respectively), paraventricular nucleus (PVN; magnocellular and 
parvocellular), periaqueductal grey area (PAG), olfactory bulbs (OBs) and ventromedial 
hypothalamus (VMH) of the aggression (AT; n=9) and non aggression (NAT; n=8) tested 








Figure 4.10: Photographs of activated oxytocin receptor containing cells in the bed 
nucleus of the stria terminalis of lactating rats after a maternal aggression test. Double 
immunocytochemistry was performed for Fos and oxytocin receptor (OTR) in the brain of a 
lactating rat following either a 30 min maternal aggression test or left undisturbed in their 
home cage with pups present. Photographs depict Fos positive OTR containing cells in the 
bed nucleus of the stria terminalis (defined by black dashed lines) in the non aggression and 
aggression tested (A and B respectively) lactating rat. High power photographs show Fos 
and OTR positive cells (black arrows) in non aggression and aggression tested lactating rats 










Figure 4.11: Photographs of activated oxytocin receptor containing cells in the lateral 
septum of lactating rats after a maternal aggression test. Double immunocytochemistry 
was performed for Fos and oxytocin receptor (OTR) in the brain of a lactating rat following 
either a 30 min maternal aggression test or left undisturbed in their home cage with pups 
present. Photographs depict Fos positive OTR containing cells in the lateral septum (defined 
by black dashed line) in the non aggression and aggression tested (A and B respectively) 
lactating rat. High power photographs show Fos and OTR positive cells (black arrows) in non 
aggression and aggression tested lactating rats (C and D respectively). Scale bars = 50µm. 







Figure 4.12: Photographs of activated oxytocin receptor containing cells in the medial 
amygdala of lactating rats after a maternal aggression test. Double 
immunocytochemistry was performed for Fos and oxytocin receptor (OTR) in the brain of a 
lactating rat following either a 30 min maternal aggression test or left undisturbed in their 
home cage with pups present. Photographs depict Fos positive OTR containing cells in the 
medial amygdala (defined by black dashed line) in the non aggression and aggression tested 
(A and B respectively) lactating rat. High power photographs show Fos and OTR positive 
cells (black arrows) in non aggression and aggression tested lactating rats (C and D 
respectively) Scale bars = 50µm. Abbreviations opt=optic tract. 
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4.6 Vasopressin binding and vasopressin V1a mRNA rec ptor expression 
throughout the peri-partum period: comparison to aggressive behaviour 
4.6.1 Method 
Brains which had been collected from rats in the first experiment of chapter 4 were 
serially sectioned using a cryostat (for details see chapter 2). Sections were then 
processed for either AVP-R autoradiography (chapter 2) in the LS, BnST, MPOA, 
PVN, MeA and CeA or AVP V1a receptor in situ hybridisation (chapter 2) in the 
MeA, CeA and PVN. Films for AVP-R autoradiography were left to expose in the 
dark room for 6 days before being developed. Slides dipped in emulsion for AVP 
V1a receptor ISH were left to expose for 10 weeks before being developed with test 
slides having been developed at 8, 9 and 10 weeks. 
4.6.2 Results 
4.6.2.1 Vasopressin receptor binding 
There was significantly lower AVP-R binding in the MeA for the PD21 group 
compared to the LD14 group (p=0.003, H4=15.7); no statistical differences were 
observed between the PD16/19/20, PD or LD4-7 groups (p>0.05, H4=15.7; Fig. 
4.13). For analysis of AVP-R as described in Chapter 2 Section 2.8.3, for each rat an 
average was taken from analysing at least four sections. Unfortunately for the LD21 
group, there were not enough sections per rat to be abl  to perform statistical 
analysis. Conversely to the MeA, in the CeA AVP-R binding was significantly 
higher in the PD group compared to LD21 (p=0.037, H5=11.8); no other group was 
statistically different (p>0.05, H5=11.8; Fig. 4.13). Within the PVN, the PD group 
had significantly greater AVP-R binding compared to LD4-7 (p=0.014, H5=14.2) but 
no other group (p>0.05, H5=14.2; Fig. 4.13). Unlike the OTR binding, there was no 
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significant difference in AVP-R binding within the LS (p=0.052, H5=11.0), BnST 
(p=0.98, H5=0.68) or MPOA (p=0.28, H5=6.2) between any groups (Fig. 4.13).  
4.6.2.2 Vasopressin V1a mRNA receptor expression 
AVP V1a receptor mRNA expression was examined in the MeA, CeA and PVN 
regions of the brain. Within the CeA, significantly higher levels of V1a mRNA 
expression were observed in the PD group compared to the PD16/19/20 (p=0.005, 
H5=16.8) and PD21 (p=0.005, H5=16.8) groups but not with any the lactation day 
groups (p>0.05, H5=16.8; Fig. 4.14). No significant differences were observed within 
the MeA (p=0.076, F(5,46)=2.16), magnocellular (p=0.46, F(5,29)=0.96) or 

























































































































































Figure 4.13: Average vasopressin receptor binding in specific brain regions of rats 
through pregnancy, parturition and lactation following a maternal aggression test. All 
rats performed a 10 min maternal aggression test followed by immediate decapitation. Brains 
were collected and frozen on dry ice before being processed for vasopressin receptor (AVP-
R) binding using receptor autoradiography. AVP-R binding was examined in the lateral 
septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area (MPOA), 
supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively) of rats 
tested on (PD16/19/20, n=21) or 21 (PD21 n=7), day of parturition (PD, 1h after birth of last 
pup; n=7) or lactation day 4-7 (LD4-7, n=6), 14 (LD14, n=7) and 21(LD21, n=8). Data are 





































































































Figure 4.14: Average vasopressin V1a receptor mRNA expression in specific brain 
regions of rats through pregnancy, parturition and lactation following a maternal 
aggression test. All rats performed a 10 min maternal aggression test followed by 
immediate decapitation. Brains were collected and frozen on dry ice before being processed 
for vasopressin (AVP) V1a mRNA expression using insitu hybridisation. AVP V1a receptor 
mRNA expression was examined in the paraventricular nucleus (PVN; parvocellular and 
magnocellular), medial and central amygdala (MeA and CeA respectively) of rats tested on 
pregnancy day 16, 19, 20 (PD16/19/20, n=21) or 21 (PD21 n=7), day of parturition (PD, 2h 
after birth of last pup; n=7) or lactation day 4-7 (LD4-7, n=6), 14 (LD14, n=7) and 21(LD21, 
n=8). Data are represented as mean +SEM. *=p<0.05. Analysis of the amygdala was done 








4.7 Correlation of maternal aggression with central vasopressin secretion  
4.7.1 Method 
The method was the same as above for the OXT microdialysis experiment. 
Dialysates for examination of AVP secretion were collected from the LS (PD19, 
n=8; PD21 n=8), BnST (PD19, n=8; PD21 n=8), PVN (PD19, n=8; PD21, n=8) and 
MeA (LD4, n=7) of rats that experienced a 10 min maternal aggression test. 
4.7.1.1 Statistics 
A two-way ANOVA was performed to determine if there was a statistical difference 
between samples within a group or across groups. If data was significant (p<0.05), a 
Tukey post hoc analysis test was done.  
4.7.2 Results 
4.7.2.1 Vasopressin secretion 
AVP secretion in the PVN was observed in the PD19 group during a maternal 
aggression test (p=0.009, F(4, 70)=6.19 for sample 3 vs sample 2) but not in the PD21 
group (p>0.05, F(4, 70)=6.19; Fig. 4.16). There was no significant differenc  between 
samples across groups for the release of AVP within the PVN (p=0.63, F(1, 70)=0.24). 
Within the LS, there was also no significant difference across samples between the 
PD19 and PD21 groups (p=0.089, F(1,70)=2.97). However for both groups, 
comparisons across samples within group showed sample 5 was significantly higher 
(PD19, p=0.019 vs sample number 2; PD21 p=0.031 vs sample number 4; Fig 4.15). 
No significant change was observed in the release of AVP in the BnST across 
samples within the PD19 (p=0.844, F(4,65)=0.35) or the PD21 (p=0.844, F(4,65)=0.35) 
groups (Fig. 4.15). However, there was a significant difference in the release of AVP 
in the BnST between tbe PD19 and PD21 groups for sample number 4 (p=0.046) and 
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5 (p=0.038) (Fig. 4.15). The MeA was examined for the LD4-7 group and no 
detectable significant change in release of AVP was ob erved during a maternal 

























































































Figure 4.15: Vasopressin release within the lateral septum and bed nucleus of stria 
terminalis of the resident rat during a maternal aggression test. Bilateral microdialysis 
surgery was performed two days prior to maternal aggression testing on all pregnant rats. 
On the day of testing (pregnancy day 19 [PD19] or 21 [PD21]), rats were connected to 
microdialysis pumps and left to acclimatize for 2h, five dialysates were then collected every 
half an hour. The first two were collected whilst the rat was left undisturbed in her home 
cage. The third sample was collected during 10 min maternal aggression test. The final two 
samples were collected with the rat left undisturbed in her home cage. All dialysates once 
collected were immediately frozen on dry ice until quantification for vasopressin by 
radioimmunoassay. Microdialysis probes were implanted into the lateral septum (LS; PD19 
n=8, PD21 n=8) or bed nucleus of stria terminalis (BnST; PD19 n=7, PD21 n=8). ^=p<0.05 
when comparing sample across groups. *=p≤0.05 when samples within the group. Data are 
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Figure 4.16: Vasopressin release within the paraventricular nucleus and medial 
amygdala of the resident rat during a maternal aggression test. Bilateral microdialysis 
surgery was performed two days prior to maternal aggression testing on all pregnant and 
lactating rats. On the day of testing (pregnancy day 19 [PD19] or 21 [PD21] or lactation day 
4 [LD4]), rats were connected to microdialysis pumps and left to acclimatize for 2h, five 
dialysates were then collected every half an hour. The first two were collected whilst the rat 
was left undisturbed in her home cage. The third sample was collected during 10 min 
maternal aggression test. The final two samples were collected with the rat left undisturbed 
in her home cage. All dialysates once collected were immediately frozen on dry ice until 
quantification for vasopressin by radioimmunoassay. Microdialysis probes were implanted 
into the paraventricular nucleus (PVN; PD19, n=8; PD21, n=7) or medial amygdala (MeA; 




In this chapter, a clear and detailed picture of the c anges in maternal aggression 
throughout the peri-partum period has been built. Different levels of aggressive 
behaviours are expressed throughout the peri-partum period however full maternal 
aggression involving fierce attacks and all aggressiv  behaviour is only first 
displayed on PD21. A study by Mayer and Rosenblatt (1984, [180]) did not observe 
an increase in nest defence in rats until PD22, just hours prior to parturition. As the 
rats in our study were killed immediately after the maternal aggression test, it is 
unknown how close to term they were. However it would be fair to assume they were 
within 24h or so therefore within the time period that Mayer and Rosenblatt mention 
for increased nest defence [180]. Thus these two results do concur that just prior to 
birth maternal aggression is expressed for the first time.  
Maternal aggression then dips slightly just after pa turition where it appears 
more beneficial for pup survival to elicit nurturing rather than attacking behaviour. 
Flannelly et al (1986, [168]) observed a higher level of maternal aggression on the 
day of birth compared to the results of study but this may depend on the time point of 
testing; rats in this study were almost immediately after birth (1h after last pup birth) 
whilst in the Flannelly study testing was done several hours after birth. One factor 
common to both studies is the very short latency to at ack on the day of parturition. 
Maternal aggression peaks during the first week of lactation as observed in previous 
studies before gradually diminishing to disappear on LD21 [168, 179]. This 
constructed model (Fig. 4.17) can now be used in correlating hormonal changes of 
































Figure 4.17: The display of maternal aggression through the peri-partum period in the 
rat. In the rat, full display of maternal aggression first appears in late pregnancy (pregnancy 
day 21). Maternal aggression then diminishes slight on the day of parturition before peaking 
during the first week of lactation. It then gradually reduces until it disappears around weaning 
(lactation day 21). 
 
In this study, this model was used to investigate both the OXT and AVP 
systems during the peri-partum period. Dynamic changes were observed in both 
relating to maternal aggression providing evidence of their important but very 
different roles in the control of maternal aggression and behaviour. 
In the OXT system, OTR binding was found to be significantly higher in the 
BnST on PD21 when maternal aggression is first expressed in full. The BnST is 
thought to be important in the long term control of anxiety via both indirect 
projections through the PVN and amygdala and direct projections to the PAG [14, 
105]. In addition, Meddle t al (2007, [307]) observed OTR mRNA expression and 
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activation of OTR expressing cells in the BnST to increase just after parturition (90 
min after the birth of the first pup). These findings plus the observed higher levels of 
OTR binding on PD21 in the current study, the day before expected parturition, 
suggest that OXT may reduce anxiety and fear in preparation for the pup arrival so 
the mother will approach her pups immediately after birth enabling the formation of 
a bond and attachment to occur between mother and offspring.  
The changes in OTR binding within the BnST supports the two theories about 
OXT actions around parturition; the first that OXT is necessary for onset of maternal 
behaviour but not maintenance [316]. The higher levels of OTR binding on PD21 
return to normal by LD4-7. This theory is further supported by higher levels of OTR 
binding on PD in the MPOA in our study which decreased by LD4-7 to levels 
comparable to pregnancy. In addition, it has been observed that OTR mRNA 
expression increased and more OTR expressing neurons are activated within the 
MPOA just following parturition [307]. The MPOA is an area important in maternal 
behaviours as electrolytic lesions here disrupt all forms of maternal care [80, 82, 
438].  
The second theory is that OXT by modulating fear and xiety indirectly 
helps maintain maternal aggression [265]. During pregnancy, OXT secretion was 
increased within the PVN during a maternal aggression test therefore one could 
hypothesise that OXT works to reduce anxiety to ensure aggressive behaviour from 
the beginning of maternal aggression expression (PD21). Furthermore, activation of 
OTR containing cells was observed to be increased within the BnST after a maternal 
aggression test on LD4-7; the time point when matern l aggression is highest. This 
suggests that the actions of OXT on maternal aggression regulation within the BnST 
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are there from the start of maternal aggression and still apparent at the time of 
maternal aggression peak. 
The LS is an area which appears to be important in the maternal aggression 
circuitry but not necessarily essential for the expr ssion of other maternal behaviours 
[12, 194, 196]. Results from this study would further ighlight its importance in the 
maternal aggression circuitry and suggest that it is highly influence by the OXT 
system. An increase in OTR binding is observed within e LS on at the peak of 
maternal aggression (LD4-7). Additionally, an increas  in the activation of OXT 
sensitive cells in the LS in aggressive lactating rats compared to non aggressive was 
observed providing further evidence that OXT is involved in the regulation of 
maternal aggression at the time of its greatest expression within the LS. However, no 
difference was observed in OXT secretion on PD19 and PD21 during a maternal 
aggression test within the LS and previous research has observed no significant 
change in OXT secretion in lactating rats (at the peak of maternal aggression peak) 
compared to virgin female rats during an maternal aggression test [424]. Thus it 
would appear in the LS, it not a change in the release of OXT regulating maternal 
aggression but activation of its receptors. Examinatio  of OTR mRNA expression in 
the LS throughout the peri-partum period would help to substantiate this idea. As no 
change was observed in LS in AVP-R binding through out the peri-partum period or 
AVP secretion during a maternal aggression test, control of maternal aggression 
within the LS would appear to be under OXT influenc. Future research examining 
the effects of direct application of selective OXT antagonists and antisense 
oligonucleotides, which specifically target OXT or OTR to decrease their expression, 
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to the LS would help to further elucidate more clearly the role of OXT in maternal 
aggression within the LS [200].  
 Another area highlighted by Fos studies as important in the maternal 
aggression circuitry is the PVN [188]. The PVN is a crucial component in the stress 
axis response and has already been shown to be an are  where OXT and AVP work 
against each other to create a balance in response t  stress [335]. It is established that 
OXT secretion increases in the PVN during a maternal aggression test at LD4 when 
maternal aggression is at its highest and manipulations of OXT within the PVN can 
affect maternal aggression expression [320, 439]. This study provides further 
evidence that OXT is the important peptide controlling anxiety and fear around the 
peri-partum period within the PVN. No change in AVP V1a receptor mRNA 
expression in either magnocellular or parvocellular PVN throughout the peri-partum 
period were observed whereas within the magnocellular PVN activation of OTR 
containing cells was seen to increase immediately postpartum [307]. Furthermore, a 
decrease in the AVP receptor binding in the PVN on LD4-7 would suggest that OXT 
works to decrease the stress axis response to enable maternal aggression. 
Examination of OTR binding within the PVN during the peri-partum period would 
provide further evidence of the importance of OXT in maternal aggression regulation 
in the PVN. However an increase in the release of AVP within the PVN was seen on 
PD19 but not PD21 when maternal aggression is first expressed. This is in contrast to 
OXT where significant increases in release are observed on PD19, PD21 and during 
the first week of lactation [439]. Studies to determine whether selective AVP 
antagonists or antisense AVP oligonucleotides applied directly to the PVN affect 
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maternal aggression would be able to provide further evidence of whether OXT is the 
crucial peptide working control maternal aggression within the PVN.  
Interestingly within the CeA, an area important in the control of fear and 
anxiety, not only was there an increase in AVP-R binding on PD but also an increase 
in AVP V1a mRNA expression [265, 266]. These changes, along with no change in 
CeA OTR binding, could lead to the proposal that in the CeA, the influence of AVP 
is more important in the control of maternal aggression and maternal behaviour 
around the peri-partum period. However previous studies have clearly defined OXT 
effects on maternal aggression within the CeA in the lactating rat; with direct OXT 
application decreasing maternal aggression and OXT antagonist increasing [431, 
432]. Also, OXT release within the CeA is increased during a maternal aggression 
test [152]. Within the CeA, distinct areas are under OXT or AVP control and it has 
been demonstrated that the area under OXT control projects via GABAergic neurons 
to the AVP inducing fear neurons thereby reducing fear expression [266, 440].  
It is interesting therefore that AVP V1a mRNA receptor expression and AVP-
R binding both increased on PD which would lead to the assumption fear expression 
is increased at this time. As binding decreases to pre-parturition levels by LD4-7 one 
could hypothesise that the increase AVP binding in the CeA causes an increase in 
fear in response to an intruder specifically after pa turition to help with creating a 
strong mother and pup bond. Lactating rats on PD spend more of their time with 
engaging with their litter during a maternal aggression test than displaying aggressive 
behaviour. Hence further research is required to elucidate the role of OXT and AVP 
in the CeA and how the two hormones work to balance the effects of each other. 
Interestingly, as discussed in chapter 4 and 7, a neurosteroid, AP, which had been 
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implicated in regulation fear, appears to increase ctivation of the CeA during 
maternal aggression [105]. Further evidence that con rol of the CeA in regulating 
fear is important in enabling the display of maternal aggression and possibly the 
actions of OXT and AP either work together or provide back-up in case one fails in 
its actions.  
In the MeA, OXT is proposed to important for the attainment of social 
memories and hence essential for social recognition as OXT KO male mice fail to 
recognise the same female during the second social test unless pretreated with an 
OXT injection into the MeA [425]. Furthermore, in these socially tested OXT KO 
mice activation of the main and accessory OBs was the same as normal mice but 
activation was decreased in the MeA, BnST and MPOA [425]. The MeA receives 
information from the OBs and then passes it onto the BnST and MPOA so these 
results suggests information is relayed as normal until the MeA where it is disrupted 
[425]. It could be proposed therefore that the increase in activation of OTR 
expressing cells in the MeA during a maternal aggression test reflects the processing 
of chemosensory information from the pups and intrude  so the intruder is recognised 
as novel and a potential threat to the pups. OTR mRNA expression is observed to 
significantly increase just after parturition possibly reflecting the initiation of the 
OXT system so social memory of the litter is obtained [307].  
In non-maternal virgin rats, the MeA is proposed to work to inhibit maternal 
behaviour [70]. Examination of Fos in non maternal but pup exposed virgin rats 
compared to fully maternal pup-sensitized rats showed activation was increased in 
anterior hypothalamic nucleus (AHN), principal BnST (BnSTpr), ventral LS (LSv), 
dorsal premammillary nucleus (PMd) and dorsomedial and central areas of the 
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ventromedial hypothalamic nucleus (VMNdm,c) [70, 98]. These areas all receive 
inputs from the MeA thus it was proposed that the MeA inhibits maternal behaviour 
in virgin rats [70]. Lesions of the MeA resulted in reduced Fos activation in AHN, 
VMN, BnSTpr, LSv and PMd in non-maternal virgin rats and lesions in the MeA 
along with AHN and VMN lesions stimulated maternal behaviour further evidence of 
that the MeA through the AHN and VMN (and possibly the BnSTpr, LSv and PMd) 
works to inhibit maternal behaviour [40]. Our study showed increased OTR cell 
activation in the MeA after a maternal aggression test which could lead to the 
suggestion that OXT during the lactation period works to disinhibit the MeA to allow 
the display of maternal behaviours including maternal aggression. Research 
investigating the effects of direct MeA OXT antagonist application to lactating rats 
or OXT to non-maternal virgin rats would test this theory. One would hypothesise 
that an OXT antagonist would allow the MeA to actively inhibit maternal behaviour 
in lactating rats whereas OXT in non-maternal virgin rats would promote maternal 
behaviour.  
 It is important to remember that when interpreting changes in AVP or OXT 
release that it is not known where or on which receptors they are acting on. The same 
is true for activation of OTR containing cells, it is unknown which peptide may be 
activating these cells. This is because the AVP andOXT peptides have similar 
structures and are therefore able to act on each other receptors resulting in cross 
interactions [200]. Thus current and future research involving antisense 
oligonucleotides specific to each peptide and their r ceptors, gene transfer virals 
(which cause overexpression of AVP or OXT receptors), KO and transgenic animals 
will help to piece together the puzzle over the specific actions of AVP and OXT 
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during the peri-partum period [200]. The generation of OXT KO mice have already 
been observed to express normal maternal behaviour hence more evidence that OXT 
is not necessary for maternal behaviour maintenance [316]. Antisense 
oligonucleotides have already been proven to cause brain region specific changes 
resulting in different behavioural outcomes, application of these oligonucleotides in 
brain regions important for maternal aggression (e.g. OXT in the LS) or maternal 
behaviour (e.g. AVP in the MPOA) would help elucidate further the precise roles of 
OXT and AVP in maternal behaviour [200]. 
 In this study, we have observed that there are specific changes in OXT and 
AVP systems in connection to the expression of matern l behaviour including 
aggression. OTR binding is increased in the BnST and MPOA at parturition whereas 
AVP V1a receptor binding is significantly higher inthe CeA possibly indicating 
where each neuropeptide may work to induce the rapid onset of maternal behaviour 
immediately after parturition. During maternal aggression expression, OXT release is 
significantly increased in the BnST, PVN and SON with higher numbers of OTR 
containing cells activated in the LS, BnST and MeA following a maternal aggression 
test also observed. AVP secretion was increased in PVN during maternal aggression 
testing, but at the peak of maternal aggression (LD4-7) a decrease in AVP V1a 
receptor binding was observed. These results indicate that these two neuropeptides 







Chapter Five: Maternal behaviour and the neurosteroid, allopregnanolone. 
5.1 Introduction 
Neurosteroids were discovered during the past decade when the brain was found to be 
able to synthesise peripheral steroids de novo [360, 362, 441, 442]. These steroids can 
regulate the main excitatory, glutamate, and inhibitory, γ-aminobutyric acid (GABA), 
neurotransmitters and their receptors of the central ervous system so they have a 
direct influence on a broad range of behaviours from anxiety to cognition and hence 
why they became known as neuroactive steroids or neu osteroids [358, 359, 361, 
441]. The progesterone metabolites, specifically 5α-dihydroprogesterone (5α-DHP) 
and 3α, 5α-tetrahydroprogesterone (3α, 5α-THP or allopregnanolone, AP), have been 
found to be potent positive modulators of the GABAA receptors [356-358]. By 
enhancing the effect of the GABAA receptors functioning, they impact upon GABA’s 
broad range of behavioural effects from being antico vulsant, anxiolytic to 
anaesthetic [358]. The sulphated versions of neuroster ids, for example 
dehydroepiandrosterone sulphate (DHEAS), however exhibit a negative modulatory 
control on GABAA receptor functioning [342]. Thus, there is a balance between the 
two types of neurosteroids as one enhances the effects of GABA causing a decrease 
in anxiety and stress behaviour, the other dampens GABAs effect resulting in the 
opposite behavioural outcomes.  
The impact of neurosteroids on GABAA receptors is influenced by local steroid 
synthesis and metabolism, subunit composition of the receptor and phosphorylation 
mechanisms [356]. Although the subunit composition is known to change through 
pregnancy, parturition and the onset of lactation, this effect on the functioning of the 
receptor and how it changes the influence of neuroste ids upon behaviour is as yet 
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unclear [346, 443]. Many researchers have put forward an argument that regardless of 
the subunit composition, the most important influence on GABAA receptor 
functioning is its phosphorylation state [444]. Koksma et al (2003) found an 
increased level of phosphorylation creates insensitivity of GABA A receptors to 5α-
DHP specifically within the SON [444]. It was also f und this GABAA receptor 
insensitivity occurred around the same time (i.e. at parturition, lactation has not been 
investigated yet) as the increase in OXT release therefore it seems reasonable to 
propose that OXT may play a role in creating GABAA receptor insensitivity to AP.   
Previous research has found the modulation of GABA receptor functioning by 
neurosteroids can influence physiology and behaviour in many ways. These can range 
from the blood volume control during pregnancy, stre s responses, seizure 
susceptibility to anxiety and depression [105, 199, 366, 368-370, 372, 441, 445-448]. 
Anxiety related disorders, for example, are thought to partly result from a dysfunction 
in the central GABAergic system [449]. Many anxiolytic drugs act by enhancing 
GABAA receptors actions, by a similar mechanism to neuroster ids. AP has been 
found to mediate the actions of one such drug, etifoxine, on anxiety behaviour in 
rodents [449]. AP is not only implicated in having a role in anxiety but also other 
related disorders such as premenstrual tension, post-traumatic stress and other social 
behaviour during periods of hormonal upheaval [358, 361, 381, 449]. AP has also 
been found to attenuate the stress response through influencing the actions of GABA 
receptors on the OXT secretion in males and in femal s during late pregnancy [199, 
446]. Interestingly one type of seizure, known as ctamenial epilepsy, occurs at 
specific times during the menstrual cycle when there is a decrease in circulating 
progesterone levels [366]. Moreover, AP levels can be inversely correlated with 
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seizure frequency in these catamenial epileptic women [366]. Thus, there are many 
roles for AP actions on GABA receptor functioning in the body across the menstrual 
cycle and during the peri-partum period when huge changes in progesterone occur. 
Despite much research focusing on elucidating these functions, few investigations 
have examined the impact of neurosteroids on maternl behaviour. 
 The disinhibition of GABAA receptors just prior to parturition allows OXT 
secretion to increase necessary for normal parturition and lactation; this occurs at the 
same time as the start of maternal behaviour [352, 431]. Although GABAA receptors 
have an effect upon many different behaviours from anxiety to cognition, the 
influence of GABAA receptors during the peri-partum period upon maternl 
behaviour is presently undefined but there is evidence for a regulatory role of GABA. 
In a study by Lee and Gammie (2007, [158]), they demonstrated in lactating mice that 
GABAA receptor agonists enhance maternal aggression. However the literature is 
conflicting as direct infusions of GABAA receptor agonists into the MPOA 
significantly reduced aggression [158, 438]. This di parity may be due to species 
differences as mice were used in the former and rats in he latter study. Differences 
between mice and rats have been observed in innate anxi ty where rats with high 
anxiety are more aggressive and for mice the converse is true [204, 205, 320]. The 
impact of GABAA receptor agonists on maternal aggression could also be brain site 
specific as maternal aggression is enhanced when GABAA receptor agonists are 
injected into LS but aggression is decreased following injection into the MPOA and 
BnST [158]. Thus, much research is required to clearly identify the role of GABA in 
maternal aggression. One area that is yet to be explor d is the modulation of GABA 
receptors by neurosteroids, especially by AP. 
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In male rodents, aggressive behaviour has been clearly linked to increased 
levels of AP [342, 373, 378-380]. AP was investigated because there was irrefutable 
data that GABAergic transmission is essentially involved in the regulation of 
aggression and AP is the most potent positive modulator of GABAA receptors known 
[379, 450]. Also, down regulation of endogenous AP synthesis was linked with 
reduced GABAA receptor signal transduction [450]. AP was discovered to have a bi-
tonic effect on aggression with low doses having no effect, and high doses being 
sedative, whereas moderate doses significantly increased the aggressive behaviour in 
male mice [342]. Thus, there is strong evidence for AP role in the control of 
aggressive behaviour in the brain of males however this is yet to be investigated in 
females.  
The aim of the experiments in this chapter is therefore to investigate how 
neurosteroids, specifically AP, impact upon maternal behaviour. The dramatic fall in 
progesterone levels towards the end of pregnancy ocurs at the same time as the rapid 
increase in synthesis and release of OXT necessary for parturition [307, 353, 451, 
452]. At this time, maternal behaviour begins to be expressed [1, 3, 51]. Hence, it is 
proposed that progesterone withdrawal allows the timed release of OXT which then 
goes on to drive maternal behaviour. For example, if progesterone levels are 
maintained to the end of pregnancy, post partum femal s do not express maternal 
behaviour [353]. Also, if progesterone is injected into estrogen primed, 
ovariectomised virgin females the onset of maternal behaviour is delayed or even 
abolished [353]. The mechanism by which progesterone exerts its effect still requires 
elucidation.  
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This current study tests the hypothesis that that progesterone drives maternal 
behaviour via the actions of its neurosteroid metabolite, specifically AP, on the 
GABAA receptors. This hypothesis is built on a number of easons. (1) It is known 
that AP mimics the levels of progesterone during pregnancy and parturition [453]. (2) 
The SON is one area highly associated with maternal behaviour functioning and has a 
large number of GABA receptors with inhibitory control over release of OXT before 
parturition to which AP is known to contribute [320, 454]. (3) OXT can cause 
insensitivity GABAA receptors to 5α-DHP thus allowing for the withdrawal of GABA 
inhibition coinciding with the expression of maternal behaviours during late 
pregnancy [444]. (4) Around parturition, the same time as the significant increase in 
OXT levels, there are dramatic changes in OXT receptor expression and functioning 
especially in areas, specifically the MPOA, BnST and SON, related to maternal 
behaviour and which also have a clear GABA functioning component [307]. 
 
5.2 The effects of allopregnanolone on maternal behaviour during lactation 
The first aim of this study was to test the hypothesis that the neuroactive steroid AP 
will inhibit the expression of maternal behaviour including the display of maternal 
aggression.  
5.2.1 Method 
Lactating rats were randomly assigned into one of four groups; AP injected and 
maternal aggression tested (APA), AP injected and maternal behaviour observed 
(APNA); vehicle injected and maternal aggression tested (VA) or vehicle injected 
and maternal behaviour observed (VNA). APA (n = 9) and APNA (n = 9) rats were 
injected s.c. 3mg/kg AP (Steraloids Inc.Ltd London; 6 mg AP in 12% ethanol and 
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corn oil) at least 20h prior and 1mg/kg AP (2 mg AP in 12% ethanol and corn oil) 2h 
prior to being exposed to a 30 min maternal aggression test or maternal behaviour 
observation (as described in Chapter 2). This dosage was chosen because it has 
already been shown to have significant actions on the s ress response within pregnant 
rats [199, 352]. Also, by injecting 20h and 2h befor  behavioural testing allowing for 
both long term genetic changes and short term acute membrane effects to occur. VA 
(n = 9) and VNA (n = 8) lactating rats were injected s.c with vehicle (12% ethanol in 
corn oil) at 20h and 2h prior to testing. All rats were transcardially perfused 90 min 
after the beginning of behavioural testing with 4% paraformaldehyde and the brains 
were collected and processed for Fos ICC (as described in Chapter 2). Fos expression 
was quantified in LS, BnST, MPOA, SON, MeA, CeA, PVN, PAG and OBs using 
the method described in chapter 2. 
5.2.1.1 Statistics 
For behavioural data, a T-test was performed when comparing the APA group with 
the VA group. The same was used to compare the VNA group with the APNA group. 
If data was not normally distributed, a Mann Whitney Rank Sum test was performed 
instead. For Fos data, a one way ANOVA was used to compare all groups. Data that 
was normally distributed were subjected to a Holm-Sidal post hoc analysis test. Data 
which were not normally distributed underwent a one way ANOVA on ranks 
followed by a Dunn’s post hoc test. Data were deemed significant when p≤0.05.  
5.2.2 Results 
5.2.2.1 Aggressive behaviour   
AP treatment had no significant effect on the number of attacks performed during a 
30 min maternal aggression test (p=0.67, t-0.4; Fig. 5.1). The average latency to attack 
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the intruder was also not significantly affected by AP treatment (p=0.33, t1.0; Fig. 
5.1). A comparison of the percentage of total time spent attacking the intruder 
between the vehicle and AP treated groups was carried out (Fig. 5.2). The data was 
subsequently analysed to either include sniffing behaviour or not because sniffing 
can be defined as both an aggressive behaviour and an investigative one. No 
significant difference was found between treatment groups when sniffing behaviour 
was included (p = 0.43, t-0.8) or not (p = 0.78, t-0.3).  
5.2.2.2 Maternal behaviour  
AP treatment had no significant effect on maternal behaviour expression between the 
aggression tested groups (p=1.0, T(9,9)=85.0; Fig. 5.2). This was also the case 
between the non aggressive groups (p=0.74, T(8,9)=68.0; Fig. 5.3).  
5.2.2.3 General behaviour  
The percentage of total time spent exhibiting general behaviour was also analysed 
and again AP had no significant effect on general behaviour expression compared to 
the vehicle treated group whether the group were aggression tested (p=0.86, 
T(9,9)=83.0; Fig. 5.2) or not (p=0.74 T(8,9)=76.0; Fig. 5.3). 
5.2.2.4 Response to aggression behaviour by the resident 
There was no significant effect of AP treatment on the percentage of total time spent 
exhibiting response to aggressive behaviour from the intruder by the resident 
compared to the vehicle treated group (p=0.72, T(9,9)=90.0; Fig. 5.2). 
5.2.2.5 Fos immunocytochemistry 
In order to map the brain areas that were activated during the maternal aggression 
test or maternal behaviour observation, Fos immunocytochemistry was performed on 
the brains of the lactating rats. Specific brain regions, namely the LS, BnST, MPOA, 
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SON, MeA, CeA, PVN, PAG and OBs, already highlighted in previous studies 
(Meddle et al, unpublished, [12, 194, 196]) to be involved in maternal aggression and 
maternal behaviour were examined.  
 Fos expression was higher in the aggression tested groups (both vehicle and 
AP treated) in the BnST (VA vs VNA, p=0.007, F(3,24)=5.16; APA vs VNA, APNA, 
p=0.007, F(3,24)=5.16) and the MeA (VA vs VNA, APNA, p<0.001, H3=17.82; APA 
vs VNA, APNA, p<0.001, H3=17.82) than the non-aggression tested (both vehicle 
and AP treated) groups. In the OB, both vehicle andAP treated aggression tested 
groups had significantly higher Fos expression than the vehicle treated non-
aggression tested group (p<0.001, H3=17.33) but not the AP treated non-aggression 
tested group.  
 Interestingly in the PVN, Fos expression was significantly higher in the 
vehicle aggression tested group compared to all other groups (p<0.001 F(3,26)=14.77). 
Similarly in the PAG, expression is highed in the vehicle aggression tested group 
compared to the AP treated aggression and non-aggression tested groups (p=0.044, 
F(3,23)=3.15) but not the vehicle treated non-aggression tested group. However in the 
CeA, Fos expression is significantly higher in the AP treated aggression tested group 
compared to all other groups (p<0.001 F(3,26)=13.02). 
 No significant difference was observed in Fos exprssion in the LS (p=0.689, 






































































































































Figure 5.1: Average number and latency to attack by the resident lactating rat during a 
maternal aggression test following allopregnanolone treatment.  A) The average 
number of attacks towards a novel virgin female intruder made by a resident lactating rat in 
her home cage with the pups present (vehicle, n=9; Allopregnanolone (AP) treated, n=8) 
during 30 min timed exposure. AP treated rats were injected with 3mg/kg (6mg AP in 12% 
ethanol and corn oil) and 1mg/kg (2mg AP in 12% ethanol and corn oil) of AP 20 and 2h 
respectively prior to behavioural testing. Vehicle treated rats were injected at the same time 
as AP treated rats with 12% ethanol and 88% corn oil. B) The average attack latency (secs) 
for resident lactating rat to attack an intruder in her home cage with her pups present during 
a 30 min maternal aggression test. Data are presented as the mean + SEM.  
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Figure 5.2: Average percentage of total time spent exhibiting different behaviours by 
resident lactating rat during a maternal aggression test following allopregnanolone 
treatment. The mean percentage of the total time (30 min) that resident lactating rats 
(vehicle, n=9; allopregnanolone (AP) treated, n=8) exhibited attacking, maternal, response to 
aggression, general or sniffing behaviours during exposure to a novel virgin female intruder 
in their home cage with their pups still present. AP treated rats were injected with 3mg/kg 
(6mg AP in 12% ethanol and corn oil) and 1mg/kg (2mg AP in 12% ethanol and corn oil) of 
AP 20 and 2h respectively prior to behavioural testing. Vehicle treated rats were injected at 
the same time as AP treated rats with 12% ethanol and 88% corn oil. There are no 




Figure 5.3: Average percentage of total time spent exhibiting different behaviours by 
the resident lactating rat during maternal behaviour observation following 
allopregnanolone treatment.  The mean percentage of total time (30 min) that the resident 
lactating rat (vehicle, n=8; allopregnanolone (AP) treated, n=9) exhibited maternal or general 
behaviour in their home cage with their pups present. AP treated rats were injected with 
3mg/kg (6mg AP in 12% ethanol and corn oil) and 1mg/kg (2mg AP in 12% ethanol and corn 
oil) of AP 20 and 2h respectively prior to behavioural testing. Vehicle treated rats were 
injected at the same time as AP treated rats with 12% ethanol and 88% corn oil. There is no 
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Figure 5.4: Average number of Fos positive cells in specific brain areas of the 
lactating rat following a maternal aggression test and allopregnanolone treatment. 
Allopregnanolone (AP) treated lactating rats were injected with 3mg/kg (6mg in 12% ethanol 
and 88% corn oil) and 1mg/kg (2mg in 12% ethanol and 88% corn oil) of AP 20 and 2h 
respectively prior to behavioural testing. Vehicle treated rats were injected at the same time 
as AP treated rats but with 12% ethanol and corn oil instead. Expression of Fos in the lateral 
septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area (MPOA), 
supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), 
paraventricular nucleus (PVN) , periaqueductal grey area (PAG) and olfactory bulbs (OBs) of 
AP or vehicle treated and aggression tested lactating rats (APA, n=8; VA, n=9) and AP or 
vehicle treated and non-aggression tested lactating rats (APNA, n=9; VNA, n=8) was 
examined using immunocytochemistry on brains perfused 90 min after the start of 
behavioural testing. Data are represented as mean + SEM. *=p≤0.05. A one way ANOVA 
was used to compare all groups followed Holm-Sidal post hoc analysis test. Data which were 









Figure 5.5: Photographs of Fos positive cells in the paraventricular nucleus of vehicle 
and allopregnanolone treated lactating rats after a maternal aggression test or 
maternal behaviour observation. Fos expression was examined in the paraventricular 
nucleus (defined by black dashed line) of allopregnanolone (AP) or vehicle treated and 
aggression tested lactating rats (APA, n=8; VA, n=9) and AP or vehicle treated and non-
aggression tested lactating rats (APNA, n=9; VNA, n=8) using immunocytochemistry on 
brains perfused 90 min after the start of behavioural testing. AP treated rats were injected 
with 3mg/kg (6mg AP in 12% ethanol and corn oil) and 1mg/kg (2mg AP in 12% ethanol and 
corn oil) of AP 20 and 2h respectively prior to behavioural testing. Vehicle treated rats were 
injected at the same time as AP treated rats with 12% ethanol and 88% corn oil. Scale bars 
= 50µm. Abbreviations 3v= third ventricle. 
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5.3 The effect of allopregnanolone on pup retrieval behaviour 
As AP treatment appeared to have no direct effects on the display of maternal 
aggression, expression of another component of maternal behaviour, specifically pup 
retrieval, was examined to observe if it was affected by AP treatment. This 
experiment was done with the assistance of student, Louise Warren. 
5.3.1 Method 
Lactating rats were injected s.c. 3mg/kg AP (Steraloids Inc. Ltd London; 6 mg AP in 
1ml 12% ethanol in corn oil; n=10) or vehicle (12% ethanol in corn oil; n=9) 20h and 
again with 1mg/kg AP (2 mg AP in 1ml 12% ethanol in corn oil) or vehicle 2h prior 
to a pup retrieval task (see chapter 2 for detail).  
5.3.1.1 Statistics 
T-tests were performed to compare the two treatment groups for both behavioural 
and Fos data. Statistical significance was deemed when p≤0.05. 
5.3.2 Results 
5.3.2.1 Latency to approach a pup  
AP treatment had no significant effect on the averag  latency to approach a pup 
(p=0.84, t0.2; Fig. 5.7). For this analysis all behaviour relating to pups was included 
i.e. approach, lick, retrieve or move. Rats took on average 6.64±1.1sec (n=19) to 
approach the pup.  
5.3.2.2 Latency to move a pup  
For the analysis of average latency to move a pup, both moving the pups and pup 
retrieval were included. There was no significant effect of AP treatment on the 
average latency for a lactating rat to move a pup compared to the vehicle treated 
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group (p=0.29, t-1.1). The vehicle treated group took 25.82±7.2sec to move a pup 
compared to 42.52±12.8sec for the AP treated group (Fig. 5.7). 
5.3.2.3 Latency to retrieve pups  
The latency to retrieve both first pup and fourth pup was analysed (Fig. 5.7). 
Retrieval was defined as the picking up of a pup (from a place other than the main 
nest), returning, and setting it down in the main nest. There was no significant effect 
of AP treatment to a lactating rat on the latency to retrieve either the first (p=0.49, 
T(9,10)=81.0) or fourth pup (p=0.60, T(9,9)=79.0) compared to the vehicle treated 
group. 
5.3.2.4 Total time spent moving or retrieving pups  
The percentage of total time spent moving and retrieving or just retrieving pups was 
analysed to investigate if there was any difference i  the time taken to return the pup 
to the nest. Fig. 5.8 illustrates pie charts depicting percentage of total time exhibiting 
these different behaviours for the two treatment groups. There was no significant 
difference in the time spent moving and retrieving pups (p=0.60, T(9,10)=97.0) or just 
























































































































































































Figure 5.6: Average latency for the resident lactating rat to approach, move or retrieve 
pup during a pup retrieval task following allopregnanolone treatment. Allopregnanolone 
(AP) treated rats were injected with 3mg/kg (6mg AP in 12% ethanol and corn oil) and 
1mg/kg (2mg AP in 12% ethanol and corn oil) of AP 20 and 2h respectively prior to 
behavioural testing. Vehicle treated rats were injected at the same time as AP treated rats 
with 12% ethanol and 88% corn oil.  All pups were removed from the lactating resident rat 
and kept warm with bedding in a separate cage. After 1h of separation, 8 pups were 
randomly scattered around the home cage of the lactating rat and the behaviour digitally 
recorded until all pups were retrieved to the sleeping nest or 30 min had passed. The 
average time (secs) for the resident lactating rat (vehicle n=9, AP Treated n=10) to approach 
a pup in her home cage (A) or to pick up and carry a pup in her mouth (includes both retrieval 
and moving scored behaviours; B) or retrieve the first (C) and fourth pup (C) were examined. 
Retrieval was defined as the picking up of a pup (from area other than sleeping nest), 
carrying and placing the pup into the sleeping nest. Data are represented as mean + SEM. 
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Figure 5.7: Average percentage of total time spent expressing different behaviours by 
the resident lactating rat during a pup retrieval task following allopregnanolone 
treatment. The mean percentage of total time (30 min) spent retrieving or moving pups or 
exhibiting other pup related or non pup related behaviours by a resident lactating rat (vehicle 
n=9, allopregnanolone (AP) treated n=10) during a pup retrieval task in her home cage. AP 
treated rats were injected with 3mg/kg (6mg AP in 12% ethanol and corn oil) and 1mg/kg 
(2mg AP in 12% ethanol and corn oil) of AP 20 and 2h respectively prior to behavioural 
testing. Vehicle treated rats were injected at the same time as AP treated rats with 12% 
ethanol and 88% corn oil.  All pups were removed from the lactating resident rat and kept 
warm with bedding in a separate cage. After 1h of separation, 8 pups were randomly 
scattered around the home cage of the lactating rat and the behaviour digitally recorded until 
all pups were retrieved to the sleeping nest or 30 min had passed. There is no difference in 
percentage of total time spent exhibiting any behaviour between the two treatment groups. 
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5.4 The effect of maintaining allopregnanolone from late pregnancy until 
lactation on parturition and maternal aggression  
The previous experiment examined the effect of AP administration during lactation 
on maternal behaviour, including maternal aggression and pup retrieval. Although no 
significant behavioural effects were observed, significant differences were observed 
in Fos expression in brains regions, such as the PVN, MPOA and CeA, suggesting 
that AP may have a regulatory effect on the stress axi and the fear and anxiety 
circuitry. Concas et al (1998, [346]) report the peak concentration of AP in the brain 
cortex is on day 19 of pregnancy, therefore this experiment aims to investigate 
whether maintaining AP levels from this time would impact firstly impact upon on 
parturition and secondly alter maternal behaviour including aggression expression. 
This experiment was done with the assistance of students, Gemma Rushton and 
Surawee Chuaiphichai. 
5.4.1 Method  
One day before expected parturition (pregnancy day 21), rats were s.c. injected with 
3mg/kg AP (6 mg AP in 12% ethanol and corn oil; n=9) or vehicle (12% ethanol and 
88% corn oil; n=10). On the morning of expected parturition, rats were injected using 
the same dose and route. Parturition was observed and digitally recorded with pup 
birth interval times noted. Following parturition, lactating rats were weighed and 
injected daily with the same dose between 9.00am and 11.00am. On lactation day 3, 
2h prior to a 10 min maternal aggression test lactating rats were injected s.c. with 
1mg/kg AP (2 mg AP in 12% ethanol and corn oil) or vehicle injection. Rats were 
perfused 90 min following the start of the maternal aggression test and the brains 
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collected for Fos ICC. Fos was examined in the LS, BnST, MPOA, SON, MeA, 
CeA, PVN and PAG using the technique described in chapter 2. 
5.4.1.1 Statistics 
A two way ANOVA was performed comparing treatment ad pup birth interval 
times. A T-test was used to compare behavioural and Fos data between the treatment 
groups. When p≤0.05, data was deemed to be statistically different. 
5.4.2 Results 
5.4.2.1 Pup birth interval 
AP administration prior to parturition had no significant effect on the timing of 
parturition onset (p=0.65, T(7,8)=86.0) or pup birth interval (p=0.789, F(1,121)=0.0718; 
Fig. 5.9) compared to vehicle treatment. 
5.4.2.2 Aggressive behaviour 
Maintaining elevated levels of AP from late pregnancy resulted in significantly more 
attacks (p=0.045, T(8,10)=99.0; AP=8.25±2.1 attacks in a 10 min maternal aggression 
test, V=3.60±.5; Fig. 5.10) but there was no signifcant effect on the latency to attack 
(p=0.25, t-1.2; AP=95.75±27.3sec, V=168.82±49.9sec; Fig. 5.10) or pe centage of 
total time exhibiting aggressive behaviour (p=0.27, T(9,10)=104.0; Fig. 5.11) 
compared to vehicle treatment. When individual aggressive behaviours are compared 
between the two treatment groups as a percentage of total aggressive behaviour time, 
no statistical difference is found in any type of behaviour (attacks p=0.93, t-0.08, 
biting p=0.49, T(9,10)=81.0, clawing p=0.22, T(9,10)=105.0, rearing p=0.13, 




5.4.2.3 Maternal behaviour 
No significant effect of AP treatment in time spent exhibiting any maternal 
behaviour (all maternal behaviours p=0.84, T(9,10)=87.0, nursing p=0.41, T(9,10)=79.5, 
general pup interaction p=0.60, T(9,10)=83.0; Fig. 5.11) compared to vehicle 
treatment. 
5.4.2.4 General behaviour 
When all general behaviour was analysed as a percentag  of total time, there no 
significant effect of AP treatment compared to vehicle (p=0.23, t-1.2; Fig. 5.11). 
However, when general behaviour was broken down into ts components and 
compared as a percentage of total general time. The AP treated group spent 
significantly more time than the vehicle treated group performing general behaviours 
(p=0.025, t2.5; Fig. 5.13) and significantly less time grooming themselves (p=0.005, t-
3.2; Fig. 5.13) than the vehicle treated group.  
5.4.2.5 Response to aggression behaviour by the resident 
There was no significant effect of AP treatment in he behavioural response of the 
resident to intruder aggressive behaviour when compared as a percentage of total 
time (p=0.59, T(9,10)=97.0) or when broken down into its individual components 
(freezing p=0.84, T(9,10)=93.0, escaping p=0.97, T(9,10)=90.0 or rearing away p=0.48, 
T(9,10)=99.0; Fig. 5.11) compared to vehicle treatment. 
5.4.2.6 Fos immunocytochemistry  
AP treatment significantly reduced Fos expression in the BnST of aggressive rats 
compared to the vehicle treated group (p=0.020, t-2.6; Fig. 5.14). No significant 
difference in Fos expression was observed in the LS (p=0.099, t=1.7), CeA (p=1.0, 
T(8,10)=75.5), MeA (p=0.16, t-1.5), MPOA (p=0.89, T=74.0), SON (p=0.22, t-1.7), 
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parvocellular PVN (p=0.89, T(8,9)=70.0) or PAG (p=0.31, T(9,10)=103.0; Fig. 5.14) 
between the AP and vehicle treated groups. There were not enough sections 
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Figure 5.8: Effect of allopregnanolone administration on pup birth interval latency 
during parturition. Pregnant rats were subcutaneously injected with allopregnanolone (AP; 
6mg AP in 12% ethanol and corn oil; n=9) or vehicle (12% ethanol and 88% corn oil; n=10) 
one day prior (deemed 21 days after seminal plug found) and on the day of parturition. The 
time (min) between the birth of each pup was recorded and is represented here as 














































































































Vehicle AP Treated  
Figure 5.9: Average number of attacks and attack latency for a resident lactating rat 
during a maternal aggression test following allopregnanolone treatment. The 
allopregnanolone (AP; n=9) group was treated daily with subcutaneous injections of 3mg/kg 
AP (6mg of AP in 120µl corn oil and 880µl ethanol (100%)) from one day prior to parturition 
until one day prior to testing. They also received an injection of 1mg/kg AP 2h prior to 
maternal aggression test. The vehicle group (n=10) was also injected at the same times as 
the AP with 12% corn oil and 88% ethanol. (A) Average number of attacks by a resident rat 
during a 10 min maternal aggression test towards a novel virgin female intruder in their home 
cage with their pups present. (B) The mean latency (secs) to attack an intruder by the 
resident lactating rat during a 10 min maternal aggression test. Data are represented as 
mean +SEM. *=p≤0.05 
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Figure 5.10: Average percentage of total time spent exhibiting different behaviours by 
resident rat during a maternal aggression test following allopregnanolone treatment. 
The allopregnanolone (AP; n=9) group was treated daily with subcutaneous injections of 
3mg/kg AP (6mg of AP in 120µl corn oil and 880µl ethanol (100%)) from one day prior to 
parturition until one day prior to testing. They also received an injection of 1mg/kg AP 2h 
prior to maternal aggression test. The vehicle group (n=10) was also injected at the same 
times as the AP with 12% corn oil and 88% ethanol. The mean percentage of total time (10 
min) spent exhibiting attacking, maternal, general, response to aggression or sniffing 
behaviours by a resident lactating rat in her home cage with her pups present during 
maternal aggression test. There was no significant difference in the display of any behaviour 
between the two treatment groups. 
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Figure 5.11: Average percentage of total aggression time spent exhibiting different 
aggressive behaviours by a resident rat during a maternal aggression test following 
allopregnanolone treatment. The allopregnanolone (AP; n=9) group was treated daily with 
subcutaneous injections of 3mg/kg AP (6mg of AP in 120µl corn oil and 880µl ethanol 
(100%)) from one day prior to parturition until one day prior to testing. They also received an 
injection of 1mg/kg AP 2h prior to maternal aggression test. The vehicle group (n=10) was 
also injected at the same times as the AP with 12% corn oil and 88% ethanol. Average 
percentage of total aggression time spent exhibiting attacking, biting, clawing, rearing, 
pinning down and lunging behaviour towards a novel virgin female intruder during a 10 min 
maternal aggression test by a lactating rat in her home cage with her pups present. No 
significant differences are observed in the expression of any aggressive behaviour between 
the two treatment groups. 
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Figure 5.12: Average percentage of total general time spent exhibiting different 
general behaviours by a resident rat during a maternal aggression test following 
allopregnanolone treatment. The allopregnanolone (AP; n=9) group was treated daily with 
subcutaneous injections of 3mg/kg AP (6mg of AP in 120µl corn oil and 880µl ethanol 
(100%)) from one day prior to parturition until one day prior to testing. They also received an 
injection of 1mg/kg AP 2h prior to maternal aggression test. The vehicle group (n=10) was 
also injected at the same times as the AP with 12% corn oil and 88% ethanol. The average 
percentage of total general time spent exhibiting eating/drinking, exploring, grooming self or 
general (defined as walking around cage without interaction with pups or intruder) by the 
resident lactating rat during a 10 min maternal aggression test with her pups present. Note 
that the AP treated group spend significantly more time grooming themselves and 




























































































































































































































































































































































Figure 5.13: Average number of Fos positive cells in specific brain areas of the 
resident lactating rat brain during a maternal aggression test following 
allopregnanolone treatment. Allopregnanolone (AP; n=9) treated rats were injected s.c. 
with 3mg/kg AP (6mg AP in 12% ethanol and 88% corn oil) daily from pregnancy day 21 until 
one day prior to behavioural testing. On the day of testing, rats received a 1mg/kg AP (2mg 
AP in 12% ethanol and 88% corn oil) injection s.c. 2h prior to a maternal aggression test. 
Vehicle treated rats (n=10) were injected at the same time as AP treated rats but with 12% 
ethanol and corn oil. Expression of Fos was examined in the lateral septum (LS), bed 
nucleus of stria terminalis (BnST), medial preoptic area (MPOA), supraoptic nucleus (SON), 
medial and central amygdala (MeA and CeA respectively), parvocellular paraventricular 
nucleus (PVN) and periaqueductal grey area (PAG) of AP or vehicle treated lactating rats by 
performing immunocytochemistry for Fos on brains perfused 90 min after the start of 
behavioural testing. Data are represented by means + SEM. *p≤0.05 
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5.5 The effect of finasteride (5α reductase inhibitor) treatment from late 
pregnancy on maternal aggression  
In the previous experiments, levels of AP were manipulated during lactation or 
prevented from decreasing from late pregnancy onwards. The number of attacks was 
significantly increased but no other behavioural measurements were affected when 
AP levels were maintained from late pregnancy. There is a possibility that AP does 
have a positive modulatory effect on maternal aggression but quantification of the 
behaviour in this study was not sensitive enough to detect the differences. It is also 
possible that a capping effect may be occurring as the behavioural test was 
performed on days 3 to 7 of lactation when the level of aggression is at its highest 
expression. Therefore in this study the aim was to examine the effect of 
administering finasteride, a 5α reductase inhibitor (the rate limiting step in the 
production of AP), daily from late pregnancy, prior t  the peak in AP (pregnancy day 
19; [346]) until lactation day 3 on maternal aggression expression.  
5.5.1 Method  
Daily injections of 50mg/kg of finasteride (50mg in 234µl of ethanol with 766µl of 
corn oil; n=7) or vehicle (234µl of ethanol with 766µl of corn oil; n=11) was initiated 
on pregnancy day (PD) 17 (because AP levels in the cer bral cortex are reported to 
be at their peak in rats at PD19 [346]). This dosage of finasteride was used because it 
was already observed to cause significant changes in behaviour including maternal 
within female rats [368, 451, 455-458]. Immediately prior to the first injection on 
PD17, a blood sample (200µl) was taken from rats by tail tipping (chapter 2).To 
investigate if finasteride had any effect on parturition and lactation, pup birth 
intervals were recorded and the pups weighed daily following birth. The finasteride 
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injections were given daily until day 2 of lactation. On the day of behavioural testing 
(lactation day 3), rats were exposed to a 30 min matern l aggression test in their 
home cage with their pups present. A lethal overdose of sodium pentobarbitone (1ml) 
was given 90 min following the start of the test and a blood sample (200µl) was 
collected from the heart with heparinised capillary tubes.  The blood samples were 
later processed for progesterone by RIA and compared to pre-finasteride levels to 
ensure that finasteride treatment has no effect on irculating progesterone levels. 
5.5.1.1 Statistics 
A t-test was used to compare the results between th two treatment groups, when 
p≤0.05 data were considered to be statistically significant. 
5.5.2 Results 
5.5.2.1 Aggressive behaviour 
Finasteride treatment had no significant effect on aggressive behaviour. The number 
of attacks (p=0.87, t-0.2; Fig. 5.15) and attack latency (p=0.18, t-1.4; Fig. 5.15) were 
not statistically different between the two treatment groups. The percentage of total 
time spent exhibiting all aggressive behaviours was not significantly different 
between the two treatment groups (p=0.11, T(7,9)=75.0; Fig. 5.15). 
5.5.2.2 Other behaviours 
Finasteride treatment had no significant effect on maternal (p=0.94, t-0.07; Fig. 5.15) 
or general behaviour (p=0.35, t-1.0; Fig. 5.15) expressed during a maternal aggression 
test compared to vehicle treatment. However, the finasteride treated group appeared 
more anxious as they spent significantly more time fre zing in response to aggressive 
behaviour from the intruder compared to the vehicle tr ated group (p=0.044, 
T(7,9)=79.0; Fig. 5.15). 
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5.5.2.3 Circulating progesterone levels 
The levels of circulating progesterone did not signif cantly differ between treatment 
groups either on pregnancy day 17 (before the start of treatment; p=0.20, t1.3; 
finasteride=75.62±3.2ng/ml, vehicle=67.65±5.0ng/ml) or on lactation day 3 







































































































































































































































































































































































































































Figure 5.14: Average number of attacks, attack latency and percentage of total time 
displaying different behaviours for a resident lactating rat during a maternal 
aggression test following finasteride treatment. The finasteride (n=7) group was treated 
daily with subcutaneous injections of 50mg/kg finasteride (50mg of finasteride in 800µl corn 
oil and 200µl ethanol (100%)) from pregnancy day 17 until one day prior to testing. The 
vehicle group (n=11) was also injected at the same times as the finasteride group but with 
80% corn oil and 20% ethanol instead. Average number of attacks (A) and latency to attack 
(B) by a resident lactating rat during a 10 min maternal aggression test towards a novel 
virgin female intruder in her home cage with her pups present. The percentage of total time 
expressing aggressive, general, maternal or response to aggression (C-F respectively) 
behaviour were also compared between the two treatment groups. Data are represented as 




The results of this study firstly suggest the AP does not play a crucial role in 
the control of parturition. AP administered in late pregnancy did not have any effect 
on parturition onset or pup birth interval times. This was also the case if finasteride 
was administered from late pregnancy. Previous reports have shown progesterone to 
delay or even inhibit parturition in rats [459, 460]. Together these results indicate 
that central progesterone actions in late pregnancy re on its own receptor and not 
through AP inducing GABA receptor inhibition of OXT cells [461]. AP is observ d 
to significantly inhibit uterine contractibility directly through its actions on the 
GABAA receptor but no effect was observed in the present tudy suggesting the 
dosage administered is not enough to cause this effect [462].  
Secondly the results show that AP does not exert a direct effect on maternal 
behaviour and aggression. Instead, AP may indirectly help enable maternal 
aggression by modulating fear and anxiety. Lactating rats are observed to display a 
lower anxiety and fear behaviour profile on the EPM, open field and defensive 
burying tests [31-33]. This reduction in fear and axiety during lactation is thought to 
be essential for normal maternal behaviour, because virgin female rats are fearful of 
pups and do not spontaneously display maternal behaviour [29]. A significant 
increase in Fos expression was detected in the CeA following AP treatment in 
aggression tested rats, a brain region important in fear regulation [105]. It has even 
been suggested that during the peri-partum period GABA transmission increases in 
this area to inhibit the CeA projections to fear-inducing nuclei [265, 440]. Thus, it 
may be hypothesised that AP acts by enhancing GABA actions to reduce fear and 
anxiety so that the dam may display aggression. 
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Although no effect of AP administration during lacttion was observed on 
maternal aggression, maintaining AP levels from late pregnancy did result in a 
significant increase in the number of attacks. Furthermore, this AP treatment resulted 
in a significantly higher level of Fos expression in the BnST compared to vehicle 
treated rats. The BnST is implicated in regulating the long term effects of anxiety 
whereas CeA mediates the short term (i.e. fear) [105].  
Finally when finasteride, a 5α-reductase inhibitor (the rate limiting enzyme in 
AP production), was administered from late pregnancy (although no difference was 
observed in aggressive, maternal or general behaviour expression) it caused an 
increase in the amount of time freezing (an expression of fear) during an aggression 
test by the lactating rat. This supports the idea that AP indirectly helps maintain 
maternal aggression by regulating fear and anxiety to low levels. 
AP potentiates GABA receptor activation and has anxiolytic, anticonvulsant 
and neuroendocrine effects similar to those produce by benzodiazepine [31, 463]. If 
diazepam, a prototypical benzodiazepine, is administered to a female rat in 
proestrous, there is a detectable reduction in anxiety levels compared to 
ovariectomised females [31, 464]. Also, finasteride a ministration to postpartum rats 
increases depressive behaviour, such as forced swimtest immobility similar to the 
increase in freezing seen in the maternal aggression test, in conjunction with 
decreased plasma and hippocampal AP levels [447]. However in the study by Picazo 
et al (1993, [33]) although they found anxiety was reduced in the defensive burying 
paradigm immediately after parturition, plasma progesterone levels were at their 
lowest at this time. Nonetheless AP can also be derived from cholesterol within the 
brain so circulating levels of progesterone may be irrelevant [32, 33].  
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Yet, the sensitivity of GABA receptors is reported not to be altered in the 
lactating rat compared to a non-lactating cycling rat in response to either GABA or 
AP and MK404, another 5-α reductase inhibitor, administration. Also, the production 
of AP from progesterone in the serum was decreased in lactating rats but there was 
no observed effect on EPM performance [32]. However th se rats were tested on 
lactation day 7 when anxiety levels are already increasing. Bitran et al (1991, [31]) 
had found greatest reduction in anxiety to be on lactation day 2. Furthermore, 
although AP production from progesterone was decreased in the serum, the level of 
AP in serum was still greater than non-lactating cycling female rats [32]. Also, there 
is a problem in using the EPM to measure anxiety in lactating rats as the observed 
increase in open arm exploration may in fact reflect in reased vigilance or searching 
for pups [32].  
However, although finasteride treatment increased freezing behaviour, an 
expression of ‘fear-like’ behaviour, in lactating rats during a maternal aggression 
test, there was no change in the level of aggression. Pup stimulation during the 
maternal aggression test may have helped the lactating rat overcome the increase in 
fear and hence still express aggression at normal levels [188]. Hence, further 
research investigating how the modulation of fear and nxiety is regulated by AP 
during lactation is warranted. 
 The reduction in anxiety behaviour observed during lactation is also detected 
during pregnancy where it has been linked with AP. Pregnancy day 19 rats spend 
more time on, and make more entries into, the open arms of the EPM compared to 
non-pregnant ovariectomised rats [34]. Anxiety is al o reduced in the defensive 
burying paradigm in pregnant rats where an increase in burying behaviour latency 
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(pregnancy day 21) and a decrease in cumulative burying behaviour (pregnancy day 
14) compared to ovariectomised rats was observed [33]. It has been characterized 
that plasma and cortical AP levels are at their highest during pregnancy [34, 346, 
458]. Finasteride administration during pregnancy (day 19) to reduce AP levels 
comparable to those of oestrus significantly increases anxiety on the EPM [34].  
Finasteride treatment has other significant effects during pregnancy, 
particularly in relation to the HPA axis. During late pregnancy, the HPA axis is 
normally inhibited by endogenous opioids induced by AP. By blocking AP 
production, finasteride removes this inhibition and the HPA axis responds to 
stressors including interleukin-1ß which mimics infection [199]. A reduced stress 
response during late pregnancy is important and is hypothesised to prevent chronic 
activation and therefore release of corticosteroids which can cross the mother-fetal 
barrier. High levels of glucocorticoids are known to be harmful to fetal development 
including the development of the limbic and neuroendocrine systems [34, 36]. AP 
could exert its protective control over the HPA axis by enhancing GABA receptor 
inhibitory activity. This altered HPA axis activity is also observed in lactating rats in 
response to pup stimulation, suggesting that AP mayalso be important in regulating 
HPA axis activity during lactation, which could indrectly impact upon maternal 
behaviour and aggression [36]. 
The results from this current study support this idea as decreased Fos 
activation was observed in the PVN and PAG following AP treatment in aggression 
tested rats. The PVN is an area important in the control of the stress response as it is 
a crucial part of the HPA axis [107, 200, 201]. The reduction in Fos expression 
observed in the PAG again links the actions of AP with the stress response as the 
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PAG has a substantial role in determining what behaviour is expressed in reaction to 
a stressor [141]. The PAG also has a role in the control of other important maternal 
behaviours especially nursing [140]. 
It is important to note that AP treatment in the prsent study appeared to only 
have minimal effects on maternal behaviour and aggression. There are several 
possible explanations for this. One possibility is that the behavioural test may not be 
sensitive enough to detect the differences. Another possibility is that a capping effect 
may be occurring. The behavioural testing is performed during lactation days 3 to 7 
when maternal aggression is at its highest, therefore i  AP has a positive effect on 
maternal aggression it will cause little or no change.  
It could be argued that our AP dosage was too low, being in the range that has 
been seen to have no effect on other forms of aggression [342, 379]. However, the 
dosage used in the current study is known to influece the actions of GABA 
receptors on OXT release in the rat. The dosage was given to virgin female rats 
where it significantly lessened the OXT secretory response to an interleukin 
challenge, leading to the proposal that GABAA receptors on OXT neurons can be 
influenced by AP [199]. Also, administration of 1mg of AP subcutaneously 
prevented the rise in vasopressin mRNA in the PVN of adrenalectomised rats [446]. 
Hence, if progesterone does modulate maternal behaviour through the actions of AP 
on GABAA receptors, the dosage used is known to cause effects within the brain and 
therefore would allow for a difference in behaviour to be expressed. Indeed, the Fos 
data show that AP has an effect in the brain but not on behaviour as significant 
differences were observed in AP treated compared to vehicle treated lactating rats. 
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 In humans, anxiolytic effects of AP are beginning to be discovered, especially 
in relation to hormonal cycles, pregnancy and the post partum period. In both 
humans and rodents, AP levels rise throughout pregnancy to create an anxiolytic 
effect so pregnancy can reach term with little deleterious damage to the fetus [465]. 
During pregnancy, women display a stable psychological status, which is 
hypothesized to be due to the increase in the anti-anxiety neurosteroid AP levels 
[453]. It has been postulated that the rapid declin in the levels of AP around the end 
of pregnancy may contribute to the development of post artum depression [441]. 
The decrease in AP levels, both blood and brain, have been found to impact upon 
many mood and anxiety disorders, including premenstrual tension (PMT) and 
pregnancy related depression which are hormone related [463]. For example, 
Montelone et al (2000, [466]) noticed that sufferers of PMT had reduced serum AP 
concentrations in the luteal phase (when symptoms of PMT are apparent) of the 
menstrual cycle in comparison with healthy controls. Seizures that occur in 
catamenial epilepsy are coupled with the changing levels of production of AP from 
progesterone [366, 441]. Even the drugs given to treat such disorders, such as 
tricyclics and selective serotonin reuptake inhibitors, have an effect on AP secretion 
[467]. Also, finasteride, when taken for the treatment of androgentic alopecia in 
human males, induces depressive like symptoms [468]. 
AP therefore appears to have important anxiolytic actions around the peri-
partum period in both humans and rodents. New reseach therefore should focus on 
how manipulations of AP levels affect anxiety and how this impacts upon maternal 
behaviour. There are several possible lines of resea ch to follow. One is to examine 
the effects of finasteride administration during lactation on the pup retrieval task in a 
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novel (i.e. stressful) cage. One would hypothesise that finasteride, by blocking AP 
production, would increase anxiety and hence impede the lactating rat in performing 
the pup retrieval task. Another line of experimentation would be to investigate the 
actions of AP in the high anxiety behaviour (HAB) line of rats. HAB rats are highly 
anxious and express excessive aggression towards conspecifics during a maternal 
aggression task [320]. AP administration to HAB rats during lactation would be 
proposed to reduce anxiety to normal levels seen in a lactating rat and hence reduce 
the aggressive behaviour displayed during a maternal aggression test. Other 
experiments could examine what would be the actions of AP in virgin female rats on 
anxiety behaviour expression and determine how this would then affect the pup-
sensitization process. Administration of AP has already been seen to reduce anxiety 
in virgin female rats to levels of pregnant rats on the EPM, therefore one would 
hypothesise that this reduction in anxiety following jection of AP would help them 
overcome their aversion to pups and thus decrease latency to display full maternal 
behaviour in a pup-sensitization task [469]. 
In this study evidence suggests that, although AP may not have a direct 
influence on maternal behaviour, AP could play an important role in reducing fear 
and anxiety behaviour during the peri-partum period t  allow for the expression of 







Chapter Six: Maternal aggression and GABA 
6.1 Introduction 
In the previous chapter, the effects of AP on maternal behaviour including maternal 
aggression were investigated. It was discovered that because of the ability of AP to 
potentiate the anxiolytic actions of GABAA receptor functioning, AP may indirectly 
impact upon maternal aggression [356-359, 361]. If AP is able to modulate maternal 
aggression through enhancement of GABAA receptor functioning then GABA 
neurotransmission itself may control maternal aggression. This study therefore 
investigates the effect of direct manipulation of GABA neurotransmission on 
maternal behaviour, including maternal aggression. 
 For male rats, the relationship between GABA and aggression is well 
established [342, 373, 378, 380]. Depaulis et al (1983) reported that an ICV injection 
of the GABA antagonist, bicuculline methiodide (BM), decreased the aggressive 
actions of killer rats in the mouse-killing behaviour (MKB) paradigm without 
affecting the expression of other behaviours [470]. Furthermore, administration of the 
GABA agonist,  4,5,6,7-tetrahydroisoxazolo-(5,4-c-)-pyrindin-5-ol (THIP), decreased 
attack and killing latencies in killer males and elicited killing behaviour in males rats 
that were previously determined to be non-killer [470]. It was observed that there 
were resemblances between MKB and offensive behaviour displayed in the resident 
intruder paradigm hence it was hypothesised that they may be facilitated by similar 
mechanisms in the brain [471]. As in MKB, ICV injection of THIP induced offensive 
male aggression to a conspecific in a neutral cage [471]. ICV BM treatment in this 
paradigm decreased aggression by reducing the number of attacks, offensive 
sideways and upright posture behaviours and increased defensive behaviour [471]. 
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On the other hand, in the shock-induced fighting paradigm the converse occurred as 
the GABA antagonists, picrotoxin and BM, were found to increase the number of 
fights [471, 472]. A possible reason for this discrepancy in behaviour could be 
because the shock induced fighting paradigm is actually measuring a defensive 
reaction rather than offensive [471, 472]. GABAergic control is therefore irrefutably 
necessary for male aggression where GABA neurotransmission enhances offensive 
aggressive and reduces defensive behaviour. Few studie  to date have examined in 
detail whether the same is true for maternal aggression. 
 GABAergic neurotransmission is known to have important functions around 
the peri-partum period. The disinhibition of GABAA receptors just prior to parturition 
allows the necessary increase in OXT secretion for parturition and lactation. It also 
plays a role in the control of blood volume during pregnancy through its mediation by 
AP [445]. A significant correlation between maternal behaviour and the activation of 
glutamate decarboxylase (GAD) synthesising neurons in the MPOA, ventral BnST 
and ventrocaudal PAG implicates GABA neurotransmission as having a regulatory 
role in the control of maternal behaviour [355]. The role of GABA in maternal 
behaviour, especially maternal aggression, is confusi g and complex. In the control of 
maternal behaviour, it appears that if GABA neurotransmission is enhanced in the 
MPOA of the lactating rat through direct infusion of GABA agonists, musimicol or 
baclofen, maternal behaviour is disrupted [438]. The MPOA plays a central role in 
regulating many components of maternal behaviour as both electrical and excitotoxic 
MPOA lesions disrupt most if not all maternal behaviour [27, 80, 82, 83, 158, 438]. 
However, Lee and Gammie (2007) reported that systemic administration of a GABA 
receptor agonist, chlorodiazepine, enhanced maternal aggression in mice [158]. This 
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disparity may be due to a species difference as rats were used in the former study. 
Yet, Hansen et al (1985) reported that following an i.p. administration of a 
benzodiazepine antagonist into a lactating rat, matern l aggression was significantly 
decreased [237]. Furthermore, the administration of BM directly into the 
ventromedial hypothalamus and amygdaloid complex significantly decreased 
aggressive behaviour especially attacks and lateral posture [390]. BM administration 
directly into the LS of lactating mice resulted in significantly less maternal aggression 
[387]. These results suggest that GABA may exert its influence on aggression in a 
similar way in both sexes but further research is warranted before this is concluded. 
Taken together the research above provides evidence for a regulatory role of 
GABA. However the extents to which GABAA receptors are involved during the 
peri-partum period to regulate maternal behaviour, specifically maternal aggression, 
are still not defined. The aim of this chapter was to test the hypothesis that a GABA 
antagonist, specifically BM, would decrease the maternal aggression when given 
directly via ICV into the brain of a lactating rat. In addition to examining the BM 
effects on lactating rats, the effects of BM administration to virgin female rats 
sensitized to pups and displaying maternal behaviour were also investigated. Virgin 
female rats will only display maternal behaviour after exposure to pups and little is 
known about whether the same mechanisms which control maternal behaviour in 
lactating rats work. The aim therefore of this study is to examine if manipulating 
GABA neurotransmission is able in influence maternal aggression in virgin female 
rats in the same as in lactating rats. A final aim was investigate where GABA may be 
acting to control maternal aggression in the brain; this was done by performing 
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double ICC for GAD 65/67 and Fos on the brain of a lactating rat following a 
maternal aggression test.  
 
6.2 The effect of the GABA antagonist, bicuculline methiodide, on maternal 
aggression in the lactating rat 
6.2.1 Method  
On lactation day 2, each rat was surgically implanted with an ICV guide cannula. 
The rats were then allowed to recover for 2 days in their home cage. On the day of 
behavioural testing, an internal cannula was inserted into the guide cannula and by 
means of a Hamilton syringe 5µl of sterile 0.9% physiological saline (Genus Xpress, 
n=9) or 100ng of BM (1mg in 50ml sterile 0.9% physiological saline; Sigma; n=14) 
was slowly infused over 1 min. Three min following ICV infusion, lactating rats 
were submitted to a 10 min maternal aggression test. Rats were perfused 90 min after 
the start of testing and the brains collected and processed for Fos ICC. 
Fos expression was examined in the LS, BnST, MPOA, SON, MeA, CeA, PVN and 
PAG using the technique described in chapter 2. 
6.2.1.1 Statistics 
A T-test was carried out to compare values for the two treatment groups when the 
data was normally distributed. If data was not normally distributed, a Mann-Whitney 






6.2.2 Results  
6.2.2.1 Aggressive behaviour   
BM treatment significantly reduced the total time spent exhibiting aggressive 
behaviours (p=0.042, t-2.17; vehicle (V)=10.29±3.1 %Total Time (TT), BM=4.13±1.2 
%TT; Fig. 6.1) including two specific aggressive behaviours, lunging (p=0.026, 
T(8,14)=125.00; V=4.06±1.8 %Total Aggressive Time (TAT), BM=0.53±0.3 %TAT; 
Fig. 6.1) and rearing (p=0.037, T(8,14)=123.00; V=3.68±1.7%TAT, 
BM=1.07±0.3%TAT; Fig. 6.1) compared to vehicle treament. However, BM 
administration did not significantly reduce the number of attacks (p=0.175, 
T(9,14)=130.00; V=5.50±1.7attacks, BM=2.43±0.6attacks; Fig. 6.2) or increase 
latency to attack (p=0.95, t-0.06; V=167.30±36.9secs, BM=169.88±23.1secs; Fig. 6.2) 
compared to the vehicle treated group. No statistical significance was observed 
between the two treatment groups in the duration of any other aggressive behaviour 
(attack p=0.23, T(8,14)=110.00, biting p=0.23, T(8,14)=110.00, clawing p=0.41, 
T(8,14)=104.50, and pinning down p=0.21, T(8,14)=111.00; Fig. 6.3). There was no 
significant difference between the two treatment groups in sniffing behaviour 
(p=0.052, t1.88) however there was a trend for the BM treated group t  sniff more. 
6.2.2.2 Maternal behaviour 
There was no significant difference in the expression of maternal behaviour either as 
a percentage of total time (p=0.12, T(8,14)=115.00; Fig. 6.1) or when broken down 
into individual behaviours and compared as percentage of total maternal time (pup 
moving p=0.43, T(9,14)=95.00, general pup p=0.054, T(9,14)=139.00, nesting p=0.63, 
T(9,14)=116.00 or nursing p=0.80, T(9,14)=103.50). 
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6.2.2.3 General behaviour 
The BM treated group spent significantly more time expressing general behaviours 
compared to the vehicle treated group (p=0.027, T(8,14)=59.00; V=40.59±3.1%TT, 
BM=61.19±5.7%TT; Fig. 6.1). The vehicle treated group spent more time self 
grooming compared to the BM treated group (p=0.032 T(8,14)=124.00; 
V=24.56±4.8% total general time (TGT), BM=11.54±2.2%TGT; Fig. 6.4). 
6.2.2.4 Response to aggression behaviour by the resident 
Treatment with BM did not result in a significant change in the response to 
aggressive behaviour from the intruder by the resident rat compared to the vehicle 
treatment (p=0.66, T(8,14)=85.00, V=0.42±0.2%TT, BM=1.94±1.0%TT; Fig. 6.1). 
6.2.2.5 Fos expression 
BM treatment had no significant effect in the number of Fos positive cells quantified 
in any specific brain region examined (BnST p=0.64 T(9,14)=100.00, LS p=0.78, 
T(9,14)=113.00, SON p=0.16, T(9,13)=125.00, MPOA p=0.47, T(9,14)=120.00, CeA 
p=0.37, t0.92, MeA p=0.64, T(9,14)=116.00, parvocellular PVN p=0.21, t-1.30, 
magnocellular PVN p=0.49,  T(9,14)=119.50 or PAG p=0.86, t0.18; Fig. 6.5) compared 




Figure 6.1: Average percentage of total time spent exhibiting different behaviours by 
the resident lactating rat during a maternal aggression test following ICV 
administration of bicuculline methiodide. The bicuculline methiodide (BM) treated group 
(n=14) were infused with 100ng of BM in physiological saline into the lateral ventricle 3 min 
prior to testing. The vehicle treated group (n=9) were infused with physiological saline at the 
same time point. Pie charts depicting the mean percentage of total time of the maternal 
aggression test (10 min) spent exhibiting aggressive, maternal, response to aggression or 
general behaviours by the resident lactating rat in her home cage with pups present. Note 
the significant decrease in percentage of total time spent expressing aggressive behaviours 
and significant increase in general behaviour exhibition in the BM treated group compared to 




































































































































Figure 6.2: Average number of attacks and attack latency for the resident lactating rat 
during a maternal aggression test following ICV administration of bicuculline 
methiodide. The bicuculline methiodide (BM) treated group (n=14) were infused with 100ng 
of BM in physiological saline into the lateral ventricle 3 min prior to testing. The vehicle 
treated group (n=9) were infused with physiological saline at the same time point. The 
average number of attacks and latency to attack (secs) the virgin intruder during a 10 min 
maternal aggression was compared between the BM and vehicle treated groups. Data are 
represented as mean + SEM.  
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Figure 6.3: Average percentage of total aggressive time spent exhibiting different 
aggressive behaviours by a resident lactating rat during a maternal aggression test 
following ICV administration of bicuculline methiodide. The bicuculline methiodide (BM) 
treated group (n=14) were infused with 100ng of BM in physiological saline into the lateral 
ventricle 3 min prior to testing. The vehicle treated group (n=9) were infused with 
physiological saline at the same time point. The average percentage of total aggression time 
by the resident spent exhibiting attacking, biting, clawing/punching, rearing, pinning down, 
lunging or sniffing behaviours towards a novel female intruder during a 10 min maternal 
aggression test with the pups present. There was no significant difference in the expression 
of any specific aggressive behaviour between the two treatment groups. 
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Figure 6.4: Average percentage of total general time spent exhibiting different general 
behaviours by a resident lactating rat during a maternal aggression test following ICV 
administration of bicuculline methiodide. The bicuculline methiodide (BM) treated group 
(n=14) were infused with 100ng of BM in physiological saline into the lateral ventricle 3 min 
prior to testing. The vehicle treated group (n=9) were infused with physiological saline at the 
same time point. The average percentage of total general time spent by the resident eating, 
drinking, exploring, grooming self or general (defined as moving around cage with no 
involvement of intruder or pups) behaviour during a 10 min maternal aggression test with the 
pups present. Note that the BM treated group spent significantly less time self grooming than 


































































































































































































































































































































































Figure 6.5: Average number of Fos positive cells in specific brain areas of the 
lactating rat brain following a maternal aggression test and ICV administration of 
bicuculline methiodide. Lactating rats were infused with 5µl of bicuculline methiodide (1mg 
dissolved in 50ml sterile physiological saline) or physiological saline by means of a Hamilton 
syringe through an internal cannula into the lateral ventricle 3 min prior to maternal 
aggression test. Expression of Fos in the lateral septum (LS), bed nucleus of stria terminalis 
(BnST), medial preoptic area (MPOA), supraoptic nucleus (SON), medial and central 
amygdala (MeA and CeA respectively), parvocellular paraventricular nucleus (PVN) and 
periaqueductal grey area (PAG) of Bicuculline Methiodide (n=14) or vehicle (n=9) treated 
rats was quantified by performing Fos immunocytochemistry on brains perfused 90 min after 
the start of behavioural testing. Data are represented as mean + SEM. 
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6.3 The effect of a GABA antagonist, bicuculline methiodide, on maternal 
aggression in pup-sensitized virgin rats 
6.3.1 Method 
Virgin females were randomly assigned to one of three treatment groups; non-
surgical control, vehicle or GABA Antagonist. Vehicle and GABA antagonist groups 
were implanted with an ICV guide cannula and left for 2 day recovery period. A non-
surgical control group, with no ICV cannulation, was included to ensure that any 
behavioural or Fos differences between vehicle and BM treated groups were the 
result of treatment and not ICV cannulation. Following surgery or not, all rats 
underwent pup-sensitization with daily monitoring for the expression of maternal 
behaviour (for details please refer to chapter 2). The day after the virgin was first 
defined as ‘fully maternal’, the pup-sensitization test was repeated. Once completed, 
if the virgin was not cannulated i.e. the non-surgical control group, the rat was 
exposed to a 30 min maternal aggression test with donor pups (n=3) present in her 
home cage. If the virgin rat was cannulated, the GABA antagonist group received a 
5µl infusion of 100ng of BM (1mg in sterile 50ml of physiological saline) whilst the 
vehicle group received 5µl of 0.9% physiological saline by means of a Hamilton 
syringe via an internal cannula 3 min prior to performing the maternal aggression test 
as uncannulated rats above. Immediately after the maternal aggression tests, a 
vaginal smear was taken from the pup-sensitized rat and analysed to see what stage 
of cycling she was at. Rats were perfused 90 min after the start of testing and the 
brains collected and processed for Fos ICC. 
Fos expression was examined in the LS, BnST, MPOA, SON, MeA, CeA, PVN and 




A one-way ANOVA was carried out to compare values for the three groups when the 
data was normally distributed. If data was not normally distributed, an ANOVA on 
Ranks was performed instead. Results were deemed statistically significant if p≤0.05. 
6.3.2 Results 
6.3.2.1 Pup-sensitization 
Thirty virgin female rats began the pup-sensitization procedure. Of those 30, 7 were 
removed from the experiment because they killed the pups during the first day of 
testing. Another 2 were removed for other experimental reasons, one had the wrong 
cannula placement and the other became injured so had to be put down. Of the 
remaining 21, 15 became maternal and 6 never became maternal even after 13 days 
of pup exposure. The overall average length for virgin female rat to become maternal 
was 7.89±0.8days, there was no significant difference between the treatment groups 
in latency to become maternal (p=0.46, F(2,17)=0.81). All virgin female rats that 
performed the maternal aggression test after becoming aternal were either in the 
proestrous or estrous stage of their cycle. 
6.3.2.2 Aggressive behaviour 
Overall, pup-sensitized virgin rats expressed little aggressive behaviour. In the whole 
experiment, only two pup-sensitized virgin rats attacked the intruder. Although both 
of these were in the GABA antagonist group, they only did this once during the 
maternal aggression test and their latency to attack was substantially higher than 
observed in normal lactating rats (pup-sensitized virgins=1541.00±106.00, vehicle 
group of experiment 6.2=167.30±36.9secs; p<0.001, t-15.6). Thus, there was no 
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significant difference in display attack behaviour between the treatment groups 
(number of attacks p=0.10, H2=4.59). 
All pup-sensitized virgins displayed other forms of aggressive behaviour, 
including biting, clawing, lunging, rearing, pinning down but there was no difference 
between the treatment groups in total time exhibiting these behaviours (p=0.33, 
H2=2.22; non-surgical control=12.12±4.1%TT, vehicle=28.34±11.1%TT, 
BM=7.46±2.7%TT; Fig. 6.6). 
6.3.2.3 Maternal behaviour 
Maternal behaviour was quantified to ensure that virgin rats were still displaying 
maternal care towards the pup during the maternal aggression test. All virgin pup-
sensitized rats displayed some of the specific matern l behaviours during the 
maternal aggression test but there was no statisticl d fference between the treatment 
groups in the total time spent expressing all matern l behaviours (p=0.25, 
F(2,17)=1.55; Fig. 6.6) or nesting alone (p=0.20, F(2,17)=1.84; Fig. 6.7) therefore there 
is no effect of BM treatment or surgery on the ability to perform maternal behaviour. 
6.3.2.4 General behaviour 
BM treatment did not significantly alter general behaviour when examined as a 
percentage of total time compared to the vehicle treated and non-surgical control 
groups (p=0.055, F(2,18)=3.49; Fig. 6.6). There was no significant effect of surgery on 
general behaviour expression either (p=0.055, F(2,18)=3.49; Fig. 6.6). 
6.3.2.5 Response to aggression behaviour by the resident 
The percentage of total time displaying a behavioural response to aggression 
behaviour from the intruder was significantly higher following BM treatment 
compared with the non-surgical control group (p=0.019, H2=7.90; Fig. 6.6) but not 
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the vehicle treated group (p>0.05, H2=7.90; Fig. 6.6). There was no significant effect 
of surgery when the non-surgical control group was compared to the vehicle treated 
group (p>0.05, H2=7.90; Fig. 6.6). The duration of freezing behaviour in BM treated 
virgins was also statistically higher when compared to the non-surgical control group 
(p=0.014, H2=8.48; Fig. 6.6) but not to the vehicle treated group (p>0.05, H2=8.48; 
Fig. 6.6). 
6.3.2.6 Fos expression 
Fos expression following maternal aggression was quantified in the same specific 
brain areas as those investigated for lactating rats following BM administration. In 
the BnST, Fos expression in BM treated pup-sensitized virgin rats was significantly 
increased in comparison to both the non-surgical control and vehicle treated groups 
(p=0.029, F(2,16)=4.61; Fig. 6.8 and 6.9). Fos expression did not differ between the 
treatment groups in any other area (LS p=0.16, H2=3.64; SON p=0.84, H2=0.35; 
MPOA p=0.99, F(2,17)=0.01; MeA p=0.90, F(2,18)=0.12; CeA p=0.088, H2=4.86; PVN 





Figure 6.6: Average percentage of total time spent exhibiting different behaviours by 
the resident pup-sensitized virgin female rat following ICV administration of 
bicuculline methiodide. Pup-sensitized virgin female rats that were confirmed as fully 
maternal were injected with 5µl of bicuculline methiodide (BM: 1mg dissolved in 50ml sterile 
physiological saline) or vehicle (physiological saline) by means of a Hamilton syringe through 
an internal cannula into the lateral ventricle 3 min prior to a 30 min maternal aggression test. 
The non-surgical control group were left untreated prior to being subjected to a 30 min 
maternal aggression test. Pie charts depicting the mean percentage of total time of the 
maternal aggression test spent exhibiting aggressive, maternal, response to aggression or 
general behaviours by the pup-sensitized resident virgin female rat (bicuculline methiodide 
n=5, vehicle n=5, non-surgical control n=8) in her home cage with her pups present. One 
should note the significantly higher percentage of total time the BM treated group spent 




















































































































































































































































Figure 6.7: Average time spent sniffing or nesting during a maternal aggression test 
by the resident pup-sensitized virgin female rat following administration of bicuculline 
methiodide. Virgin female rats one day after being confirmed as fully maternal following 
sensitization to donor pups in their home cage and that were cannulated were injected with 
5µl of bicuculline methiodide (1mg dissolved in 50ml sterile physiological saline) or vehicle 
(physiological saline) by means of a Hamilton syringe through an internal cannula into the 
lateral ventricle 3 min prior to a 30 min maternal aggression test. The non-surgical control 
group were left untreated prior to being subjected to a 30 min maternal aggression test. 
Average time in seconds spent sniffing the novel virgin female intruder or nesting on donor 
pups by the pup-sensitized resident virgin female rat (Biucuclline Methiodide n=5, vehicle 
n=5, non-surgical control n=8) in her home cage during a maternal aggression test. Data are 






































































































































































































































































































































































Figure 6.8: Average number of Fos positive cells in specific brain areas of the resident 
pup-sensitized virgin rat following a maternal aggression test and ICV administration 
of bicuculline methiodide. Virgin female rats were sensitized to 3 donor pups in their home 
cage until they displayed full maternal behaviour. One day after being confirmed as fully 
maternal,  cannulated pup-sensitized virgin female rats were injected with 5µl of bicuculline 
methiodide (1mg dissolved in 50ml sterile physiological saline) or vehicle (physiological 
saline) by means of a Hamilton syringe through an internal cannula into the lateral ventricle 3 
min prior to a 30 min maternal aggression test. The non-surgical control group were left 
untreated prior to being subjected to a 30 min maternal aggression test. Expression of Fos in 
the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area 
(MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA 
respectively), parvocellular paraventricular nucleus (PVN) and periaqueductal grey area 
(PAG) of Bicuculline Methiodide (n=5) or vehicle (n=5) treated or non-surgical control (n=8) 
groups was quantified using Fos immunocytochemistry on brains perfused 90 min after 













Figure 6.9: Photographs of Fos positive cells in bed nucleus of stria terminalis pup-
sensitized female virgin rats after a maternal aggression test and ICV administration 
of bicuculline methiodide. Pup-sensitized virgin female rats that were confirmed as fully 
maternal were injected with 5µl of bicuculline methiodide (1mg dissolved in 50ml sterile 
physiological saline) or vehicle (physiological saline) by means of a Hamilton syringe through 
an internal cannula into the lateral ventricle 3 min prior to a 30 min maternal aggression test. 
The non-surgical control group were left untreated prior to being subjected to a 30 min 
maternal aggression test. Photographs depicting Fos positive cells in the BnST in the non 
surgical control (n=8, A), vehicle (n=5, B) or bicuculline methiodide (n=5, C) treated pup-
sensitized female virgin rats following a 30 min maternal aggression test. D shows a lower 
power photograph of the BnST area (marked with dashed lines). Scale bars = 50µm. 
Abbreviation: AC= anterior commisure, LV= lateral ventricle, 3V = third ventricle. 
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6.4 Mapping GAD containing cells in the maternal agression circuitry in the 
lactating rat 
6.4.1 Method 
Brains were collected from lactating rats perfused 90 min that were subjected to a 30 
min maternal aggression test (AT; n=9) or left undisturbed (NAT; n=8) with their 
pup present. Fos and GAD65/67 double ICC was performed as described in the 
Chapter 2 and examined in the LS, BnST, MPOA, SON, MeA, CeA, PVN and PAG 
(brain regions already linked to maternal aggression). For rats exposed to a maternal 
aggression test, aggressive behaviour was analysed to nsure it was expressed at 
levels previously recorded. 
6.4.1.1 Statistics 
A T-test was performed to compare values for the two groups when the data was 
normally distributed. If data was not normally distributed, a Mann-Whitney Rank 
Sum test was performed instead. Results were deemed statistically significant if 
p≤0.05. 
6.4.2 Results 
6.4.2.1 Aggressive behaviour 
Aggressive behaviour in aggression tested rats was comparable to levels observed in 
vehicle treated lactating rats from the AP and matern l behaviour study (chapter 4). 
The average latency to attack was 194.0±63.6 secs (vehicle group for AP and 
maternal aggression experiment was 167.1±38.8; p=0.86, T(9,9)=88.0) and average 
number of attacks was 10.0±2.3 (vehicle group for AP and maternal aggression 




6.4.2.2 GAD65/67 and Fos positive cells expression 
There were significantly fewer GAD65/67 cells activa ed in the SON (p=0.013, t2.92; 
NAT=18.77±1.6, AT=13.50±1.0; Fig 6.10 and 6.11) but significantly more in the 
MeA (p<0.001, T(7,8)=41.00; NAT=11.57±0.9, AT=25.12±2.1; Fig. 6.10 and 6.11) 
following an aggression test. 
There was no significant difference in the number of cells double labelled for 
GAD65/67 and Fos observed in the BnST (p=0.24, t1.23), LS (p=0.84, t0.21), MPOA 
(p=0.53, t-0.65), CeA (p=0.21, t-1.32), Parvocellular (p=0.46, t(7,8)=49.00) or 




























































































































































































































































































































































































































Figure 6.10: Average number of Fos and GAD 65/67 positive cells in specific brain 
areas of the resident lactating rat following a maternal aggression test. Lactating rats 
were subjected to a 30 min maternal aggression test or left in their home cage undisturbed 
with their pup present (n=8-18). Expression of Fos and GAD65/67 cells the lateral septum 
(LS), bed nucleus of stria terminalis (BnST), medial preoptic area (MPOA), supraoptic 
nucleus (SON), medial and central amygdala (MeA and CeA respectively), parvocellular 
(parvo) and magnocellular  (magno) paraventricular nucleus (PVN) and periaqueductal grey 
area (PAG) of aggression tested (AT, n=9) and non aggression tested (NAT, n=8) rats was 
examined using double immunocytochemistry on brains perfused 90 min after behavioural 










Figure 6.11: Photographs of double labelled GAD65/67 and Fos positive cells in the 
supraoptic nucleus of lactating rats following a maternal aggression test. Photographs 
depicting Fos positive cells in the supraoptic nucleus (defined by black dashed line, as 
shown in A) in the lactating rats (non aggression tested, n=8, and aggression tested, n=9; B 










Figure 6.12: Photographs of double labelled GAD65/67 and Fos positive cells in the 
medial amygdala of lactating rats following a maternal aggression test. Photographs 
depicting Fos and GAD65/67 positive cells (black arrows) in the medial amygdala (defined 
by black dashed line) in the lactating rats (non aggression tested, NAT, n=8, and aggression 
tested, AT, n=9) at low (A and B) and high (C and D) power. Scale bars = 50µm. 




Blocking GABA neurotransmission using the antagonist BM did not decrease 
number of attacks or latency to attack, but did significantly decrease total time spent 
displaying aggressive behaviour in lactating rats. BM treatment decreased the 
duration of lunging and rearing behaviours in particular. This is in accordance with 
Hansen and Ferreria (1986) who reported a significat decrease in frequency of 
lateral posture behaviour in lactating rats following direct injection of BM into the 
ventromedial hypothalamus and amygdaloid complex [390]. However in their study 
they do not mention upright or rearing behaviour so it is unknown whether they 
observed the same difference as the present study did [390]. In male aggression, 
Depaulis et al (1985) reported a decrease in duration in what they ermed offensive 
sideways and upright posture behaviours, probably similar to the effects in the 
present study [471].  
Similarities between changes in general behaviour in the BM treated lactating 
rat in the present study and the BM treated male can also be observed. A significant 
decrease in self grooming behaviour was found in BM treated lactating rats. This is 
in agreement with the results reported for male rats following administration of BM 
where cage exploration was increased and allogrooming was decreased [471]. Thus, 
the results of this study support the hypothesis that GABA neurotransmission 
enhances the expression of certain offensive aggressive behaviours.  
It was mentioned in the introduction that GABA agonists, muscimol and 
baclofen, reduced maternal aggression, however this wa  only significant when 
examining percentage level of aggression [438]. There was no difference in number 
of attacks or latency to attack [438]. There is no analysis of individual aggressive 
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behaviours discussed, i.e. offensive (such as lunging, biting) or defensive (such as 
escape), so it is unknown in what specific aspect of maternal aggression this decrease 
occurred. Hence it may have been in defensive behaviours, which would be in 
keeping with the current theoretical idea that GABA enhances offensive behaviours 
whilst decreasing defensive ones. This form of control is not restricted to the rat. In 
the cat, direct administration of the GABA agonist, muscimol, into the PAG 
decreased the affective defence response but had no effect on the active biting 
predatory attack (offensive) responses [473].  
During pregnancy and parturition, there are dramatic changes in the GABAA 
receptor complex that impact upon its functioning. During pregnancy there are 
significant decreases in the amount of mRNA of GABAA receptor subunits γ2l and 
α5 in the cerebral cortex, however at term these return to normal levels [443]. When 
the γ subunit is present in the GABAA receptor complex, an increase in the GABAA 
receptor sensitivity to benzodiazepines has been fou d. If both γ and α5 subunit 
included in the GABAA receptor complex, it expresses its highest affinity for GABA. 
Together these findings suggest that during pregnancy GABAA receptor functioning 
is decreased to protect from overstimulation by ovarian hormones and neurosteroids 
whose levels increase dramatically through pregnancy, only to return to normal at 
parturition in readiness for the control of maternal behaviour [346, 443]. This is 
supported by the evidence that not only application of a GABAA receptor antagonist, 
BM in this present study, but also administration of benzodiazepine antagonists is 
able to decrease aggression during lactation [237]. 
Examination of activated GAD65/67 cells after a maternal aggression test 
highlighted two brain regions where GABA neurotransmission may be acting to 
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control maternal aggression, namely the SON and MeA. In the SON, there was a 
decrease in the number of activated GAD 65/67 cells following maternal aggression. 
Within the SON there are a large number of GABAA receptors which inhibit OXT 
secretion [444, 454]. OXT, which is mainly secreted by the SON and PVN, is 
implicated as being essential for the control of maternal aggression [152, 188, 198, 
227, 265, 268, 269, 282, 320, 431, 439, 474]. Thus t e decreased activation of GAD 
65/67 containing cells within the SON may indicate th  disinhibition of GABA 
controlled OXT secretion within the SON to increase central OXT release to enable 
maternal aggression. Investigation of the effect of a direct application of GABA 
receptor antagonist on central OXT secretion and matern l aggression would 
elucidate whether this hypothesis was correct or not. 
Intracerebral infusions of BM into the amygdaloid complex of lactating rats 
reduces maternal aggression therefore the increase in activation of GAD65/67 cells 
in the MeA alone of lactating rats suggests this division of the amygdala may be 
important in the control of maternal aggression [390]. Future experiments should 
examine the effects of direct infusions of BM into this area on maternal aggression. It 
would be advisable to first perform a dose response curve to accurately identify the 
correct dose [475, 476]. GABA is the main inhibitory neurotransmitter in the brain 
and hence impacts on many different functions not just behavioural ones, therefore a 
dose response curve should be performed to ensure the dosage of GABA 
administered will cause a behavioural effect but no dangerous side effects such as 
motor impairments.  
 The effect of BM on maternal aggression was also examined in pup-
sensitized virgin female rats to investigate whether  aggressive behaviour induced 
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by pup-sensitization is under the same GABAergic control as observed in lactating 
rats. However, only very low levels of maternal aggression were observed in pup-
sensitized virgin female rats with no difference between the treatment groups. This 
suggests, as observed in chapter 2, that pup-sensitization alone it not enough to 
induce maternal aggression in the virgin rat and inhibiting GABA neurotransmission 
does not affect this.  
Interestingly, there was a significant increase in time spent freezing in BM 
treated pup-sensitized virgin rats. As freezing is an expression of ‘fear-like’ 
behaviour, it is speculated that the GABA antagonist treatment could increase 
neophobia (fear of something new). This idea is further supported by the significant 
increase in Fos expression in the BnST following BMtreatment, an area important in 
fear regulation [105]. This is in concordance with the effects of GABAA receptor 
agonists on neophobia behaviour in male rats; application of GABAA receptor 
agonists increased time spent in open arms of a the EPM whereas the GABA 
antagonist (BM) decreased it [477]. Research has observed the pup-sensitized virgins 
rats do display reduced neophobia typical of lactating rats, so application of a GABA 
antagonist may have dampened this reduced neophobia induced by the pups [174, 
406]. To confirm this though, testing pup-sensitized virgin rats treated with a GABA 
antagonist in fear behaviour testing paradigms is required. One would predict 
treatment with a GABA antagonist would increase fear or neophobia compared to 
vehicle treatment. 
However, no difference was observed between BM and vehicle treated 
lactating rats in the expression of freezing behaviour. Reduced freezing behaviour in 
lactating rats is thought to be partly due to the leve  of interaction with pups [42, 237, 
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390]. Therefore, the difference observed in anxiety behaviour display (freezing 
behaviour) between lactating and pup-sensitized virgin ats may be due to a lack of 
experience of specific pup behaviours which involve high levels of pup interaction 
such as suckling. Suckling is known to enhance GABA action, resulting in increased 
aggression [390].   
This is interesting in relation to the data presented in the previous chapter. AP 
treatment reduced anxiety in lactating rats by potentiating GABAA receptor 
functioning proposed to be necessary for allowing aggressive behaviours to be 
expressed. This suggests that GABA may not only have a direct role over maternal 
aggression, especially certain offensive behaviours, but also indirectly through the 
actions of AP which enhance aggression by reducing anxiety via GABAA receptors.  
 In conclusion, GABA neurotransmission around the peri- artum period has 
many important functions. During pregnancy, its inhibition of OXT neurons ensures 
there is no early delivery allowing full development of the unborn pups. In addition, 
GABAA receptor potentiation through AP reduces anxiety in the pregnant mother 
preventing overstimulation of the HPA axis and therefo e harmful steroids passing to 
the developing fetus [34, 36]. At term, disinhibition by GABA is essential for 
allowing the increase in OXT secretion to allow parturition and lactation to occur.  
In terms of specific maternal behaviours, inhibition of GABA 
neurotransmission appears important for pup retrieval and nursing [416, 438]. 
However, for maternal aggression enhancement of GABA neurotransmission is 
required [158, 237, 390]. It may be that these two features of GABA 
neurotransmission are interlinked in controlling maternal behaviour. For example 
suckling has been shown to affect the pathways projecting from the peripeduncular 
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nuclei resulting in enhancement of GABA neurotransmis ion in the amygdala which 
may be necessary for the display of aggression [390]. This enhancement in the 
amygdala may in turn cause an increase in GABA neurotransmission to areas such as 
the MPOA which control maternal care, to switch offther maternal behaviours 
allowing expression of only maternal aggression. When aggression diminishes, the 
decrease in GABA neurotransmission in the amygdala turns off GABA 
neurotransmission to the MPOA allowing the expression of other maternal 
behaviours. The amygdala and MPOA are used as examples here because they are 
two brain areas with clear maternal behavioural functio s linked with GABA 
neurotransmission; in the MPOA, which is important for maternal care, enhancement 
of GABA neurotransmission decreases pup related behaviours [416, 438]. In the 
amygdala inhibiting GABA neurotransmission results in a decrease in the display of 
aggression [390]. It also should be noted that both regions display an increase in 
activation in GAD65/67 cells following maternal behaviour (MPOA) and aggression 
(MeA) respectively. Such findings however do not tell us how these neurons are 
acting, they may be projecting an inhibitory input to another area or act locally [355]. 
Retrograde tracer injections would enhance our knowledge as to how and where 
these inhibitory neurons may be located.  
GABA neurotransmission is therefore important and critical during the 
lactation period; it is required for both maternal behaviour and aggression. Maternal 
behaviour may be switched off whilst aggression is di played with both being 




Chapter Seven: General Discussion 
 
7.1 Maternal aggression: expression of behaviour 
 
One of the main aims of this thesis was to build a complete picture of the changes in 
maternal aggression during the peri-partum period in the rat. Comprehensive 
examination of maternal aggression throughout the peri-partum period has provided 
data to construct Fig. 7.1a. This now allows for direct comparisons with mice in 
which maternal aggression through the peri-partum period is already clearly defined 
(Fig. 7.1b) [6, 54, 169]. Maternal aggression peaks during the first week of lactation 
in both rats and mice, however in rats just prior t parturition, a small peak in 
maternal aggression is observed whereas the intensity of aggression in mice remains 
low. On the day of parturition there is a dip in the intensity of maternal aggression 
before rising to its peak the day after. Maternal aggression in rats starts to recede 
earlier than in mice with diminishing maternal aggression levels observed from the 
start of lactation week two. This is not seen in mice until midway through lactation 
week two. The difference in the expression of maternal aggression between these 
rodent species highlights the possibility that neuromodulators may control maternal 
aggression differently between species. 
This thesis has for the first time clearly defined the expression of each 
specific component of maternal aggression throughout the peri-partum period and 
also following pup removal (chapter 4 and 3 respectiv ly). With these data, direct 
comparisons can be made between lactating rats under diff rent experimental 
conditions. In this thesis, maternal aggression is observed to diminish in lactation day 
21 rats to levels similar to those expressed by lactation day 7 rats (chapter 4), whose 
































Figure 7.1: Maternal aggression levels throughout the peri-partum period in rats and 
mice. Schematic diagrams of the change in maternal aggression levels through pregnancy, 
parturition and lactation in rats (A) and mice (B). A is derived from data in chapter 3 of this 
thesis and B is modified from Gammie and Lonstein (2006) [54]. Maternal aggression in rats 
has a small peak during late pregnancy before dipping slightly on day of parturition and then 
intensifying for greatest maternal aggression expression during the first week of lactation. 
Maternal aggression then diminishes by lactation day 14 in rats. Mice, by contrast, show a 
gradual rise in maternal aggression during late pregnancy before dropping back down to 
very low levels on the day of parturition. Maternal aggression then reaches peak expression, 
like rats, in the first week of lactation before gradually diminishing by lactation day 20 slightly 
later than in rats. 
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latency to attack p=1.0, T(8,9)=57.0). From this, one can propose that not only does 
the exhibition of maternal aggression depend on the s age of the peri- partum period 
the female rat is at, but also on significant input from the pups. This is important 
evidence to support the idea that the hormonal changes of pregnancy and parturition 
in the body and the brain ‘prime’ the future mother to respond to pup cues at 
parturition. These cues then maintain maternal aggression and other maternal 
behaviours through lactation [3, 44, 51, 56, 180, 184, 348, 400, 478]. Pup removal 
for 6h in this thesis resulted in significant reduction in maternal aggression; others 
have observed a significant decrease by 4h leading to the conclusion that between 4 
and 6h after pup removal the mother switches off the ability to express maternal 
aggression.  
 The presence of pups has been proven to be necessary for lower neophobia 
and fear expression in both lactating and pup-sensitized female rats during anxiety 
and fear behavioural testing paradigms; reduced neophobia and fear is proposed to be 
essential for maternal aggression [42, 174, 210, 39406]. Many studies observe a 
decrease in anxiety when maternal aggression intensity is high in lactating mice and 
rats [29, 31, 32]. However, this reduced neophobia and fear phenotype is not always 
seen alongside high levels of maternal aggression. Therefore lower neophobia may 
only be essential at parturition in order to initiate the onset of maternal behaviour (a 
pre-requisite for maternal aggression) [15, 206-208, 400]. But once maternal 
behaviour and therefore maternal aggression begins, pup cues maintain maternal 
aggression so the lower neophobia phenotype is not a necessity [169, 179, 190]. 
Indeed, as discussed in the introduction of chapter 3, olfactory and sensory cues from 
pups are essential in maternal aggression maintenanc  with different regulatory 
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effects in mice and rats during lactation [169, 179, 184, 188, 190, 225, 400]. This 
does not rule out the possibility that there may be sp cies or strain differences. 
Therefore further research is still needed to investigate the true link between fear, 
neophobia and maternal aggression in the lactating rodent.  
Removal of pups for 24h results in maternal aggression levels similar to those 
observed on lactation day 21, but little is known about what changing cues from pups 
causes the natural decline of maternal aggression. Pup cues must be able to regulate 
the intensity of maternal aggression as lactation day 8 rats who fostered 18 day old 
pups expressed lower maternal aggression compared to lactation day 8 rat with 8 day 
old pups [191]. This indicates that cues from pups must contain information about 
their age, or more likely ‘independence’ and it is his which is crucial in controlling 
the intensity of maternal aggression. Olfactory cues are also expected to play a role. 
One way to examine this would be to observe maternal aggression in rats late on in 
lactation whose pups were immobilised. If unchanging olfactory cues were the most 
important factor then there would be no change in the intensity of maternal 
aggression. If physical and visual cues are important then one would expect mothers 
whose pups were mobile to express significantly less maternal aggression than 
mothers whose pups were immobile. 
 Input from pups is essential in maintaining maternal aggression and 
preventing the switch off of maternal aggression until the required time (i.e. late 
lactation), but where the pup cues act in the brain is as yet undefined. Pup removal 
for 2h resulted in significantly lower Fos expression within the BnST, MeA, SON 
and PVN indicating these regions may be highly sensitive to pup cues. Furthermore, 
significant positive correlations between Fos expression in these brain regions and 
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the time spent expressing specific maternal aggression behaviours are further 
evidence that pup cues may work through these brain regions to regulate maternal 
aggression (section 7.3 will discuss further how these brain regions are proposed to 
be involved in the maternal aggression neuro-circuit y).  
This thesis describes observations, along with previous research, that 
although maternal behaviour is easily induced in virgin female rats by constant 
exposure to pups, maternal aggression is not [10, 174]. Pup-sensitized virgins 
expressed most if not all of the specific maternal aggression components in both the 
GABA antagonist experiment (chapter 6) and pup removal experiment (chapter 3), 
however the observed levels are only comparable to dams with pups removed for 24h 
or lactation day 21 dams. Yet, previous studies have observed that pup-sensitized 
virgins express a fear and neophobia profile similar to lactating rats when their pups 
are present [42, 174, 390, 406]. Furthermore, Fos expression in the PAG and PVN of 
pup-sensitized virgin rats with pups present during maternal aggression testing was 
not significantly different from lactating rats with their pups present (chapter 3). 
Thus pup-sensitized virgins display lower fear and neophobia levels (and more 
activation in brain regions which control fear and eophobia) proposed to be 
essential for enabling maternal aggression, but some ther component is missing, 
hypothesised to be the hormonal influences of pregnancy, preventing the full 
expression of maternal aggression.  
Previous research has shown the importance of ovarian hormones; if a pup-
sensitized rat is treated with estrogen and progesterone to mimic pregnancy, attack 
behaviour increases [53]. Indeed, pup-sensitization for 18 days will induce higher 
levels of maternal aggression; this long period of pup-sensitization induces a 
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pseudopregnant state at the time of maternal aggression testing [172]. 
Pseudopregnancy causes hormonal changes similar to those observed during 
pregnancy hence this could explain why the higher level of maternal aggression is 
observed [172]. However, because the full suite of maternal aggression behaviour 
was not observed, and a lengthy pup-sensitization period is required before maternal 
aggression is expressed, other neuromodulators mustalso have an important role. 
Evidence for which particular neuromodulators may be involved in regulating 
maternal aggression is discussed in the next section but the pup-sensitized virgin rat 
model provides an excellent means to examine the relationship between 
neuromodulators and maternal aggression. The pup-sensitiz d virgin rat does not 
experience the hormonal changes of pregnancy (unless exposed to pups for a long 
time); so they will be expected to have baseline circulating levels of hormones and 
neuromodulators. Thus the effect of administering a specific neuromodulator either 
brain wide or to specific brain regions on maternal aggression expression can be 
examined. 
 
7.2 Maternal aggression: neuromodulator control 
Oxytocin 
From the summary figures 7.2 and 7.3, it can be observed that there are significant 
changes in the OXT, AVP, AP or GABA systems in the brain following maternal 
aggression testing. 
Many changes are observed in the central OXT system that are correlated 
with maternal aggression in the lactating rat. Fig 7.4 summarises the changes in the 
OXT system in different brain regions in an aggressive lactating rat from data 
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collected during this thesis. OXT is therefore important in the control of maternal 
aggression but the mechanisms by which OXT works to regulate maternal aggression 
still remain uncertain.  
OXT has a great influence over the HPA axis activity and was proposed to be 
important for the blunted HPA axis response to a stres or during lactation [126-129, 
227],[35]. However, ICV OXT antagonist administration has no effect on the HPA 
axis response to stressors in the lactating rat, but OXT antagonist treatment does 
affect their anxiety behaviour [35]. Hence OXT may enable maternal aggression to 
be displayed by reducing fear but the link between f ar, anxiety and maternal 
aggression needs to be investigated further. However, th re is evidence from the 
established changes within the OXT system at parturition that could account for the 
reduction in fear and anxiety necessary for the onset of maternal behaviour. In this 
thesis, OXT binding is increased in the BnST and MPOA on day 21 of pregnancy 
and previous research has shown that OXT antagonist treatment prevents the onset of 
maternal behaviour [131, 316, 317]. The BnST and MPOA are essential for driving 
maternal behaviour control because direct lesions in these brain regions result in 
impairment of all maternal behaviour [27, 67, 79]. OXT may therefore work in or 
through the BnST and MPOA to reduce fear and anxiety to enable the mother to 
approach her pups as soon as they are born, and express maternal behaviour.  
Increased OXT secretion in the PVN on day 19 of pregnancy was observed 
only during a maternal aggression test. The pregnant rat therefore may increase OXT 
secretion to reduce fear and anxiety in response to a s ressor but examination of OXT 
secretion in the PVN of a virgin rat during a residnt-intruder paradigm is required to 






= increased double labelling for Fos and 
OTR
= decreased binding
= increased AVPv1a receptor expression
 
Figure 7.2: Changes in the oxytocin and vasopressin systems in specific brain 
regions of the female rat after maternal aggression testing. Figure A depicts the 
significant alterations in Fos and OTR expression, oxytocin binding and secretion in specific 
brain regions of the female rat during the peri-partum period after maternal aggression 
testing. Figure B shows the different changes in the vasopressin V1a receptor mRNA 
expression, vasopressin secretion and binding in specific brain regions of the lactating rat 
after maternal aggression testing. 
 256 
 
Figure 7.3: Changes in the GABA and allopregnanolone systems in specific brain 
regions of the female rat after maternal aggression testing. Figure A depicts the specific 
brain regions which exhibited a significant higher number of Fos and GAD 65/67 cells in the 
female lactating rat after maternal aggression testing. Both figures depict the specific brain 
regions which showed significant changes in Fos expression (higher or lower) after 
application of a GABA antagonist or AP (figures A and B respectively) in the lactating or pup-
sensitized virgin female rat after maternal aggression testing.  
= increased double labelling for Fos and 
GAD65/67 
= increased Fos after MA 




activity so that the developing fetus is not exposed to the deleterious effects of 
glucocorticoids. However, no changes in OXT binding  the PVN or PAG were 
observed during the peri-partum period, two regions k own to be important in 
expression of fear and anxiety and regulation of the HPA axis. Therefore, further 
research should focus on where and how OXT may act to induce a reduced fear and 
anxiety phenotype at the correct time during the peri- artum period. 
Furthermore, this action of OXT in reducing fear and anxiety pre-partum to 
enable maternal aggression post-partum does not explain why there is an increase in 
OXT secretion in the BnST and PVN during maternal aggression testing on lactation 
day 4. Or why increased Fos expression was observed in OXT sensitive neurones in 
the BnST, LS and MeA of the lactating rat during maternal aggression testing. As 
OXT is not modulating the HPA axis response to the intruders which may be viewed 
as a stressor, this increased OXT secretion must have functions elsewhere in the 
brain [35]. The PVN and BnST are known to project to he PAG and LS which has 
OXT sensitive neurones and hence may OXT influence the actions of the motor 
control aspect of maternal aggression [90, 308, 479-483].  
There is an increase in the activation of OTR containing cells in aggressive 
lactating rats in the LS, but no difference was found in the PAG. However further 
research is required before the idea that OXT may modulate the motor control of 
maternal aggression can be totally ruled out, as non-aggressive lactating rats was still 
performing other maternal behaviours which may still require the action of the OXT 
sensitive cells in the PAG. Therefore, investigation of OXT secretion in the PAG by 
microdialysis during a maternal aggression test in the lactating rat is required. Also, 
by further experiments that examine the effects of direct OXT or OXT antagonist 
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treatment into the PAG on the display of maternal aggression would establish if this 
theory that OXT can modulate the motor output of maternal aggression is correct. 
In the LS, OXT secretion does not change during matern l aggression testing 
despite an increase in OXT binding on lactation day 4-7 and increase in Fos 
activation in OXT sensitive cells. This suggests that OXT sensitive neurones that are 
important for the maternal aggression circuitry may project through the LS. Tracer 
studies would enable the identification of where thse OXT projections come from. 
Recently, direct administration of a GABA antagonist to the LS decreased maternal 
aggression in mice suggesting that GABA functioning  the LS may directly 
influence upon maternal aggression [387]. However, no changes in maternal 
aggression or Fos activation in the LS were observed after AP or finasteride 
treatment suggesting that GABA neurotransmission has no effect on maternal 
aggression in the lactating rat. Although this does not rule out that the possibility this 
GABA may function in the LS to increase maternal aggression and this may be 
independent of AP influences. Nonetheless, there were no differences in Fos 
activation in GAD65/67 containing cells in the LS between aggressive and non-
aggressive lactating rat. This could be an example of a neuromodulator controlling 
maternal aggression differently in individual species as in mice direct application of 
BM to the LS significantly reduces maternal aggression; to confirm this investigation 
of the effect of a GABA antagonist directly applied to the LS of a lactating rat on 
maternal aggression is required. 
Allopregnanolone and GABA 
One neuromodulator that may control the blunted respon e of the HPA axis 
to stress during lactation is AP. Although there were only minor effects observed on 
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maternal aggression after AP or finasteride application, Fos expression was 
significantly lower in the PVN and PAG of lactating rats following a maternal 
aggression test. This reduction in Fos expression, especially within the PVN, could 
reflect the action of AP preventing the activation of the HPA axis in response to the 
intruder. During pregnancy, AP is known to prevent a HPA axis responses to an 
immune stressor [199]. Research should therefore focus n investigating if AP has a 
direct effect on the HPA axis response to a stresso during lactation. This could 
indirectly enable maternal aggression, therefore the actions of AP in influencing 
maternal behaviour directly or indirectly still warr nts further investigation. 
 One way in which AP may directly modulate maternal aggression is through 
its actions on GABA receptors which are already established in regulating 
neophobia and fear [356-359, 361]. Subcutaneous AP administration to lactating rats 
before maternal aggression testing resulted in a decrease in Fos expression in the 
BnST and an increase in attack number. The BnST is involved in the long term 
control of fear so the decrease in Fos expression may reflect inhibition of the BnST 
by GABA to attenuate fear allowing increased maternal aggression [105]. In pup-
sensitized virgin rats, however, bicuculline methiodide (BM) treatment caused an 
increase in freezing (indicating fear) and an increase in Fos expression in the BnST 
compared to vehicle treated pup-sensitized virgins during a maternal aggression test. 
This suggests that GABA neurotransmission inhibition increases fear in conjunction 
with an increase in BnST activity [105]. Examining the effects of BM treatment to 
the pup-sensitized rat in anxiety behaviour paradigms would test if this theory is 
correct. To show it is the actions of AP controlling GABA actions on fear, testing the 
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effect of direct AP injections into the BnST prior to testing fear responses in the 
lactating rat is required.  
Administration of AP also increased Fos expression within the CeA, an area 
well established as part of the fear circuitry [84, 95  375, 423, 440, 484, 485]. Thus, 
AP may directly influence maternal aggression by regulating fear in the BnST and 
CeA through its effects on GABAA receptors. However there is substantial evidence 
linking OXT actions in the CeA to maternal aggression whereby only a small effect 
of AP administration was observed. One could propose though that AP may provide 
a backup to OXT through its ability to manipulate GABA actions within the BnST 
and the CeA. Thus future research should investigate the effects of applications of 
GABA, AP and OXT agonists and antagonists directly into the CeA to establish if 
this theory is correct. 
Vasopressin 
 AVP plays an important role in regulating maternal aggression. As proposed 
in the discussion of chapter 4, the actions of AVP on maternal behaviour are the 
opposite to OXT. AVP binding decreased on pregnancy day 21 in the MeA, a region 
important for processing olfactory information [30, 70]. Olfactory cues from pups 
processed by the MeA are proposed to inhibit aggression in virgin rats [30, 70, 89, 
98-100]. Pregnancy day 21 is the time when maternal esponsiveness increases, 
hence the decrease in AVP binding may reflect the switch in MeA processing of 
olfactory inputs from pups as fearful to salient to enable maternal behaviour 
immediately after parturition. Interestingly, AVP binding in the CeA was increased 
at parturition as well as increased AVP V1a receptor mRNA expression. The CeA is 
involved in short term fear regulation so this may reflect a transient increase in fear 
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of the intruder preventing maternal aggression, but instead allowing the lactating rat 
to focus on her pups to create a strong mother pup bond [105]. This is proposed 
because on the day of parturition a drop in the level of maternal aggression is 
observed in the lactating rat. 
 All four (OXT, AVP, AP and GABA) neuromodulators studied in this thesis 
have an important role in regulating maternal aggression but the timing of their 
actions is critical and is evoked in response to specific stimuli. It is of course 
important to remember that these four neuromodulators are not the only cues 
involved in the regulation of maternal aggression as it is already established that 
prolactin, serotonin and dopamine are all implicated [188]. 
 
7.3 Maternal behaviour and maternal aggression: brain circuitry 
There are many brain regions indicated as being involved in the highly complex 
maternal aggression circuitry (see general introduction) and the results of this thesis 
and previous research lead to the proposed maternal aggression circuitry summarised 
in Fig. 7.4.  
 The hormonal experience ‘primes’ the rat to express maternal behaviour. This 
is required before maternal aggression can be expressed [15, 206-208, 400] . In the 
PVN and SON, the hormonal changes of pregnancy result in a hyporesponsive HPA 
axis to stressors and a reduced fear and anxiety phenotype [37, 38, 135-137]. This 
reduced fear and anxiety is important as it enables th  dam to approach pups 
immediately after parturition and hence initiate maternal behaviour. The PVN may 
centrally control the expression of fear and anxiety by regulating the activity of CeA 
and PAG. Projections from the PVN to the PAG are linked with the control of fear 
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and anxiety during lactation [308, 479]. These projections are related to the OXT 
system which links significantly with maternal aggression as discussed above [308, 
479]. Links between the CeA and fear expression are well established in connection 
to the OXT system [84, 95, 423, 440, 484, 485]. 
 The action of the MPOA is crucial to the onset of maternal behaviour [27, 67, 
79-83]. However evidence from this thesis indicates the MPOA does not play a 
direct role in the regulation of maternal aggression. No difference was observed in 
Fos expression following pup removal when maternal aggression diminishes over 
time. Instead significantly higher levels of Fos expression were observed in pup-
sensitized virgin female rats that spent longer time nesting than lactating dams during 
maternal aggression testing. Furthermore, Fos expression within the MPOA was not 
significantly correlated with the expression of any specific component of maternal 
aggression. Yet, previous studies have shown significa tly higher Fos and other IEGs 
expression within the MPOA following maternal aggression testing [12, 194]. This 
may indicate that the MPOA is required to switch off other maternal behaviours to 
allow the full suite of maternal aggression behaviours to be displayed, and therefore 
this means that the MPOA may have an indirect role in maternal aggression 
regulation. Further research is required to test thi  t eory, this would best be done 
through direct MPOA application of specific neuromodulators as direct MPOA 
lesions significantly disrupt maternal behaviour. Hence it would be hard to deduce 
whether the effects of the lesion on maternal aggression are due to poor maternal 
behaviour or direct impairment of maternal aggression.  
The MPOA may be central to the control of other maternal behaviours, but 
the BnST may be the brain region at the heart of the maternal aggression neuro-
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circuitry. Fos studies reveal that the BnST is highly activated during a maternal 
aggression test and Fos expression within the BnST was significantly lower 2h after 
pup removal. In addition, correlations between Fos expression and expression of 
specific maternal aggression components found the BnST to be positively related to 
most aspects of maternal aggression. The hypothesis that the BnST is central to the 
maternal aggression is still in its infancy and as indicated on Fig. 7.4 there are many 
connections between the BnST and other brain regions n relation to maternal 
aggression yet to be established. 
The PAG may control fear and neophobia, but positive correlations of Fos 
expression with the expression of specific maternal aggression behaviours clearly 
indicate it too has an important direct role in maternal aggression [141-145]. The 
PAG regulates motor function in the brain and hence on  could propose that the 
BnST receives olfactory information from pups via the MeA and passes that 
information onto the PAG which activates the motor aspect of maternal aggression 
[30, 70]. However, pup removal reduces Fos expression w thin the PAG after as little 
as 6h indicating the PAG is also sensitive to pups cues. As PAG lesions significantly 
disrupt nursing, licking and retrieval behaviour all of which involve sensory input 
from pups, it could be proposed that sensory information from the pups (also 
important in maintaining maternal aggression) passes through the PAG to the BnST 
which then process all the information before it drves maternal aggression [90-92, 
140]. 
These may seem to be conflicting roles for the BnST and PAG in that they 
both receive pup cues and are also directly regulating maternal aggression. This 
thesis, however, has only examined the BnST and PAGas whole regions. Like the 
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amygdala, both these regions can be divided into sub-regions and it may be that 
within specific sub-regions of the BnST and PAG that these proposed functions of 
the BnST and PAG are controlled.  
The MeA has links with both the inhibition and facilitation of maternal aggression 
[10, 12, 70, 98, 188]. Many studies observe a higher activation in the region 
following a maternal aggression test in lactating rats and mice [12, 188, 194, 196]. 
This was also observed in this thesis in the AP and maternal aggression and the 
maternal aggression and EPM experiments (chapters 5 and 3 respectively). 
Furthermore in this thesis, the level of Fos expression was significantly correlated 
with many specific aggressive components of maternal aggression. Therefore, there 
must be some switch that occurs in the MeA which changes it action from inhibiting 
maternal behaviour to enabling maternal aggression. It would appear that this 
influence is likely to be hormonal as Fos expression in lactating rats following a 
maternal aggression test was only significantly lower 24h after pup removal. This is 
proposed to be under the control of AVP as discussed in section 7.2. However, it is 
important to note that pup cues influence MeA activity as pup exposure alone will 
induce maternal behaviour in naïve virgin female rats hence overcoming the MeA 
inhibition [10, 70, 98].   
The MeA is involved in the flow of olfactory information to the MPOA and 
BnST from the OBs and hence is likely to be the crucial site for the processing of 
olfactory information from the pups to enable maternal aggression and maternal 
behaviour in lactating rats but prevent it in virgin female rats [70, 98, 402, 403]. 
Lesions of the OBs are able to significantly reduce the latency for virgin female rats 











































































































































































































































































































Figure 7.4: Maternal aggression circuitry. The flow chart depicts how the specific brain 
regions of the female rat brain are interacting to control maternal aggression during the 
lactation period. Firstly hormonal changes of pregnancy and parturition make the PVN and 
SON hyporesponsive to stressors. These regions project to the CeA and PAG to create a 
low anxiety and fear profile in the lactating rat. Pregnancy hormonal changes also prime the 
BnST to respond to information coming from the pups to enable maternal aggression by 
activating the LS and PAG areas. The cues from pups can be olfactory in nature, so will pass 
through and be processed by the olfactory bulb and MeA before reaching the BnST. There 
are also sensory cues (*) and these may be processed in the brain by the PVN before being 
passed along to the BnST. Connections in black are already established but connections 
depicted in blue are as yet to be clearly established in relation to maternal aggression. 
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indicated as involved this has not been proven [4, 30, 486].  
The LS is one area whose role in the maternal aggression circuitry remains 
unclear. Fos expression is increased during maternal aggression testing in the 
lactating rat and this expression positively correlat s with the expression of specific 
maternal aggression behavioural components. One current theory regarding the 
function of the LS is that it acts as ‘an effector’ in the maternal aggression circuitry, 
i.e. it enables maternal aggression, rather than ‘a mediator’ which controls maternal 
aggression [151]. The LS receives projections from the PVN and projections 
between BnST and MeA pass through the LS. Thus the LS could receive information 
from these regions informing it what component of maternal aggression to allow. 
7.4 Concluding remarks 
The circuitry for maternal aggression and maternal behaviour is highly complex and 
integrates many different brain areas which are involved in controlling the motor, 
motivational, fear and anxiety outputs (Figs. 7.2-74). This thesis has started to piece 
together how these brain regions influence each other; currently one would propose 
that the greatest influence on the neural circuitry comes from OXT and AVP which 
work oppositely to control maternal aggression by influencing by level of fear and 
anxiety in (Fig. 7.2). OXT is also indicated in control of the motor functioning of 
maternal aggression. Evidence in this thesis also implicates the involvement of AP 
and GABA especially in relation to fear regulation (Fig. 7.3). However, it remains 
unclear if these work in conjunction with OXT to enable maternal aggression or if 
they are a back up mechanism for OXT secretion malfunctioning. One hopes future 
research will be able to elucidate how these all integrate and impact upon each other 
to control maternal aggression and maternal behaviour.  
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By understanding the maternal aggression neural circuitry and the influences 
of neuromodulators on its regulation, would provide a means to manipulate maternal 
aggression by administration of specific neuromodulators. This knowledge could 
then be applied to the human mother and has the potential to create therapies for 
mothers who experience peri-partum disorders (for example postnatal depression) 
which disrupt their maternal care. Prevention and treatment of these disorders is not 
only beneficial to the mother to enable her to care for her offspring, but is also 
crucial for her offspring’s development to prevent adulthood disorders stemming 
from their early life experience. Such experiences an have a dramatic effect on their 











































Appendix One: Brief description of expression changes of maternal behaviour 
components during lactation period. 
 
Pup retrieval is immediately expressed in dams at a high rate at parturition, it 
declines between lactation day 12 and 16 when pups start opening their eyes and 
become mobile [1, 2, 7]. For proper expression of pup retrieval, rats require 
attachment to a stable nest area, as manipulation of ec logical conditions (e.g. 
temperature, light, air current or crowded social conditions) can result in movement 
of the nest location. This causes scattering of the pups and a decline in maternal care 
that may result in pup death [1]. Nursing is first expressed once all pups are born and 
cleaned and the nest is completed [1]. It generally starts with the dam licking the 
pups to induce them to attach to the presented nipple which will enable milk ejection. 
Nursing continues for two to three weeks but by the third week pups are gradually 
weaned [487]. During weaning, when pups try to initiate feeding the dam will 
prevent any access to mammary glands forcing pups to search for alternative food 
sources [1]. Nest building is the one maternal behaviour which normally occurs 
before parturition. As the dam prepares for birth an area will be cleared with small 
walls of bedding surrounding [1, 487]. Once parturition has occurred the nest is then 
fully formed and maintained until the second week of lactation when the pups 
become mobile and start to venture from the nest [1]. By the third week, there is no 
definable nest area as the large pups will generally huddle in their own groups 




























Appendix Two: Brain maps 
 
Below are rat brain maps, from The Rat Brain in Stereotaxic Coordinates by G. 
Paxinos and C. Watson, illustrating brain regions aalysed during the studies. 
 
Figure 1: Rat brain maps highlighting specific brain regions. Highlighted in the rat brain 
diagrams are the lateral septum (blue), bed nucleus of stria terminalis (red), medial preoptic 
area (orange), supraoptic nucleus (pink), paraventricular nucleus (parvocellular – fuchsia, 
magnocellular – dark purple), amygdala (medial – green, central – purple) and 







Appendix Three: Behavioural photographs 
 
The following pictures are examples of the different types of behaviour scored using 




    
Attack Biting Clawing/Punching Pinning Down 
 
   
Sniffing Lunging Rearing  
 
Response to Aggressive Behaviour: 
   
Freezing Escape Rearing Away 
 
Pup-related Behaviours 
     





     







Appendix Four: Behavioural analysis programs 
 
The graphical user interface used by the observer for analysing the behavioural 
videos. Figure 1 depicts the interface for Observer 5.0 and figure 2 for Observer XT 
7.0 used for analysing maternal behaviour or aggression videos. Figure 3 displays the 






















Table depicting timing 






selection of subjects 
or behaviour for 
recording. 
Timing of the video. 
 
Video controller to enable 
observer to pause, stop, fast 


























Video controller to 
enable observer to 
pause, stop, fast 
forward, rewind or 
slow down video. 
Table showing 
selection of subjects 
or behaviour for 
recording. 
Table depicting timing 






























The arena, in this case the 
EPM, is marked out (the 
yellow line) and labelled 
(the yellow tag, EPM). 
Each section of the arena is also 
outlined (blue lines) and labelled 
(the blue tags; e.g. Closed Arm 
2). This means when the 
computer is running a trial, it can 
automatically calculate time in 
the section, number of times 
entered, distanced moved within 





























information on trial 
running. 
The white outline 
depicts the EPM, 
which had been 
defined as seen in 
Figure 3. 
 
Behaviour can be analysed 
along side the EPM trial, 
these are the codes set up to 
score the behaviour. 
The rat is detected by setting pixel 
threshold levels for the appropriate 
size of the rat. If the rat is missing, 
i.e not picked up by the computer 
this will be shown in the trial 
information as sample missing. 
Settings can then be adjusted and 
the trial restarted. 
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Appendix Five: Solution recipes 
Recipes for solutions in materials and methods chapter: 
(All reagents were made using glass distilled water) 
Acetic Alcohol Fixative 
 10ml 40% Formaldehyde 
 5ml Glacial (100%) Acetic Acid 
 85ml Absolute Ethanol 
 
Heparinised Saline  
1000ml  Glass Distilled water 
9g   NaCl 
129mg  Heparin (Sigma) 
 
4% Paraformaldehyde in 0.1M Phosphate Buffer 
 40g   Paraformaldehyde 
 11.5g   Disodium hydrogen orthophosphate 
 2.72g  Sodium dihydrogen orthophosphate 
 1000ml  Distilled water 
 
15% sucrose in 4% Paraformaldehyde in 0.1M Phosphate Buffer 
 15g sucrose per 100ml of solution above. 
 
30% sucrose in 4% Paraformaldehyde in 0.1M Phosphate Buffer 
 30g sucrose per 100ml of solution above. 
 
1M Phosphate Buffer (PB; pH7.4):  
115g  Disodium hydrogen orthophosphate 
27.2g  Sodium dihydrogen orthophosphate 
 1000ml Distilled water 
 
0.1M PB (pH7.4) with 0.3% Triton X-100 (PB-T): 
 3ml   Triton X-100 
 1000ml  0.1M PB 
 
0.3% Hydrogen Peroxide: 
 99ml   0.1M PB 
 1ml  30% Hydrogen Peroxide 
 
1% Normal sheep serum:  
 99ml  PB-T 
 1ml  Normal Sheep Serum 
 
0.2M Sodium Acetate (pH 6.0): 
 16.4g   Sodium Acetate 





 0.08g  Ammonium Chloride 
 2.5g  Nickel Ammonium Sulphate 
 100ml  0.1M Sodium Acetate  
25mg   Diaminobenzidine tetrachloride (DAB; normally stored at  
25mg/ml) 
 
Slide Gelatinization Solution: 
 500ml   Distilled Water 
 2.5g  Gelatine 
 0.25g  Chromic Potassium Sulphate  
 
Oxytocin Receptor Fixative (OTR; 1L): 
 1000ml Glass Distilled Water 
10.2g  Disodium hydrogen orthophosphate 
3.85g  Sodium dihydrogen orthophosphate 
 40g  Paraformaldehyde 
 13.7g  L-Lysine 
 2.14g  Sodium m-periodate 
 
Acid Alcohol: 
 700ml  Alcohol 
 300ml  Distilled Water 
 10ml  Hydrochloric Acid 
 
Scott’s Tap Water Substitute (STWS): 
 1000ml Distilled Water 
 20g  Magnesium Sulphate  
 3.5g  Sodium Bicarbonate 
 
1% Eosin: 
 100ml  Distilled Water 
 1g  Eosin 
 
5% Potassium Aluminium: 
 100ml  Distilled Water 
 5g  Potassium Aluminium Sulphate 
 
50mM Tris Buffer (pH 7.4): 
 50ml  1M Tris  
 1000ml Distilled water 
 
Tris MgCL2 Buffer:  
 60.3g  Tris Base 
 20g  MgCL2 





0.1% Paraformaldehyde in 50mM Tris Buffer: 
 1g  Paraformaldehyde 
 1000ml 50mM Tris Buffer 
 
0.1% BSA in Tris MgCL2 Buffer:  
 0.1g  BSA 
 100ml  Tris MgCL2 Buffer  
 
All reagents are below autoclaved prior to use to reduce/eliminate RNase activity. 
0.1% DEPC- H20: 
 1ml  Diethylpyrocarbonate 
 1000ml Double Distilled water 
 
4% Paraformaldehyde in Phosphate Buffer Saline (pH 7.2):
 1000ml DEPC- H20 
 40g   Paraformaldehyde 
 8.0g   NaCl  
 0.2g  KCl 
 1.44g  NA2HPO4 
 
TE Buffer (pH 7.4): 
 1000ml Double Distilled water 
 10ml  1M Tris 
 2ml  0.5M EDTA 
 
10X TBE Buffer: 
 1000ml Double Distilled water 
 108g  Tris 
 55.7g  Boric Acid   
 4.7g  EDTA 
 
20X Saline Sodium Citrate (SSC; pH 7.0): 
 1000ml DEPC- H20 
 175.3g  NaCl 
 88.2g  Tri-sodium Citrate 
 
Deionised Formamide:  
 10g  Amberlite 
 100ml  ‘AnalR’ Formamide 
 
1M Dithiothretol (DTT): 
 0.82g  Dithiothretol 





Appendix Six: Correlation graphs between Fos expression in specific brain 
regions and expression of specific maternal aggression components 
Attack No vs SON 
Plot 1 Regr
BnST
Number of attacks during a 30 min MA test
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Figure 1: Correlations between number of attacks and Fos cells in specific brain regions of rats during a 
maternal aggression test. Graphs depicting Spearman correlations between the number of attacks and number of 
Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area (MPOA), 
supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular nucleus 
(PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have performed a 30 
min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female rats that were 






































































































































































































































































































Figure 2: Correlations between attack latency and number of Fos cells in specific brain regions of rats 
during a maternal aggression test. Graphs depicting spearman correlations between the attack latency (secs) 
and number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic 
area (MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have 
performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female 




































































































































































































































































































Figure 3: Correlations between attack duration and number of Fos cells in specific brain regions of rats 
during a maternal aggression test. Graphs depicting spearman correlations between attack duration (secs) and 
number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area 
(MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have 
performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female 






































































































































































































































































































Figure 4: Correlations between biting duration and number of Fos cells in specific brain regions of rats 
during a maternal aggression test. Graphs depicting spearman correlations between the biting duration (secs) 
and number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic 
area (MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have 
performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female 






































































































































































































































































































Figure 5: Correlations between clawing duration and number of Fos cells in specific brain regions of rats 
during a maternal aggression test. Graphs depicting spearman correlations between clawing duration (secs) and 
number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area 
(MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have 
performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female 

































































































































































































































































































Figure 6: Correlations between lunging duration and number of Fos cells in specific brain regions of rats 
during a maternal aggression test. Graphs depicting spearman correlations between lunging duration (secs) and 
number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area 
(MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have 
performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female 
rats that were perfused 90 min after the start of the behavioural testing. 
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PinningDownDuration vs SON 
Plot 1 Regr
BnST
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Figure 7: Correlations between pinning down duration and number of Fos cells in specific brain regions of 
rats during a maternal aggression test. Graphs depicting spearman correlations between pinning down duration 
(secs) and number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial 
preoptic area (MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), 
paraventricular nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats 
who have performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from 




































































































































































































































































































Figure 8: Correlations between rearing duration and number of Fos cells in specific brain regions of rats 
during a maternal aggression test. Graphs depicting spearman correlations between rearing duration (secs) and 
number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area 
(MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have 
performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female 
rats that were perfused 90 min after the start of the behavioural testing. 
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Figure 9: Correlations between sniffing duration and number of Fos cells in specific brain regions of rats 
during a maternal aggression test. Graphs depicting spearman correlations between sniffing duration (secs) and 
number of Fos positive cells in the lateral septum (LS), bed nucleus of stria terminalis (BnST), medial preoptic area 
(MPOA), supraoptic nucleus (SON), medial and central amygdala (MeA and CeA respectively), paraventricular 
nucleus (PVN) and periaqueductal grey (PAG) of lactating (n=30) and pup-sensitized (n=16) rats who have 
performed a 30 min maternal aggression test. Brains were collected for Fos immunocytochemistry from the female 
rats that were perfused 90 min after the start of the behavioural testing. 
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Appendix Seven: Chemical index 
Reagent Company Code 
Ab-2 Fos antibody  Calbiochem PC05-100µg 
Acetic anhydride Sigma A6404 
Allopregnanolone Steraloids P3800-000 
Amberlite  BDH 551794K 
Ammonium chloride  Sigma A4514 
‘AnalR’ formamide  BDH 103264R 
ATP, CTP, GTP Promega  
Bicuculline Methiodide Sigma 14343 
Biotinylated anti rabbit Ig Vector BA-1000 
Boric acid Sigma B7660 





sulphate 12 hydrate 
BDH 2775845 
Deionised Formamide Sigma F9037 







DPX mountant VWR 360294 
Disodium hydrogen  
orthophosphate  
BDH 103834G 
Dithiothretol (DTT) Sigma D9779 
Emulsion (Ilford) Calumet P9281 
Ethylene diamine 
tetracetic acid (EDTA) 
Sigma E7889 
Ethylene glycol Sigma 102466 
Finasteride Steraloids P3500-000 
GAD 65/67 antibody  Chemicon AB1511 
Gelatine  BDH 440454B 
Glycerol Fisher Scientific G/0600/17 
Heparin Sigma H0777-500KU 
Hydrogen peroxide (30%) Sigma H1009 
L-Lysine Sigma L5501 
Magnesium chloride Sigma M8266 
Magnesium sulphate Sigma M7506 
Methyl green Sigma M8884 
Nickel ammonium 
sulphate 
Fisher Scientific S/3160/63 
NICK column (Sephadex) Amersham 17-0855-01 
Normal sheep serum Sigma  S2263 
Oxytocin receptor Perkin Elmer NEX2540 10µCi 





Potassium chloride Sigma P3911 or 9541 
Progesterone 
radioimmunoassay 
Oxford Bioinnovations DSL 3900 
Salmon sperm DNA Sigma  D9156 
Simplex rapid liquid Kemdent ACR921 
Simplex rapid powder Kemdent ACR806 
Sodium acetate Sigma S9513 
Sodium bicarbonate Sigma S8875 




Sodium m-periodate Sigma  S1878 
Sucrose  Sigma  S7903 or 179949 
SYBR safe DNA gel stain Invitrogen 533102 
Toludine blue Sigma  
Triethanolamine Sigma T1377 
Tris Sigma T8524 
Tri-sodium citrate Sigma S4641 
Triton X-100 Sigma T9284 
Vasopressin receptor Perkin Elmer NEX3100 10µCi 
Vectastain ABC elite kit Vector Labs PK6100 
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